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The bridges between fields: chemical techniques applied to biological systems 
Scientific disciplines began diverging in the eighteenth century, emerging in the 
nineteenth century as dedicated funding for laboratories arose.1 Evolving specializations 
caused the distinctions between disciplines to intensify during the growth of academia.  
By the 1950s, scientists were noting—and sometimes lamenting—the resulting isolation.1 
Based on frequency of cross-discipline citations, the trend of division took a turn in the 
1970’s, and interdisciplinarity began to steadily rise.2 Bridges were built to re-establish 
relationships between the disciplines and participate in interdisciplinary research. 
Seeking to integrate the tools, concepts, and theories of complimentary fields, 
interdisciplinarity allows synergistic approaches. This is typified by collaboration, holistic 
understanding, and coordination.1 
Chemistry is perfectly poised to participate in these joint endeavors. Often focused on 
synthesizing material and measuring molecular-level events, chemical techniques can be 
readily adapted to probe questions from life science and test biological hypotheses. 
Modern fields like chemical biology and ecotoxicology draw from multiple disciplines, 
frequently involving an explicit connection between chemical methodology and biological 
inquiry.  
Herein, interdisciplinary chemistry is used to investigate three biological systems—each 
with a unique question. The questions range from cellular to ecological in scope and 
include both prokaryotic and eukaryotic organisms. However, they are unified by a central 
theme of connecting chemical tools and collaborative perspectives. In these approaches, 
chemical and biological data are woven together with complementarity to illuminate trends 
and mechanisms. 
A chemical toolbox 
The following chapters draw from synthetic organic chemistry as well as analytical 
chemistry in an integrated approach. Organic synthesis, broadly defined as the intentional 
construction of organic molecules using chemical reactions, is a classical tool of the 
chemist. The capacity to create new entities of matter and re-create naturally produced 




means to amass large quantities of pure biomolecules to facilitate in situ, in vitro, and in 
vivo studies. This is particularly vital when isolation of these molecules from natural 
sources requires astronomical opportunity cost. In the following chapters, organic 
synthesis is employed to facilitate simplified in vitro assays and verified instrumental 
detection of two classes of molecules.  
On the analytical front, mass spectrometry (MS) is a powerful technique that is widely 
applied to biological systems due to its high specificity and broad adaptability. In short, it 
revolves around the manipulation of charged particles to detect individual molecules by 
their mass. Ultra-performance liquid chromatography coupled with high resolution mass 
spectrometry (UPLC-HRMS) allows both temporal resolution and mass resolution of 
biomolecules to facilitate a technique which can confidently discriminate specific analytes 
within a complex sample. Due to these attributes, LC-MS is advantageous over other 
spectroscopic techniques for high-throughput analyses of many molecules in a 
convoluted matrix. The broad adaptability of MS has encouraged the development of 
various instrumental platforms featuring unique ionization mechanisms and mass 
analysis methods. For biomolecules with a high composition of heteroatoms, electrospray 
ionization (ESI) is the preferred method of ionizing liquid eluants from UPLC. Orbitrap 
mass analyzers rely on the Fourier transform of a frequency signal from oscillating ions 
to produce highly accurate mass identifications (<5 ppm). With UPLC, ESI and Orbitraps 
enable a highly modular platform for the analysis of biologically active molecules—
including both polypeptides and small molecules. Therefore, UPLC-ESI-HRMS is used in 
all three forthcoming chapters as an adaptable technique for detection and quantitation.  
Ecotoxicology of small molecules in the environment 
In the first part of this work (Chapter Two), the effect of biocide exposure on the 
environment is evaluated using chemical and biological data. It establishes the emerging 
common thread of developing chemical methodologies and applying them to address 
biological inquiries. This chapter relies more heavily on mass spectrometry methodology, 




Hydraulic fracturing, first developed in 1949, has expanded to a vast industry, with nearly 
2.5 million fracture treatments performed between its inception and 2010.3 The basis of 
hydraulic fracturing is the injection of a nonexplosive fluid into the ground to stimulate oil 
wells.3 Currently, most of these fluids are water-based solutions that contain a number of 
additives.3, 4 Since bacterial growth can clog equipment and inhibit gas extraction, it is 
common to add disinfectants, or ‘biocides’ to fracturing fluid.4 Environmental 
contamination with fracturing fluid, both through leaching and runoff, has been 
demonstrated.4 Thus, some of these biocides are escaping into the environment, raising 
questions about the impact of continued exposure on local ecosystems.  
Glutaraldehyde, a small, bifunctional molecule, is a frequently-employed fracturing 
biocide used in nearly 30% of fracturing operations.4 Glutaraldehyde is a broad-spectrum 
biocide, and the mechanisms of its  antiseptic action are still being characterized.5 
However, it is evident that glutaraldehyde acts at cell surfaces and membranes, likely 
inhibiting transport and causing other structural modifications to impede cell viability.5 This 
is due, at least in part, to its ability to crosslink.5 
Herein, a comprehensive study is conducted to evaluate the effect of prolonged exposure 
to fracturing fluid on the ability of a microbial environment to tolerate the biocide 
glutaraldehyde. This study is multi-faceted, and compiles both chemical and biological 
data to inform its conclusions. One specific inquiry was aimed to determine if bacterial 
ecosystems were adapting to more rapidly metabolize glutaraldehyde. UPLC-HRMS 
method development and chemical analysis were crucial for answering this question. 
Chemical biology: the interdisciplinary science 
Chemical biology, the collaborative scientific field that applies chemical tools in the study 
of and intervention in biological processes, is poised to investigate molecular regulators 
of cellular respiration. Chemical biologists are progressively applying techniques such as 
organic synthesis and mass spectrometry to elucidate the roles of molecules in 
metabolism. Herein, a chemical biology approach is used to investigate the expression 




respective kingdoms. While these two investigations are distinctly unique, they can each 
be thoroughly studied with a similar toolbox. 
Chemical biology, as a field, is largely an applied science. However, to enable this 
application, continual evolution of methodology is invaluable. In the quest to apply 
chemical tools in the pursuit of biological answers, methods must be developed, 
optimized, and adapted to facilitate the desired purpose. In the investigation of these 
regulatory molecules described above, a collection of methodologies is purposefully 
constructed to generate the desired data. Some of these methods are established 
chemistries with well-described protocols that are widely available. Others, with more 
niche application, required substantial optimization, modification, and even de novo 
development. While the projects described herein are introduced with substantial 
emphasis on the biological systems in question, an equal amount of attention is given to 
the development and improvement of methodology. In the current work, many of the initial 
conclusions are based on methodological successes that are stepping stones on the way 
to garnering biological data. 
Central metabolism and ancillary networks 
For much of recent scientific history, biochemical investigations of observed phenotypes 
have focused on the central dogma of molecular biology: DNA is transcribed to RNA, 
which is then translated to proteins with biological functions. Thus, many research efforts 
have focused on the expression of macromolecules, whether nucleic acid or protein. In 
comparison, small and medium-sized biomolecules have traditionally received less 
research attention. Focus is continually expanding, however, to include investigation of 
smaller molecules. Efforts to understand and exploit the functions of small molecules are 
rapidly mounting. These studies are revealing promising candidates for regulation or 
characterization of phenotype expression. While many of these analyses were initially 
focused on a few essential pathways of small-molecule metabolism, modern scientific 
discoveries have continued to unveil new pathways and metabolite classes—constantly 




Cellular respiration is the set of central metabolic pathways that organisms use for energy 
production. Despite the incredible diversity among the kingdoms of life, many of the 
processes involved in cellular respiration are conserved across all living organisms. In 
aerobic respiration, glycolysis converts nutrients into 3-carbon molecules which continue 
through the tricarboxylic acid (TCA) cycle with the aid of other nutrient-derived 
metabolites. These pathways culminate with oxidative phosphorylation to synthesize 
adenosine triphosphate (ATP), the ubiquitous energy currency molecule. In eukaryotes, 
the TCA cycle and oxidative phosphorylation are localized in the mitochondria—energy 
production organelles. In prokaryotes, the process is similar, but occurs throughout the 
cell in the cytoplasm or by complexes anchored in the plasma membrane. In both cases, 
electrochemical gradients are essential for the function of the culminating protein 
complex, ATP synthase (Figure 1-1). 
From glucose, to pyruvate, to ubiquinone, there are many key small-molecule players in 
cellular respiration. Together, they comprise the most recognized molecular framework in 
metabolism. While these are the direct facilitators of cellular respiration, other distinct 
classes of biomolecules can play various regulatory roles. Membrane disruptors are a 
broad class of molecules that can impact the central aerobic energy pathways by 
interference with respiration. These regulators may produce advantageous effects under 
optimal expression and may be leveraged to impact health and disease if properly 
 
 





understood. While some of these regulators are macromolecular, there are current efforts 
to investigate small and medium-sized molecules that effect cellular respiration. In 
contrast to the metabolites involved in the central energy pathways that have well-
characterized functions, many of these ancillary regulators are secondarily expressed and 
therefore less studied; however, they may be essential for understanding and leveraging 
adaptive metabolism. The second part of this dissertation (Chapters Three and Four) is 
focused on molecules that are believed to regulate cellular respiration. 
Small-molecule mitochondrial uncouplers and obesity management 
 
Mitochondrial uncouplers are molecules which disconnect nutrient metabolism from its 
terminal step of ATP synthesis.6, 7 These inhibit ATP synthesis without affecting electron 
transport or ATP synthase. The predominant mechanisms of uncoupling include 
disruption of the proton gradient and membrane depolarization (Figure 1-2). Thus, the 
driving force of ATP synthase is abolished without interrupting any other respiration 
pathways.7 In animals, mitochondrial uncouplers can act as ways to promote adaptive 
thermogenesis and energy expenditure. Therefore, mitochondrial uncouplers attract 
attention as therapeutics in obesity mitigation.6 Until 1938, 2,4-dinitrophenol (DNP) was 
used by approximately 100,000 patients as weight loss drug.6 However, its 
pharmaceutical use was banned in the United States because of safety concerns despite 
some evidence that DNP can extend lifespan and treat metabolic diseases related to 
obesity. Exogenous uncouplers continue to pose risks when used as therapeutics, so 
endogenously-produced uncouplers illicit more excitement in the healthcare community.8 
Some of the most well-studied endogenous uncouplers are macromolecules. Mammals 
use uncoupling protein 1 (UCP1), which is expressed in brown and beige adipose tissue, 
as a prominent means of regulating respiration to facilitate nonshivering thermogenesis.9, 
10 When considered for therapeutic application, small molecule mitochondrial uncouplers 
are more desirable than protein uncouplers due to the comparative ease of synthesis and 
delivery. Avians lack UCP1 and therefore serve as suitable model organisms for 






Figure 1-2: Effect of uncouplers on central energy metabolism. Interruption of the proton gradient (shown 
in black) interrupts the proton motive force and inactivates ATP synthase. 
 
Some of the most well-studied endogenous uncouplers are macromolecules. Mammals 
use uncoupling protein 1 (UCP1), which is expressed in brown and beige adipose tissue, 
as a prominent means of regulating respiration to facilitate nonshivering thermogenesis.9, 
10 When considered for therapeutic application, small molecule mitochondrial uncouplers 
are more desirable than protein uncouplers due to the comparative ease of synthesis and 
delivery. Avians lack UCP1 and therefore serve as suitable model organisms for 
investigation of small molecule mitochondrial uncouplers.  
N-Acyl amino acids (N-AAAs), condensation products of amino and fatty acids, have been 
recently shown to uncouple mitochondria for thermogenesis.11 These small molecule 
uncouplers are produced in many animals including mice, humans, and avians. Because 
of their endogenous expression, they are especially attractive candidates for obesity 
therapy.8 Given the recently emerging interest in N-AAAs and energy expenditure, little is 
known about their expression across phenotypes. Therefore, systematic studies 
designed to understand the ties between endogenous N-AAA profiles and dietary 
variations are valuable to both medicine and basic science. Using broiler chicks as a 
model organism, expression of N-AAAs can be monitored throughout fasting-induced 
lipolysis and among various fat-enriched diets. Ultimately, this should inform future 




Membrane disruptors in the intermediate molecular space 
 
Given the emergence of metabolomics and other techniques, studies focused on small 
biomolecules are increasing. Yet, despite the emergent focus on small molecule 
metabolites, little attention has been directed towards the intermediate space between 
biopolymer macromolecules (>10,000 Da) and small molecules (<1,500 Da). These 
medium-sized molecules span a variety of structural families including polypeptides 
containing fewer than 50 amino acids. These peptides, which some consider too small to 
even bear the designation of “protein”, can no longer be overlooked.12 Expressed by direct 
translation of small open reading frames (ORFs), these small proteins have been 
implicated in several biological roles in recent years.12 Their localization is often pertinent 
to function, and they are often positioned in or at cell membranes.12 
Z-protein often repeated (ZorO), a 29-amino acid peptide, is one such small protein. 
Encoded by a small ORF in wild type enterohemorrhagic Escherichia coli (EHEC), ZorO 
appears to confer toxicity to colonies.13, 14 When overexpressed, it initiates cell death. 
However, it is suspected that endogenous ZorO expression may serve to regulate cell 
growth in response to environmental stressors. Once this growth stasis has served its 
purpose, cells self-rescue by expression of an sRNA antitoxin (orzO) which prevents 
translation of ZorO-encoding mRNA.14 This toxin-antitoxin locus is absent in 
domesticated laboratory strains of E. coli, indicating that it may be valuable for growth in 
indigenous environments.  
Like other small proteins, ZorO appears to be membrane localized.13, 15 Preliminary data 
has shown that ZorO may oligomerize in the inner membrane, creating ion channels 
which disrupt the proton gradient that drives ATP synthase—thus uncoupling nutrient 
metabolism from ATP generation. In this way, it may be acting as a prokaryotic equivalent 
of a mitochondrial uncoupler (Figure 1-2). This toxin-antitoxin locus is a valuable research 
target, as it may facilitate an improved understanding of pathogenic E. coli resilience or a 
selective means of combating EHEC infections. To investigate these possibilities, detailed 
studies are needed to fully elucidate the structure, function, expression, and localization 




Addressing the need for interdisciplinarity in science education 
As discussed above, interdisciplinary research is on the rise and has become prominent 
in science. However, university-level undergraduate science education has largely 
maintained the separation between disciplines by establishing distinct departments. As a 
final component of this work, an interdisciplinary laboratory course is intentionally 
designed to familiarize undergraduates with chemical biology. The conception of this 
course was built on a foundation of research experience and peer-reviewed literature, 
drawing from published experiments and incorporating many of the techniques introduced 
earlier in this dissertation. This novel course was independently developed to highlight 
innovative applications of chemical methodology towards the elucidation of biological 
structures and mechanisms. Specific focus is placed on influential chemical techniques 
and prominent classes of biomolecules. Since its inception, the course was piloted for 
several consecutive semesters and is undergoing further evolution to more effectively 
introduce undergraduate scientists to scientific interdisciplinarity. Ultimately, the 
implementation of such a course will serve the scientific community by graduating 
chemistry majors who are more aptly poised for either collaborative research trajectories 






CHAPTER TWO: IMPACT OF HYDRAULIC FRACTURING ON 







The environmental impacts of hydraulic fracturing, particularly those of surface spills in 
aquatic ecosystems, are not fully understood. The goals of this study were to: (1) 
understand the effect of previous exposure to hydraulic fracturing fluids on aquatic 
microbial community structure and (2) examine the impacts exposure has on 
biodegradation potential of the biocide glutaraldehyde. Microcosms were constructed 
from hydraulic fracturing-impacted and non-hydraulic fracturing-impacted stream water 
within the Marcellus shale region in Pennsylvania. Microcosms were amended with 
glutaraldehyde and incubated aerobically for 56 days. Microbial community adaptation to 
glutaraldehyde was monitored using 16S rRNA gene amplicon sequencing and 
quantification by qPCR. Abiotic and biotic glutaraldehyde degradation was measured 
using ultra performance liquid chromatography—mass spectrometry and total organic 
carbon. It was found that non-hydraulic fracturing-impacted microcosms biodegraded 
glutaraldehyde faster than the hydraulic fracturing-impacted microcosms, showing a 
decrease in degradation potential after exposure to hydraulic fracturing activity. Hydraulic 
fracturing impacted microcosms showed higher richness after glutaraldehyde exposure 
compared to non-impacted streams, indicating an increased tolerance to glutaraldehyde 
in hydraulic fracturing impacted streams. Beta diversity and differential abundance 
analysis of sequence count data showed different bacterial enrichment for hydraulic 
fracturing-impacted and non-hydraulic fracturing-impacted microcosms after 
glutaraldehyde addition. These findings demonstrated a lasting effect on microbial 
community structure and glutaraldehyde degradation potential in streams impacted by 
hydraulic fracturing operations. 
Preface 
The work presented in this chapter is published in a manuscript entitled Impacts of 
Glutaraldehyde on Microbial Community Structure and Degradation Potential in Streams 
Impacted by Hydraulic Fracturing (DOI: 10.1021/acs.est.8b00239). It has been 
reproduced with permission from Environmental Science & Technology (2018, 52 (10), 
pp 5989–5999) copyright 2018 American Chemical Society. The contribution of Caleb M. 




generation and interpretation of the chemical data. Maria Fernanda Campa (MFC) 
conceived the experiment with input from Stephen M. Techtmann (SMT) and Terry C. 
Hazen (TCH). Nikea Ulrich (NU), Regina Lamendella (RL), and Christopher J. Grant 
(CJG) organized the sampling expedition, and MFC and CJG collected samples. MFC, 
CMG, Megan Patterson (MP), and Amanda Garcia de Matos Amaral (AGMA) performed 
the experiments. MFC, CMG, Xiaojuan Zhu (XZ), and Shawn R. Campagna (SRC) 
analyzed the data.  
In order to preserve the complete account, the manuscript is included in its entirety; 
however, special attention is given to the chemical methodology and data.  
Forward 
The aim of this collaborative project was to evaluate the effect of hydraulic fracturing on 
the local microenvironment. Namely, tolerance of and adaptation to the biocide 
glutaraldehyde were evaluated in microbial communities exposed to hydraulic fracturing 
and unexposed control groups. Initially, the hypothesis was that microbial communities 
exposed to hydraulic fracturing would adapt to more rapidly metabolize glutaraldehyde 
than unexposed communities. To test this, a UPLC-HRMS method was developed to 
quantify glutaraldehyde over time in cultured microenvironments. To do so, careful 
consideration was given to the solution equilibrium and potential reactivity of 
glutaraldehyde to ensure that an accurate picture of glutaraldehyde concentration was 
achieved.  
Mass spectrometric data illustrated a trend opposite of the hypothesis, with 
glutaraldehyde degrading more quickly in communities unexposed to hydraulic fracturing. 
To confirm this observed trend, the oxidized metabolite of glutaraldehyde, glutaric acid, 
was also quantified. Corroborating the trend in glutaraldehyde degradation, glutaric acid 
production was increased in microenvironments previously unexposed to fracturing fluid. 
This raises an intriguing discussion about the propensity of the microbial environment to 





The use of hydraulic fracturing (HF) has grown 702% since 2007.16 Since 2011, seven 
shale plays have been responsible for more than 90% of the oil and gas production growth 
in the U.S. The most productive of these plays is the Marcellus Shale in the northeastern 
U.S., producing more than 18,000 mcf of natural gas per day.17 Despite the proposed 
economic and energy security benefits of HF, many environmental questions and 
potential unforeseen consequences remain. The exact mixture of chemicals and water 
(i.e. HF fluids) used in a HF job is proprietary and dependent on company and/or shale 
play geochemistry. However, HF fluids components often include gelling and foaming 
agents, friction reducers, crosslinkers, breakers, pH adjusters, corrosion inhibitors, iron 
control chemicals, clay stabilizers, surfactants, and biocides.18 Biocides are added to HF 
fluids to prevent the corrosion, bioclogging of pipes and equipment, and gas souring that 
are caused by sulfate-reducing bacteria and acid-producing bacteria. High volumes of HF 
fluids are injected under great pressure to crack open the shales deep beneath the 
surface. A portion of this fluid then resurfaces as wastewater, called “flowback” water. 
This flowback fluid requires special handling and disposal. Biocides have been identified 
as some of the most toxic chemical additives in HF fluids.18, 19 
The efficacy of biocides in HF operations is unclear. Previous studies report active and 
diverse microbial communities in flowback waters despite biocide use.20-26 
Glutaraldehyde (GA) is the most commonly used biocide in HF.19 There are a number of 
ways GA can degrade abiotically in the environment. The compound is water miscible 
and does not tend to bioaccumulate. It hydrolyzes as pH increases, and it can also be 
photo-degraded.27, 28 Previous studies have shown that GA is biodegradable under 
aerobic and anaerobic conditions, but degradation rates can be affected by concentration, 
pH, salt, temperature, chemical interactions, and bacterial resistance.27-31 Under aerobic 
conditions, GA can be biodegraded to carbon dioxide via glutaric acid, and under 
anaerobic conditions, the biocide is metabolized to 1,5-pentanediol.28 Despite its 
biodegradability, GA is considered acutely toxic to both terrestrial and aquatic organisms 
– freshwater fish in particular—at concentrations as low as 2.5 mg/L for embryos and 4.7 




To date our review of the literature suggests that few if any studies have examined the 
fate of GA in an aquatic environment previously exposed to HF fluids. To address this 
gap, this study employs a combination of next generation sequencing and detailed 
chemical analysis. The goal of the study is to understand how GA affects aquatic microbial 
communities previously exposed to HF fluids and to measure the degradation of GA in 
an exposed aquatic system as compared to a non-exposed aquatic system. 
Materials and methods 
Stream selection   
Streams were selected using Pennsylvania (PA) Department of Environmental Protection 
records and GIS surveys. The sampling area was forested and there were no physical 
indications of past mining activity prior to HF development in that region. The selected 
streams had minimum variation in watershed characteristics caused by anthropogenic 
impacts other than HF. There was no indication of conventional drilling, acid mine 
drainage, or other industrial activities. Each of the HF-impacted  (HF+) streams selected 
had either a history of surface spills (stream names: Alex Branch (AB) and Little Laurel 
(LL))33 or more than 20 well-heads (unnamed tributary (UNT) Naval Hollow) in the 
vicinity.34 In 2009, LL received flowback from a broken pipe for over two months, to a 
lesser extent AB also received flowback from the same pipe. Furthermore, AB received 
input from an 8,000-gallon spill of water and HF fluids. Each of the HF-not impacted (HF-
) streams, UNT East Elk Fork (EE), UNT West Elk Fork (WE), and Dixon Run (DR), 
selected as baseline, had Fracking well construction in its vicinity, but no HF activity had 
commenced. 
There was documented use of GA in wells associated with the three HF+ streams 
selected according to FracFocus.org.35 Detailed selection of streams, screening process, 
collection and description of the sites have been discussed elsewhere.36-38 Past studies 
surveying these and other streams in central and northwestern PA showed that the 
microbial community composition and indicator taxa can be used to predict HF past 
exposure, even years after a documented spill.36, 39 Indicator taxa enriched in streams 




no history of spills. This suggests that direct spills are not the only source of HF impacts 
in the aquatic ecosystem.36, 39 In addition to persistence of microbial indicator taxa, 
streams in North Dakota impacted by flowback water spills maintained the geochemical 
and isotopic signatures of the spill for up to 4 years after documented spills.40  
Sample collection   
Stream water was collected from HF+ and HF- streams in northwestern PA in June 2015 
using sterile Nalgene bottles. All streams were sampled within a two-week period, and 
depending on the stream, were stored for 3 or 4 weeks at 4°C until use. Geochemical 
parameters, including temperature, pH, conductivity, total dissolved solids, and salinity 
were measured at the time of sample collection with a Eutech PCSTestr, 35 Multi-
parameter test probe that was calibrated weekly using a three point-calibration.41 Refer 
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Figure 2-1: Map showing the location of the PA watersheds used as 






The amount of biocides used in HF fluids varies widely between 10 to 800 mg/L.18 Dow 
Chemicals has shown a 6-log reduction of acid producing bacteria and sulfate reducing 
bacteria, the standard in the oil and gas industry, at a concentration of 100 mg/L of GA. 
42 Thus, microcosms were established with 260 mL of stream water amended with 100 
mg/L of GA. A 50% solution of GA (CAS number 111-30-8, catalog number 340855) was 
bought from Sigma Aldrich (St. Louis, MO, USA). Abiotic controls were autoclaved prior 
to GA amendment to measure abiotic biocide degradation. Additionally, negative 
biological controls were setup with stream water and no GA addition to examine bottle 
effect on the microbial community. Both control sets had a volume of 20 mL. All 
microcosms were setup in triplicate and incubated for 56 days under minimal light 
exposure and at ambient temperature. Microcosms were uncovered only for sampling 
events. 
Ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) 
Abiotic and biotic microcosms were sampled at day 1 before and after amendment of GA, 
and at day 7, 28, and 56. One mL of water from each microcosm was collected, filtered 
thought a 0.2 µm Sterivex nylon filter, and frozen at -20°C until analysis at the University 
of Tennessee’s Biological Small Molecule Mass Spectrometry Core. The samples were 
diluted 1:10 with HPLC grade water. A 10 μL injection volume of each sample was 
subjected to UPLC separation (LC Dionex Ultimate 3000) on a Synergi 2.5 μm Hydro-RP 
100 Å, 100 x 2 mm column. (Phenomenex, Torrance, CA). Solvent A consisted of 0.1% 
formic acid in water, and solvent B was 0.1% formic acid in acetonitrile. The separation 
gradient featured an initial ramp from 0% to 50% B over 6.5 min, and the conditions were 
held constant for 1 min. This was followed by a return to initial conditions over 0.25 min 
and a 3.5 min equilibration at 0% B for a total runtime of 11.25 min. The flow rate was 
held constant at 300 μL/min. Mass spectra were recorded in positive mode with an 
Orbitrap Exactive Plus mass spectrometer (Thermo Scientific, Waltham, MA) under the 
following parameters: Positive-mode heated electrospray ionization, sheath gas flow of 
25 units, aux gas flow of 8 units, capillary temperature of 300°C, aux gas heater 




and a scan range of 90 to 300 m/z. GA was detected in positive mode as the [M+H] (m/z 
= 101.0600) with a retention time of 2.8 min. The GA metabolite glutaric acid (purchased 
from Sigma-Aldrich, CAS number 110-94-1, catalog number G3407) was measured with 
an identical instrument and column using an established negative-mode ion-pairing 
UPLC-MS method.43, 44 Concentrations were calculated using the standard curves in 
Figure 2-2. Average HF+ and HF- concentrations with their respective standard error 
were reported. 
Total organic carbon (TOC) 
 
TOC associated with GA was quantified at days 0, 7, and 56 using a Shimadzu TOC-L 
equipped with an ASI-L autosampler (Shimadzu, Kyoto, Japan). 1 mL of sample was 
filtered through a 0.2 µm Sterivex nylon filter and then diluted 1:25 or 1:10 with DI water 
acidified to pH 3 with HCL. This released the inorganic carbon present in the samples. 
Samples were collected prior to GA addition to subtract the background TOC. GA 
standards were run to calculate TOC associated with GA. Time point 0 sample (after 
addition of biocide) for the biotic microcosms was depleted during preparation. However, 
as the same concentration of GA was added to both biotic and abiotic microcosms, the 
time point 0 TOC measurement for the abiotic microcosms was used to calculate percent 




Figure 2-2: Calibration curves for glutaraldehyde (left) and its metabolite glutaric acid (right) 
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16S rRNA gene amplicon library preparation and sequencing 
 
Bacterial community changes can be used as biosensors for contamination even after the 
contaminants are fully degraded.45 In the case of these streams, prior exposure to GA 
may lead to microbial adaptation which may affect the degradation of GA. To test this 
hypothesis, 25 mL of water from the GA amended microcosms was filtered for DNA 
collection to track microbial community changes and perform qPCR for the 16S rRNA 
gene. Samples were collected prior to GA amendment and at days 7, 21, 35, 49 and 56. 
The no-GA control microcosms were sacrificially sampled at day 56 to perform the same 
DNA-analyses. The water collected was filtered through a 0.2 µm Sterivex nylon filter 
(Millipore Sigma, St. Louis, MO). Filters were frozen at -20°C until use. The plastic casing 
of the filter was cracked opened with sterile pliers in a biohazard hood. The filter was 
removed with sterile tweezers and cut with a sterile knife. The filter pieces were extracted 
for genomic DNA using PowerSoil DNA isolation kit (Qiagen) according to the 
manufacturer’s manual. The v4 region of the 16S rRNA gene was amplified using the 
protocol described by Caporaso et al.46 Primer dimers were removed using the Select-a-
Size DNA Clean and Concentrator Kit (Zymo Research, Irvine, CA) following the 
manufacturer’s instructions to remove fragments smaller than 300 bp. The size of the 
amplicons were visualized and quantified using a 2100 Bioanalyzer and DNA 1000 chip 
(Agilent Technologies, Santa Clara, CA). Samples were quantified using a Qubit 
Fluorometer (ThermoFisher Scientific) and pooled based on equimolar concentrations to 
a final pool of 10 nM. The concentration was verified using qPCR utilizing KAPA SYBR 
FAST qPCR kit (KAPA Biosystems, Wilmington, MA). Final pools of 10 nM each were run 
in an Illumina MiSeq (San Diego, CA) using a v2 kit (2 x 150 reads), according to 
manufacturer’s manual. 
Quantification of bacterial 16S rRNA gene  
 
qPCR amplification was performed using the universal bacterial primers Bac1055YF47, 48 
and Bac1392R.48 Each 10 μl reaction was loaded using a QIAgility (Qiagen, Hilden, 
Germany) automated PCR loading robot. Each reaction contained 2 μl of template DNA, 
3.94 μl of water, 4.00 μl of Applied Biosystems Power SYBR GreenPCR Master Mix 




reverse primer respectively. qPCR reactions were performed in a QuantStudio 12K Flex 
Real-Time PCR system (ThermoFisher Scientific) using the qPCR cycle parameters 
described in Ritalahti et al.47 
16S rRNA gene amplicon sequencing data analyses  
 
Data analyses were performed using the QIIME pipeline (version 1.9.1) 46 and the 
Phyloseq 49 package in R.50 Briefly, the forward and reverse raw reads were joined using 
the assembler fastqjoin 51 embedded in QIIME. De-multiplexing and quality filtering was 
performed at an average Q-score of more than 19. The sequences were then chimera 
filtered using the UCHIME method and applying the USEARCH program.52, 53 Both de 
novo and reference-based chimera detection were used. For the reference-based 
detection, the Greengenes database (version May 2013)54 filtered to up to minimum 97% 
sequence identity was used. Open reference OTU picking was performed using the 
command pick_open_reference_otus.py using the UCLUST method 52 using the 
Greengenes database as described above. Representative sequences for each OTU 
were aligned using the PyNAST method55 and taxonomy was assigned to each 
representative sequence using the RDP classifier56 trained against the Greengenes 
database.54, 57, 58 OTUs were then filtered to remove sequences with counts below 
0.005%. The samples were then rarefied to 1,220 sequences. The BIOM file generated 
was then converted to JSON file and diversity analyses were performed using Phyloseq 
49 using R.50 
Statistics 
 
Geochemical parameters were compared between HF+ and HF- microcosms using a T-
test. GA degradation over time was compared between HF+ and HF- microcosms to test 
if degradation rates changed based on impact status. Degradation between biotic and 
abiotic samples was also compared to test if the main driver of degradation was biotic or 
abiotic. To do this the biocide concentration was log10 transformed and a baseline of 
100mg/L was used for day 0. A complete randomized design (CRD) with a split-split plot 
was used. Impact statuses (HF+ and HF-) were assigned to the whole plot and applied to 




taken for measurement at days 7, 28, and 56 (sub-sub-plot). Data was then divided 
between biotic and abiotic. A CRD with repeated measures was applied to each. The 
same was performed with glutaric acid concentrations. The mixed effect ANOVA method 
was employed to analyze the data using SAS 9.4, and least squares means separated 
with a Bonferroni method. The alpha level was set at P = 0.05. A Pearson correlation of 
pH and GA concentrations was performed for day 56. 
The 16S rRNA gene abundance was compared to understand the effect previous 
exposure to HF fluids have on aquatic microbial community structure after GA addition. 
This was done using a CRD with split plot using impact status (HF+ vs. HF-) as the whole 
plot factor and time (days) as the split plot factors using a mixed effect ANOVA model (R 
nlme package59). The least squares means were computed and separated with 
Bonferroni method (R emmeans package60). 16S rRNA gene copies/mL were log10 
transformed to meet normality and variance assumptions for ANOVA. To compare the 
no-biocide control at day 0 and at the end of the experiment (day 56), the same model 
was run. To determine differences between HF+ and HF- at day 0, an independent 
sample T test was run with data for only that time point.  
Alpha diversity, beta diversity and DESeq261 analyses were performed using un-rarefied 
OTU table. Difference in community evenness and richness between HF+ and HF- 
streams was measured using Simpson, Chao1, Observed diversity, and Shannon alpha 
diversity metrics. Alpha diversity results were used as a proxy for microbial resistance 
and resilience against GA. Microbial community alpha diversity values were rank 
transformed and compared using the same model as for 16S rRNA gene copies/mL. Beta 
diversity measures were calculated using weighted UniFrac distance matrix62 and 
visualized using a principal coordinate analysis (PCoA). Finally, microbial community beta 
diversity was compared using a nested PERMANOVA using the adonis command in the 
VEGAN63 R package. 
The DESeq261 R package was used to find microbial taxa enriched through time by 
comparing each time point (day 7, 21, 35, 29, and 56) to the day 0 No-GA control. Day 




controls were also compared. At each time point comparison between HF+ and HF- was 
performed to identified differentially enriched taxa between HF impact status. The same 
was performed with HF- streams. The Wald test61 was performed using the parametric 
fit-type and a Benjamini & Hochberg adjusted P-value with an alpha < 0.01. Biomarkers 
without Family level taxa classification were removed.  
Results and discussion 
 
The objective of this study was to understand the lasting effect of HF impacts on the 
biocide resistance and degradation potential of surface water microbial communities. To 
do this, GA—the most common biocide used in the HF industry—was added to 
microcosms of water from streams impacted and not impacted by HF as determined by 
previously published studies.36-38, 64 
Physiochemical parameters of stream water in situ 
Temperature, pH, conductivity, total dissolved solids, and salinity were measured at the 
time of sample collection and results are shown in Table S1. HF+ streams had an average 
temperature of 16.8°C and HF- streams had an average temperature of 12°C. HF+ 
streams had an acidic pH averaging 4.9, while HF- had a neutral pH of 6.5. The average 
conductivity for HF+ streams was 26.3 μS/cm, and for HF- streams 33.7 μS/cm. The 
average total dissolved solids for HF+ was 23.67 ppm and for HF- 23.93. Finally, the 
average salinity for HF+ streams was 19.2 ppm and 18.9 ppm for HF- streams. There 
were no statistically significant differences in the physiochemical parameters between 
HF+ and HF-. It is worth noting that others have documented higher conductivity in 
surface waters impacted by unconventional oil and gas extraction (UOG) wastewaters65 
as UOG wastewaters are high in salinity.20, 26 The streams described by Akob et al.65 were 
impacted by their proximity to UOG wastewater disposal facility, which suggests that the 
high salinity could have been caused either by a recent spill or constant inflow of 
wastewater to the streams. In that study, the pathway of contaminants to disposal facility 
could not be assessed. However, a 5 year-long study of these 6 streams and others in 




parameter between the impacted and not impacted streams39, indicating that a one-time 
spill is not enough to alter conductivity for a long time as input waste is diluted overtime.  
GA speciation 
 
Given the probability that GA exists in equilibrium with many different hydrated forms, 
searches were conducted for any other GA related chromatographic peaks. In both the 
standard and experimental samples, a peak corresponding to the sodium adduct of the 
GA hydrate ([M+H2O+Na+] = 141.0526 m/z) was observed (Figure 2-3) at an identical 
retention time to the molecular ion (2.8 min), indicating that hydration/dehydration was 
occurring in-source. Likewise, the sodium adduct of molecular ion was observed 
([M+H2O+Na+] = 123.0417 m/z, r.t 2.8 min) (Figure 2-3). However, these additional 
peaks were minor components compared to the observed molecular ion, with areas and 
intensities at least 1 order of magnitude lower to the molecular ion. The detection of 
multimeric forms of GA has been addressed in previous reports.66 Ferrer and Thurman66 
analyzed GA (among other HF additives) and detected peaks for GA oligomers. The 
oligomers are formed in solution by aldol condensation instead of in-source, as evidenced 
by their separate retention times. In the current study, GA standards and samples 
produced a peak corresponding to the sodium adduct of the singly hydrated aldol dimer 
([M+H2O+Na+] = 223.0941 m/z, r.t. 4-5 min) (Figure 2-3). Additionally, a peak was 
observed that corresponded to the mass of the sodium adduct of a doubly hydrated aldol 
dimer ([M+2H2O+Na+] = 241.1038 m/z, r.t. 4-5 min) formed in-source (Figure 2-3). In all 
cases, the area and intensity of the dimer peak was at least 2 orders of magnitude lower 
than that of the parent molecular ion of GA. The mass range of the experiment excluded 
the sodium adduct of the doubly hydrated aldol trimer observed in past reports66, and no 
other forms of the trimer were detected. Despite the presence of other detected forms of 
GA, the chromatographic peak for the chosen molecular ion of 101.0600 m/z is the best 
means of quantitation (Figure 2-3). If any environmental variable between streams 
influenced the detected amount of GA, then the changes can be reflected in the abiotic 






Figure 2-3: Glutaraldehyde species detected 
 
GA abiotic and biotic degradation over time measured with UPLC-MS   
It was observed that abiotic degradation of GA was negligible and independent of HF 
impact status and the difference in GA concentrations between HF+ and HF- abiotic 
microcosms through time was not statistically significant. The final concentration of GA in 
the abiotic HF+ control was 101.9 ± 4.2 mg/L and 106.79 ± 5.1 mg/L in abiotic HF- control 
(Figure 2-4a). Additionally, biotic degradation of GA was detected in both HF+ and HF- 
microcosms. The final concentration of GA in the HF+ biotic microcosms was 47.3 ± 5.2 
mg/L and in the HF- biotic microcosms was 31.7 ± 3.8 mg/L. The difference in degradation 
over time was found statistically significant (P < 0.05). The HF- communities degraded 
GA faster by day 56, a 68.3% removal of GA with half-life of 33.8 d, while HF+ 






Figure 2-4: Biotic and abiotic degradation of glutaraldehyde and glutaric acid production over time. (a) 
Biotic and abiotic degradation of glutaraldehyde in HF+ and HF- microcosms. The blue dot represents the 
added amount of GA, 100 mg/L. (b) Biotic and abiotic production of glutaric acid in HF+ and HF- 
microcosms; the zoom in graph shows abiotic concentration over time. Error bars represent one standard 
error (n = 9). 
 
Glutaric acid is a known degradation product of the oxidation of GA 27. Glutaric acid was 
produced in the microcosms, validating the GA degradation measurements. Minimal 
production of glutaric acid was observed in the abiotic microcosms, with pronounced 
production in the biotic microcosms (Figure 2-4b). By day 56, abiotic HF+ microcosms 
produced 8.0 ± 1.0 μg/L of glutaric acid and abiotic HF- microcosms produced 6.9 ± .5 
μg/L. This difference was statistically significant (P < 0.05). Meanwhile, by day 56, 12.2 ± 
2.4 mg/L of glutaric acid were produced in the HF+ biotic microcosms and the HF- biotic 
microcosm produced 20.7 ± 2.7 mg/L. The difference between the abiotic and biotic 
glutaric acid production and the difference between biotic HF+ and biotic HF- glutaric acid 
production over time were also statistically significant (P <0.05). The steady increase of 
glutaric acid in the biotic microcosms as compared to the abiotic microcosms shows that 
the main pathway of GA depletion after day 7 is microbially mediated.  
Other studies have shown abiotic degradation of GA in oxic and anoxic conditions, but 
their experimental conditions included soil, where GA can be lost to sorption.28, 30 




was slower than the rates reported in the review by Leung.28 Leung describes the 
degradation of lower concentrations (0.9 to 50 mg/L) than the study described here 
(100mg/L) and GA degradation was indirectly quantified in the review using oxygen, 
carbon dioxide, or dissolved organic carbon measurements as proxies for GA 
degradation.28 Leung reported a variable GA half-life of 0.4-24 d, due to enhanced 
microbial inhibition at higher GA concentrations, which increases the half-life of GA. 
Another study measuring the biodegradation of GA in combination with 5 other HF 
chemicals also showed an increase in GA half-life at increasing concentrations.30 In that 
study, microcosms containing 100 mg/L of GA did not experience more biodegradation 
than the abiotic controls, indicating complete microbial inhibition, with an extrapolated 
half-life of more than 93 d. The addition of 5 other HF chemicals could have exacerbated 
microbial toxicity, particularly as the inoculum in those microcosms came from pristine 
soil with no previous exposure to HF chemicals.30 In this study, the HF+ source water had 
prior exposure to HF, and there was no competing chemical interactions or toxicity to 
inhibit microbes other than GA. 
GA associated TOC in biotic and abiotic microcosms   
 
It was observed that TOC decreased in the first 7 days (day 0 to 7) for both abiotic and 
biotic microcosms (Figure S6). After the initial TOC reduction, abiotic microcosms stayed 
constant, and by day 56 there was 8.64% removal in HF+ and 7.04% removal in HF-. In 
contrast, the biotic microcosms observed a higher TOC removal by day 56, 57.06% 
removal in HF+ and 62.81% removal in HF-. These findings agree with the trends 
observed with direct GA and glutaric acid measurements by UPLC-MS, showing a 
pronounced difference between biotic and abiotic degradation, and HF- microcosms 
degrading GA faster than HF+. 
The decrease in TOC after GA addition may suggest a decrease of GA in the first 7 days 
in both biotic and abiotic microcosms. This correlates to what McLaughlin et al.29 
observed in their microcosms with agricultural topsoil and synthetic surface water. 






Figure 2-5: TOC over time 
 
 
Because the microcosms described here did not have sediment as a confounding 
variable, it is likely that the observed initial depletion was from less prominent reversible 
GA hydrates forming in solution (Appendix A1). The results indicate that GA persists 
longer in a sediment free aquatic environment than in a sediment-water matrix such as 
the one described by McLaughlin et al.29 as their reported half-life for GA was 10 d. 
Furthermore, previous HF impacts and pH variations may increase GA persistence in the 
environment.  
qPCR 
The abundance of 16S rRNA genes was determined from initial samples before addition 
of GA (Figure 2-6). All the pre-GA treatment 16S rRNA gene concentrations were on the 
order of 104 gene copies/ mL, averaging 4.03 x 104 gene copies/mL in the HF+ streams 





Figure 2-6: Impacts of glutaraldehyde in abundance of 16S rRNA gene over time. The first three clusters 
are the HF-impacted streams, and the last three clusters represent the non-HF-impacted streams. Data 
point “56 days-No GA” represents bottle effect on the microcosms as no GA was added. Error bars 
represent one standard error (n = 3). 
 
 
The difference between HF+ and HF- was not statistically significant. Seven days after 
addition of GA, 16S rRNA gene copy number observed a log2 fold change (FC) in all 
microcosms independent of HF impacted status. HF+ microcosms showed a smaller 
change with an average of -2.92 log2 FC compared to -4.62 log2 FC in HF- microcosms. 
However, by day 21 the bacterial population recovered, returning to the original order of 
magnitude and with all streams surpassing the original gene copies except for NH (HF+) 
and DR (HF-), which were slightly lower. HF+ streams had an average of -0.45 log2 FC 
from the original gene copies/mL on day 21, while HF- streams had surpassed the original 
concentration with an average of 0.56 log2 FC. Finally, by day 56 all of the microcosms 
underwent 16S rRNA gene enrichment, exhibiting a higher enrichment on HF- 
microcosms. Additionally, HF+ microcosms underwent a 4.79 log2 FC from day 0, while 
HF- was 7.18 log2 FC. The difference through time (day 7 to 56) between HF+ and HF- 
was statistically significant (P > 0.05). In contrast, at day 56 the no-GA controls had a 
similar log2 FC, independent of previous HF status. No-GA HF+ microcosms had an 




significant. When compared the same time points, microcosms with no GA had higher 
16S rRNA gene copies/mL at day 56 than the GA-amended microcosm. This can be 
attributed to the GA-free microcosms not experiencing inhibited growth and having 
sufficient nutrients from the source water to promote growth. Thus, without GA addition, 
the biomass of the microbial communities increased to the same final gene copies/mL, 
showing that the difference in gene copies/mL between the GA-amended HF+ and HF- 
microcosms can be attributed to the microbial community response to GA.  
Quantification of the 16S rRNA gene also showed that HF+ microcosms were able to 
tolerate and resist the biocide better than HF- microcosms at day 7, the critical response 
phase to GA biocidal action (Figure 2-6). However, both HF+ and HF- microbial 
communities recovered rapidly after 21 days suggesting adaptation by certain microbial 
populations and enrichment of those microbes able to tolerate and resist GA in both the 
HF+ and HF- water, especially as GA’s concentration decreases over time. Furthermore, 
the differences in 16S rRNA gene copies over time showed that HF+ and HF- microcosms 
had a distinct adaptation and tolerance to GA.  
Microbial community changes between HF+ and HF- over time 
 
Richness, as measured by Shannon, Observed Species, and Chao1, showed that before 
GA amendment HF- streams were more diverse than HF+ streams (P < 0.05) (Figure 2-
7) while the difference was not significant for Simpson alpha diversity measurements. 
Seven days after addition of GA, HF+ maintained higher richness and evenness than HF-
, a significant trend observed with Chao1, and Observed diversity measurements (P < 
0.01 through the duration of the experiment) but not with Simpson and Shannon. The 
interaction between impact status (HF+ and HF-) and days was not significant. A 
comparison of no-GA control microcosms at day 0 and day 56 showed that there were no 
significant changes in alpha diversity (Observed, Chao1, and Simpson) over time except 
with Shannon diversity (P < 0.05). Thus, the control (no GA added) at day 56 maintained 
high diversity, comparable to the diversity before GA addition, independent of HF-impact 
status. This shows that the diversity differences observed after GA addition are not 




The overall alpha diversity found in this study’s HF- microcosms was higher than the 
HF+ microcosms preamendment of GA. This is in agreement with the in situ study that 
examined these streams and other streams in the region.39 After amendment of GA, 
HF+ microcosms maintained higher richness than HF- streams when calculating 
diversity with metrics that focus on unique OTUs (Observed) and the importance of rare 
OTUs (Chao1), whereas evenness seems to be decreasing through time as a couple of 
taxa dominated over time in both HF+ and HF- microcosms as seen by similar Simpson 
and Shannon diversity trends between the groups (Figure 2-7). High diversity and 
richness in a community after a perturbation is a sign of adaptation to chronic exposure 
to perturbations.67 This shows that more unique members of the HF+ microbial 
community were able to tolerate and resist the biocide than HF- microbial communities. 
 
Beta diversity was calculated using weighted UniFrac distance matrix. Data was ordinated 
using a Principal Coordinate Analysis (PCoA) as described. Clustering by PC 1 explains 
65.4% of the variation in the microbial community, while clustering by PC 2 explains 10%. 
Results showed a visible clustering by days and impact status (HF+ and HF-) in the GA 
added microcosms by both PC1 and PC2, while the no-GA microcosm mostly clustered 
by PC 2 (Figure 2-8). Statistically significant differences were observed between HF+ 
and HF- microbial communities (P < 0.01), treatments (GA vs No Biocide with P < 0.001), 
treatments through time (P < 0.001), the interaction between impact status (HF+ and HF-
) and treatments (P < 0.02), and the interaction between impact status, treatments, and 
days (P < 0.03). Results showed that the microbial community response to the biocide in 
these microcosms included phylogenetically distinct organisms based on previous 






Figure 2-7: Alpha diversity measurements over time. Different richness and evenness alpha diversity 
estimators comparing HF+ and HF- microcosms over time; the estimators used were (a) Shannon 
Diversity, (b) Observed Diversity, (c) Chao1, and (d) Simpson Diversity. Red and green box plots 
represent HF+ glutaraldehyde (days 7 to 56) and no glutaraldehyde added (days 0 and 56 only). Blue and 
purple box plots represent HF- glutaraldehyde and no glutaraldehyde added. The box plots show the 
distribution of the data points: upper whisker to the beginning of the box is the first quartile, beginning of 
box to median represents the second quartile of the data, median to end of box is third quartile, and end 






Figure 2-8: Principal coordinate analysis (PCoA) plot of phylogenetic microbial community changes over 
time in HF+ and HF- impacted microcosms amended or unamended with glutaraldehyde as described by 






Differentially enriched taxa over time in HF+ and HF- microcosms 
 
Overall, many members of the original microbial community in HF+ and HF- microcosms 
were not able to tolerate GA over time as seen by a decrease in diversity (Figure 2-7) 
and by an increase in differentially abundant OTUs between day 0 and the next 4 
sampling events (days 7, 21, 35, and 49). By the last sampling event, day 56, the number 
of differentially abundant OTUs decreases, a sign of population resilience, and/or GA 
reaching concentrations below inhibition level. 
Specifically, 7 days after addition of GA, 239 OTUs were differentially enriched. Twenty-
seven OTUs experienced a positive log2 FC while 212 OTUs experienced a negative 
log2 FC and, hence, were inhibited by exposure to GA. The highest log2 FC corresponded 
to an OTU identified as the genus Myroides (19.09 log2 FC), followed by OTU identified 
as Robinsoniella (18.64 log2FC). Interestingly, 6 OTUs corresponding to the marine clade 
SAR406 were also enriched (all corresponding to Family A714017 but different or 
unclassified genus). However, all of these enriched OTUs were in low abundance (<2%) 
except for Alcanivorax (2.77 log2 FC). There were 71 differentially enriched OTUs 
between HF+ and HF- prior to the addition of GA. Seven days after addition, only one 
OTU was differentially enriched between HF+ and HF- identified 
as Psychroserpens (7.80 log2 FC). However, it was at low abundance (below 2%). By day 
21, there were 315 OTUs differentially enriched as compared to the original pre-GA 
population. Eight OTUs were enriched at this time point. The only OTUs with abundance 
of more than 2% of the population were Idiomarina (4.90 
log2 FC), Methylobacterium (2.78 log2 FC), and Bacillus (2.06 log2 FC). There were not 
significant differences in enrichment between HF+ and HF- that passed the stringent 2 
log2 FC cutoff that was imposed. 
By day 35, there were 407 OTUs differentially enriched as compared to the original, day 
0 microbial population. These OTUs were classified as Amphritea (5.29 
log2 FC), Methylobacterium(5.19 log2 FC), and Beijerinckia (3.23 log2 FC). Three OTUs 
were differentially enriched in HF+ vs HF- at day 35. The genus Acinetobacter had a 3.60 
log2 FC in HF-, while Beijerinckia and Janthinobacterium had an 8.17 and 3.94 log2 FC, 




to the pre-GA microbial population. Only four OTUs were positively enriched at day 49; 
those OTUs correspond to Myroides (14.00 log2 FC), Robinsoniella (10.61 
log2 FC), Methylobacterium (6.02 log2 FC), and Beijerinckia (2.93 log2 FC). One OTU 
was differentially enriched in HF+ vs HF- at day 49. The genus Beijerinckia had an 8.97 
log2 FC in HF+ as compared to HF-. 
By day 56, there were 174 differentially enriched OTUs. Of those, 66 were enriched in 
day 56 as compared to day 0. The ones with more than 2% abundance 
were Methylobacterium (12.19 log2 FC), Beijerinckia (10.20 
log2 FC), Mycobacterium (7.81 log2 FC), Alcanivorax (5.74 
log2 FC), Stenotrophomonas (5.24 log2 FC), Bacillus (3.48 log2 FC), Idiomarina (3.28 
log2 FC), and Burkholderia (3.04 log2 FC). Only one OTU identified as the 
genus Beijerinckia (9.36 log2 FC) was enriched in HF+ microcosms as compared to the 
HF-. Day 56 GA-microcosms were also compared to no-GA microcosms at day 56. There 
were 263 enriched OTUs, of those 44 were enriched in the GA 
microcosms: Methylobacterium (10.31log2 FC), Alcanivorax (5.81 log2 FC),  
Mycobacterium (5.67 log2 FC), Beijerinckia (5.21 log2 FC), Idiomarina (4.42 log2 FC), 
and Bacillus(3.13 log2 FC); day 0 and day 56 no-GA microcosms were also compared to 
see how the community changed over time due to bottle effect. There were 209 
differentially enriched OTUs. It is worth noting that Bacillus (−2.77 log2 FC) 
and Idiomarina (−5.10 log2 FC) were suppressed at day 56 no-GA as compared to day 0 
and that Myroides (5.09 log2 FC) experienced an enrichment. 
These enrichments over time suggest which OTUs were driving the response to 
GA. Alcanivoraxwas a dominant first responder, and after an adaptation 
period, Idiomarina, Methylobacterium, and Bacillus responded as 
well. Methylobacterium differential enrichment continued until the end of the experiment, 
dominating in abundance (71% in HF+ and 84% in HF- microcosms at day 56, (Figure 2-








Figure 2- 9: Microbial Community Shifts Over Time. A) Phylum level shifts over 56 days with and 





It is worth noting that it was not enriched right after GA addition, possibly indicating that 
a lag period was needed for adaptation. By day 35, other 
than Methylobacterium, Beijerinckia is worth highlighting, as it was preferentially enriched 
in HF+ microcosms. The trend of Methylobacterium and Beijerinckiacontinued until the 
end of the experiment. In addition, by day 56, Alcanivorax and Idiomarina were enriched 
when comparing both day 56 with day 0 no-GA and with day 56-no-GA. 
Studied members of the enriched genus can provide better understanding of the 
interactions at play. Alcanivorax are commonly found in hydrocarbon-impacted marine 
environments and have been observed to degrade alkanes and other hydrocarbons and 
use them as their sole carbon source,68 and the alkane degradation pathway employs 
aldehyde dehydrogenases,69, 70 which may help this genus thrive and possibly help 
degrade GA. Furthermore, isolated strains of Alcanivorax spp. were shown to be resistant 
to antimicrobials by the use of efflux pumps,71 which could also facilitate tolerance for 
GA. Idiomarina is frequently detected in hydrocarbon-rich environments such as oil 
spills;68 HF produce water and flowback,23 but their role and/or mechanisms in 
hydrocarbon degradation is unknown. It is possible that enrichment of Idiomarinais also 
associated with the aldehyde dehydrogenases. Alcanivorax and Idiomarina are members 
of the Gammaproteobacteria class, which observed enrichment after a week of exposure 
to GA (Figure 2-9); enrichments of this class have been observed in aquatic 
environments after perturbations from hydrocarbon sources, sewage runoff, 
antimicrobials, and other anthropogenic sources.72 Most of the 
enriched Gammaproteobacteria families are known to be halotolerant such 
as Alteromonadaceae,73 Pseudoalteromonadaceae,74 Alcanivoracaceae,75 
Idiomarinaceae,76 and Halmonadaceae77 (Figure 2-9). Moreover, Vikram et al.25 showed 
that genes needed for responding to osmotic stress, membrane integrity, and protein 
transport are up-regulated when the bacteria are exposed to HF produced and flowback 
water, and this up-regulation was correlated with increased bacterial tolerance to biocide 
exposure. Another recent study indicated that, in pathogens, GA resistance can be 
mediated through an increase in efflux pumps, which will increase the rate of export of 
the biocide.78 It has also been reported that efflux pump encoding genes increase in 




mechanism to stress caused by HF chemicals and high salinity.79 This could help explain 
why Gammaproteobacteria associated with saline aquatic environments are enriched 
after GA addition, since the mechanisms to control osmotic stress might be a key genetic 
trait for microbial survival against GA. 
These microcosms experiments did not explore the impacts of high salinity with respect 
to microbial response and degradation of GA. High salinity might affect the tolerance to 
GA as shown by Vikram et al.;25 however, as shown by this work, higher tolerance does 
not translate to higher degradation. Another study showed inhibited biotic degradation of 
GA in a mixture with 30 000 mg/L NaCl and two other HF chemicals on agricultural top 
soil as compared to GA alone, while the abiotic degradation of the GA, NaCl, and HF 
chemicals was faster than GA alone.29 Degradation of low concentration (1.5–3.0 mg/L) 
GA has also been shown in seawater and its native organisms.28 Halotolerant microbes 
seem to be able to degrade GA; however, it is unclear how salt would affect degradation 
rates in freshwater streams in the case of a HF fluid spill containing GA and the high salt 
content associated with HF flowback. 
The increase in Alphaproteobacteria (accounting for more than 90% of the microbial 
community in the microcosms after day 49 of GA amendment, Figure 2-9) as the 
microbial system adapted to the GA perturbation suggests that this bacterial class is 
better at tolerating the GA as a stressor in the long term compared 
to Beta and Gammaproteobacteria. Alphaproteobacteria are known to experience 
horizontal gene transfer more frequently than other Proteobacteria, and their extensive 
genomes are known to have a larger number of mobile elements.80 This may contribute 
to the higher “memory effect” or adaptation detected in the HF+ aquatic microbial 
community with genetic material being shared between the sediment’s sessile microbial 
community, the epilithic bacteria from rocks, and the free-floating microbes collected for 
the microcosm setups.81 Moreover, Alphaproteobacteria are Gram-negative and, 
therefore, are known to be more resilient to antimicrobials because of their outer 
membrane, as compared to Gram-positive bacteria.82 The genus Methylobacterium was 
the most abundant Alphaproteobacteria in both HF+ and HF- streams; however, it is more 




Family Methylobacteriaceae are commonly found in the environment growing on single 
carbon compounds, the microbe’s sole energy source, in addition to more complex 
carbon compounds.83 Enrichment of methylotrophs has also been observed in studies 
pertaining to triclosan and quaternary ammonium antimicrobials and other environmental 
pollutants like hydrocarbons and chlorinated compounds as these bacteria are able to 
cometabolize these pollutants through the production of methane monooxygenase.84, 
85 However, Methylobacteriaceae response might be antimicrobial specific and 
dependent on oxygen availability as a study utilizing anaerobic microcosm inoculated with 
UOG impacted and unimpacted sediment described a significant decrease in abundance 
of after the addition of the biocide DBNPA.86 Another interestingly 
enriched Alphaproteobacteria was the genus Beijerinckia, preferentially enriched in HF+ 
microcosms. These genera are members of the order Rhizobiales, which has similarly 
been detected in streams adjacent to UOG disposal facilities.65 Isolated members of this 
genera have been shown to be nitrogen-fixing, nonsymbiotic, chemo-heterotrophic 
bacteria capable of degrading recalcitrant aromatic compounds because of their 
methanotrophic capabilities.87  
Overall, the microbial communities of HF+ and HF- microcosms had different 
phylogenetic responses to the addition of GA even though Methylobacteriaceae was the 
most dominant taxa in both. The phylogenetic differences are driven by lower abundance 
microbes that respond to GA based on past HF activity exposure. HF- had a more 
prominent negative response to GA, as seen by biomass and richness loss. This suggests 
HF fluids exposure causes different microbial responses and adaptation to the biocide 
GA. 
A long list of studies have described the adaptation of microbes to chemical stressors, 
which they then use as energy sources or acquire the ability to cometabolize.88 An 
increase in this effect has previously been observed in ecosystems that were exposed to 
contaminants;89 however, adaptation did not provide a degradation advantage to GA in 
the HF+ microcosms. This suggests the difference in degradation rates might not be biotic 
alone but rather driven by abiotic–biotic interactions. HF- microcosms source water had 




(average pH = 4.9), and the pH was negatively correlated (Pearson = −0.83) to the 
concentration of GA at day 56. Thus, higher pH experienced more biodegradation of GA. 
Higher pH difference has the potential to affect the availability of reactive sites in the 
microbial cell walls surface, causing a faster biocidal effect (and a faster 
depletion/deactivation of GA).5 These factors may explain why GA decreases more 
rapidly over time in the HF- streams. The site with the most GA depletion by day 56 was 
EE (Appendix A2), the HF- stream with the highest pH (pH = 7.3). 
However, the microcosms did not maintain constant pH over the incubation period; 
independent of HF impact status, source water location, or biotic or abiotic conditions, all 
of the microcosms pH increased over time (Appendix A3). While GA is more stable at 
lower pH, its bactericidal properties are impaired in acidic environments where there are 
fewer available active sites on the cell wall. This effect of pH will require more future 
studies, but it is still our hypothesis that it is affecting GA degradation in a number of ways. 
As explained above, the microbial community from HF+ microcosms was shown to better 
tolerate the biocide, however it did not degrade the biocide faster than HF- microcosms. 
Therefore, a further study of the biodegradation mechanisms associated with varying pH 
is needed to better understand the nuances of the abiotic-biotic interactions driving GA 
biodegradation.  
Environmental Implications of this study 
 
This study shows that there are long lasting effects in streams impacted by HF, which 
need to be considered for environmental impact assessment and bioremediation 
strategies. Abiotic factors such as acidified pH can affect the microbial community’s ability 
to respond to a second or continuous exposure to HF waste, causing HF chemicals to be 
more persistent in the environment than expected. As HF practices keep expanding 




CHAPTER THREE: EXPLORING ENDOGENOUS EXPRESSION OF N-






Adaptive thermogenesis has re-emerged as an important component of energy 
expenditure. N-acyl amino acids (N-AAAs) can contribute to adaptive thermogenesis by 
uncoupling mitochondrial respiration. Hypothesizing that lipolysis promotes the formation 
of N-AAAs, the connection was studied in an avian model (chickens) because lipolysis is 
readily induced by acute (~ 4 hr) food withdrawal. An avian model also allowed evaluation 
of N-AAA production in the absence of brown adipose tissue, which was reported to 
contribute the enzyme (peptidase M20 domain containing 1 (PM20D1)) that catalyzes 
their synthesis. Serum samples were collected from 21 d broiler chicks that were fed ad 
libitum, fasted for 4, 8, or 12 h, or fasted for 12 h and then re-fed for 2 h (n=10/group). 
Samples were profiled for levels of 27 N-AAA species using a novel UPLC-HRMS 
method. In short, a single Ultra-Performance Liquid Chromatography—High Resolution 
Mass Spectrometry (UPLC-HRMS) method was developed and validated with 27 N-acyl 
amino acid standards and 20 bile acid standards. (Given their shared relevance for 
obesity research and their similar physio-chemical properties, a single analytical method 
for the simultaneous detection of these metabolites is desirable). Reversed-phase 
chromatography and Orbitrap mass spectrometry were used in tandem to detect the 47 
metabolites in a 20.5-minute method. The standards were detected with a high degree of 
mass accuracy (less than 2 ppm for all N-AAAs and less than 7 ppm for all bile acids). In 
addition, protocols for the extraction of these metabolites from biological media were 
tested.  
Fasting progressively increased the serum pool of N-AAAs (p=1.8-06), in parallel with 
increased non-esterified fatty acid (NEFA) levels (p=0.0003). Refeeding for 2 h rapidly 
restored the N-AAA pool to fed levels (p=0.99; fed vs. 12 h fast-refed). Percent abundance 
of some species (e.g., oleoyl-l-valine; p=2.8-04) increased with fasting while others (e.g., 
stearoyl-l-leucine; p=1.9-05) declined, suggesting molecule-specific regulation of N-AAA 
synthesis.  Expression of PM20D1 in adipose tissue (subcutaneous and abdominal) and 
in liver was not affected by fasting. Effect of diet on N-AAA expression was also evaluated 
using the same boiler chick model. Four unique diets, containing a supplement of 
flaxseed, canola, fish, or animal (lard) oil were administered to chicks, which were then 




directly reflected in the tail composition of each N-AAA profile. This suggests that 
substrate availability may be a prominent means of N-AAA regulation.  
Preface 
The following chapter is adapted from two manuscripts: a methods paper by Gibson et. 
al. submitted to Metabolomics and an applied biological paper by Gibson et. al. in final 
preparation for submission to the American Journal of Physiology-Endocrinology and 
Metabolism.  
Contributions for methods paper 
 
CMG and Eric D Tague (EDT) developed the methods and analyzed samples. Sheev M. 
Zaver (SMZ) synthesized standards and performed extractions. CMG characterized 
synthetic standards. Brittni M. Woodall (BMW) and SMZ assisted with method validation. 
Emmanuelle T. Torchon (ETT), Brynn H Voy (BHV), and Hans-Rudolf Berthoud (HRB) 
provided biological samples. BHV and HRB prompted method creation and biological 
rationale. CMG, EDT, Shawn R. Campagna (SRC), and BHV wrote the manuscript. 
Contributions for biological paper 
 
CMG and SMZ ran samples. ETT and BHV conducted the animal studies and provided 
samples. SMZ extracted and prepared samples. BHV conceptualized the experiments. 
CMG and BHV performed statistical analyses and interpreted the data. CMG, BHV, and 
SRC wrote the manuscript.  
Forward 
 
As previously discussed, small molecule mitochondrial uncouplers possess therapeutic 
potential for the treatment of obesity and related metabolic disease. Exogenous 
uncouplers like DNP have been historically applied in therapeutic roles with mixed 
response, due to their potential side-effects. In contrast to these foreign uncouplers, N-
acyl amino acids are endogenously produced metabolites that induce thermogenesis, 
promote glucose homeostasis, and increase energy expenditure. Long and coworkers 




describing the uncoupling abilities of N-AAAs in 2016.11 Their findings prompted a letter 
published in Science magazine, enthusiastically entitled “The Quest to Burn Fat, 
Effortlessly and Safely”.8 Adaptive thermogenesis, regulated endogenously, represents a 
rich area of research for both basic and applied science, and N-AAAs are at the forefront 
of the discussion. 
Since these molecules are therapeutically promising and conserved across many animal 
species, research opportunities are abundant. Efforts to fully ascertain the natural 
biological roles of N-AAAs are essential. To this end, a method was developed that 
allowed the analysis of N-AAAs by UPLC-HRMS. Given the related biological relevancies, 
efforts to profile N-AAAs were combined with concurrent endeavors to measure bile acids. 
Successful method development yielded a single general method for detecting both 
classes of molecules from biological matrices with the desired resolution. While 
orthogonal efforts to study bile acid expression have been undertaken, the following work 
is focused the measurement and biological roles of N-AAAs.  
Using broiler chicks as a model system for studying adiposity and uncoupling, animal 
experiments were conducted with the aim of elucidating the endogenous expression of 
N-AAAs. A group of chicks was subjected to incremental fasting to acutely induce 
lipolysis. A parallel experiment involved dietary supplementation with various fatty acids. 
In both cases, samples were collected from the chicks and analyzed via UPLC-HRMS to 
determine changes in N-AAA profile. 
All UPLC-HRMS data was interpreted using statistical tools. Notable among these is 
partial least squares discriminant analysis (PLS-DA), a multivariate analysis algorithm 
which can be applied to classification problems to accomplish descriptive modeling.90-92 
PLS-DA reduces data dimensionality to assign components and constructs a predictive 
model. As a result, it allows the variance across data groups to be visualized and identifies 
the variables responsible for the differences. In addition, post hoc statistical power 
analysis was employed to illustrate that the pair-wise differences between means were 
significant for the given number of samples. The power level denotes the probability of 




which communicates the probability of inadvertently assigning false differences. Lastly, 
analysis of variance (ANOVA) is used as a way to generalize the t-test and compare 
means across three or more groups. 
Chapter 3A: A single UPLC-HRMS method for the profiling of bile acids and N-
acyl amino acids, two classes of obesity-mediating metabolites 
Introduction 
 
Obesity is a growing epidemic. From 2011 to 2014, the prevalence of obesity in the United 
States was 36% in adults and 17% in children.93 As an underlying cause of diabetes, 
cardiovascular disease, cancer, hypertension, and many other widespread medical 
conditions, obesity is a common culprit for morbidity and mortality.94 In addition to the 
direct health effects of obesity, the indirect societal effects include an impending 
inundation of health care resources.94 The epidemic has inspired focused research 
initiatives to increase fundamental scientific knowledge and investigate potential 
therapies for combating obesity and related illnesses. In recent years, N-acyl amino acids 
and bile acids, two classes of small, amphipathic biomolecules have emerged as 
possessing potential weight-regulating activities. Further investigation of these families of 
molecules may inform the global fight against obesity.  
N-acyl amino acids are condensation products of fatty acids and amino acids. Sometimes 
designated as elmiric acids, these compounds are endogenously produced and have 
been shown to possess various physiologic and pharmacological effects.95 To date, 
approximately 70 of these naturally occurring elmiric acids have been identified.95 Initially 
investigated for their potential analgesic and anti-inflammatory properties, N-acyl amino 
acids have been implicated in vasodilation, cell migration, and selective inhibition of 
cancer cell proliferation.95-100 More recently, a class of N-acyl amino acids featuring 
lipophilic amino acids has been demonstrated in brown adipocytes of mice to bind directly 
to mitochondria and uncouple cellular respiration.11 Administration of these endogenously 
produced lipoamino acids improved glucose homeostasis and promoted energy 
expenditure.11 The enzyme implicated as being responsible for catabolism and anabolism 




their role in activating mitochondria for thermogenesis, these compounds attract immense 
attention as promising candidates for the safe combat of obesity.8, 11 Predictably, as 
endogenously-produced uncouplers of respiration, they are more attractive therapeutic 
candidates than foreign chemical uncouplers. Despite the promise they possess, the 
endogenous expression of these thermogenesis-promoting N-acyl amino acids has only 
begun to be studied. These compounds are an interesting class of potential biomarkers 
for investigating molecular variations across various dietary and metabolic states such as 
fasting and lipolysis.  
Bile acids are cholesterol-derived steroid acids found predominantly in the bile of 
vertebrates.101 A structurally diverse group of steroids, bile acids exist in various forms 
that are related though reduction/oxidation, esterification, and amidation.101 They occur 
naturally in both free forms (such as cholic acid) and conjugated forms which have been 
condensed with amines (primarily taurine).101 Collectively, bile acids aid in the digestion 
of dietary fats and absorption of lipids. This is due to an distinctive ability to emulsify 
products of lipolysis by forming solubilizing micelles around free fatty acids, 
monoglycerides, and cholesterol.102, 103 A growing body of evidence indicates that specific 
bile acids also regulate metabolism by acting as ligands for farnesoid X receptor (FXR) 
and takeda G receptor 5 (TGR5).104, 105 The farnesoid X receptor is a nuclear receptor 
that transcriptionally controls lipid metabolism by forming a heterodimer with retinoic X 
receptor α, and the takeda G receptor 5 exerts its metabolic effects by activating protein 
kinase A upon binding of bile acids at the cell membrane. These metabolic actions of bile 
acids may underlie some of the benefits of Roux-en-Y gastric bypass surgery, which 
increases levels of circulating bile acids. Independent studies have demonstrated that bile 
acids may help mediate type-II diabetes and promote weight loss after gastric bypass.106-
108 In addition, bile diversion independent from surgical rearrangement of the GI tract has 
been shown to initiate weight loss and improve homeostasis for glucose and lipids.109 The 
benefits of bile diversion are comparable to those of bariatric surgery and are 
accompanied by elevated levels of bile acids, which may be responsible for the observed 
effects.109 Most recently, bile acids have been identified among the most important 
biomarkers for achieving a stable metabolic state after bariatric surgery.110 Together, this 




Because of the pharmacological significance of bile acids and N-acyl amino acids in 
lipolysis, glucose homeostasis, thermogenesis, and weight control, methods for the 
detection and quantitation of these biomolecules are desired. Since their roles in 
metabolism may be related and given that these two classes of compounds occupy a 
similar mass range, possess similarly amphiphilic properties, and share a preference for 
negative-mode ionization, it is plausible that they may be simultaneously extracted from 
biological samples and analyzed using a single Ultra-Performance Liquid 
Chromatography—High Resolution Mass Spectrometry (UPLC-HRMS) method.  
The research interest in these classes of molecules is emerging, so relatively few 
methods for their detection have been reported. To our knowledge, no method for the 
simultaneous detection of both classes has been reported. The LC-MS detection of 
several endogenous N-acyl amino acids was reported in 2010 using a targeted lipidomics 
method.111 Another targeted approach using triple quadrupole mass spectrometry was 
recently used to profile endogenous elmiric acids in serum of mice.11 Bile acids have been 
measured via LC-MS using an array of methods which generally employ tandem MS in 
targeted approaches.112-118 At least one of these MS/MS methods used select deuterated 
bile acids as internal standards for enhanced quantitation.115 Compared to other LC-MS 
techniques, the increased performance offered by UPLC-HRMS provides increased 
resolution both in the time domain and the mass domain. In contrast to the targeted 
methods, an untargeted approach allows information to be collected across all m/z’s 
instead of selecting m/z’s of interest. This is beneficial because the data can be 
reanalyzed later, and more compounds can be identified as future biological 
investigations are undertaken. Herein, a UPLC-HRMS method designed for the 
untargeted profiling of both bile acids and N-acyl amino acids is described, validated using 




N-dodecanoyl valine (DDV), N-dodecanoyl leucine (DDL), N-dodecanoyl phenylalanine 




(PMOL), N-palmitoyl leucine (PML), N-linoleoyl valine (LINV), N-oleoyl valine (OLV), N-
stearoyl valine (STV), N-linoleoyl leucine (LINL), N-oleoyl leucine (OLL), N-stearoyl 
leucine (STL), N-eicosapentaenoyl valine (EPAV), N-palmitoleoyl phenylalanine (PMOF), 
N-palmitoyl phenylalanine (PMF), N-eicosanoyl valine (EIV), N-eicosapentaenoyl leucine 
(EPAL), N-eicosanoyl leucine (EIL), N-docosahexaenoyl valine (DHAV), N-linoleoyl 
phenylalanine (LINF), N-oleoyl phenylalanine (OLF), N-stearoyl phenylalanine (STF), N-
docosahexaenoyl leucine (DHAL), N-eicosapentaenoyl phenylalanine (EPAF), N-
eicosanoyl phenylalanine (EIF), and N-docosahexaenoyl phenylalanine (DHAF) were 
synthesized in-house using a method previously reported.11 Characterization data for all 
the standards in included in Appendix B. In short, fatty acids were activated by 
conversion to acyl chlorides using oxalyl chloride (1.2 eq.), concentrated, and coupled to 
amino acids (1.5 eq.) in a one-pot, two-step sequence (Figure 3-1). Synthetic lipoamino 
acids were purified via flash chromatography using 1:9 tetrahydrofuran in hexanes before 
UPLC-HRMS analysis.  
 
 
Figure 3-1: Synthetic scheme for N-acyl amino acid standards 
 
Bile acid standards were purchased from various sources, predominantly as salts: Cholic 
acid (CA) and deoxycholic acid (DCA) were purchased from MP Biomedicals (Santa Ana, 
California). Taurocholic acid (TCA), taurodeoxycholic acid (TDCA), and 
taurochenoxeodycholic (TCDCA) acid were purchased from Millipore Sigma (Darmstadt, 
Germany). Chenodoxycholic acid (CDCA), hyodeoxycholic acid (HDCA), 
ursodeoxycholic acid (UDCA), α-muricholic acid (aMCA), β-muricholic acid (bMCA), 
glycolithocholic acid (GLCA), glycocholate (GCA), glycochenodeoxycholate(GCDA), 




tauroursodoexycholate (TUDCA), tauro-α-muricholate (TaMA), tauro-ω-muricholate 
(TwMA), and tauro-β-muricholate (TbMA)were purchased from Steraloids (Newport, RI). 
Deuterated bile acid standards cholic acid-d4 (dCA), glycochenodeoxycholic acid-d4 
(dGCDCA), chenodeoxycholic acid-d4 (dCDCA), glycocholic acid-d4 (dGCA), and 
taurocholic acid-d4 (dTCA) were purchased from Cambridge Isotope Laboratories 
(Tewksbury, MA).  
Formic acid, HPLC grade water, and HPLC grade acetonitrile were purchased from 
Thermo Fisher Scientific (Waltham, MA).  
UPLC−HRMS method 
 
For each sample, a 10 µL injection volume was subjected to UPLC separation on a 
Dionex UltiMate 3000 (Thermo Fisher Scientific, Waltham, MA). A Synergi 2.5 μm Hydro-
RP 100 Å, 100 × 2 mm column (Phenomenex, Torrance, CA) was used at 40°C in a 
temperature-controlled compartment for the duration of the run. The mobile phase was 
comprised of a two-solvent system: Solvent A consisted of 0.1% formic acid in water, 
while solvent B was 0.1% formic acid in acetonitrile. Gradient: t = 0 min, 100% solvent A, 
0% solvent B; t = 13 min, 0% solvent A, 100% solvent B; t = 14 min, 0% solvent A, 100% 
solvent B; t = 14.5 min, 100% solvent A, 0% solvent B; t = 20.5 min, 100% solvent A, 0% 
solvent B. The flow rate was a constant 0.300 mL per minute. The chromatograph was 
coupled to an Orbitrap Exactive Plus mass spectrometer (Thermo Fisher Scientific, 
Waltham, MA) equipped with a heated electrospray ionization (HESI) source. Negative-
mode HESI and mass-spectrometric analysis were performed according to the following 
parameters: sheath gas flow of 25 units, aux gas flow of 8 units, capillary temperature of 
300 °C, aux gas heater temperature of 150 °C, spray voltage of 4.2 kV, ACG target of 3 
× 106, resolution of 140 000, and a scan range of 150−1000 m/z. 
Data analysis 
 
Post-processing was conducted by converting .raw files to .mzml and integrating 
Extracted-Ion Chromatograms (EICs) using Metabolomic Analysis and Visualization 




Least Squares Differential Analysis (PLS-DA) was performed using a series of R 
packages in RStudio version 1.1.423.122-124 Box and whisker plots were also generated 
with R (version 3.4.3). 
Differentiation of isobaric N-acyl amino acids using parallel reaction monitoring 
 
To further distinguish the pairs of isobaric elmiric acids, tandem MS was used to fragment 
the parent molecular ions. Standards were analyzed using identical instrumental 
parameters on a hybrid Orbitrap Q Exactive (Thermo Fisher Scientific, Waltham, MA) 
using parallel reaction monitoring (PRM). The parent molecular ions of 400.2857 and 
426.3014 m/z were selected using the quadrupole mass filter with an isolation window of 
± 0.4 m/z and fragmented using a collision energy of 35 eV. Product ions were detected, 
and their chromatograms were integrated using Xcalibur Quan Browser (Thermo Fisher 
Scientific, Waltham, MA) for comparison and quantitation. 
Sample preparation 
 
Bile acid standards were prepared in 1:1 water:ethanol prior to the creation of a combined 
stock solution. Four stock solutions were used to individually analyze BAs with identical 
m/z to determine if isomers were separable via chromatography. Calibration levels were 
as follows (in µM): 0.001, 0.005, 0.025, 0.050, 0.100, 0.250, 1.0, 2.5, 10, 20, and 100. A 
mixture of internal standards was spiked into all calibration standards and biological 
samples at a final concentration of 50 nM. N-acyl amino acid standards were suspended 
in 10% chloroform in methanol for serial dilution and calibration. N-acyl amino acid 
standards were prepared from stock solutions containing mixtures compounds at the 
following concentrations (µM): 0.001, 0.005, 0.010, 0.050, 0.100, 0.500, 1.0, 5.0, 10.0, 
50, and 100. 
Given the amphiphilic properties of both bile acids and N-acyl amino acids, some liberty 
with regards to extraction from biological matrices can be available. However, certain 
extraction protocols increase sensitivity and yield maximized ion intensities and peak 
areas. N-acyl amino acids and bile acids were extracted from test matrices using two 




M formic acid125 and b) a biphasic solvent mixture containing 0.1 N aqueous 
HCl/MeOH/chloroform in a 1:1:1 ratio126. In the former procedure, samples were 
resuspended in 300 µL Milli-Q water after extraction and concentration. In the latter, all 
samples were resuspended in 300 µL 10% chloroform in MeOH. Both methods were able 
to extract N-acyl amino acids and bile acids, but the latter method yielded increased 
intensities for N-acyl amino acids. Biological samples used for bile acid analysis were 
extracted using the acidic acetonitrile extraction.   
Exact quantitation of bile acids 
 
Calibration plots were created by integrating the areas under the curves for all external 
standards and internal standards. Not all external standards had a matched internal 
standard due to the limited commercial supply of isotopically labeled bile acids. Thus, 
internal standards were chosen to match the compound closest in m/z and 
chromatographic retention. The pairings of deuterated standards with analytes are 
provided in the Supporting Information. The log of the ratios for the external standard’s 
area were compared to the internal standard’s area (log[Aex/AIs]) and then plotted against 
the log of ratios for the external standard’s concentration compared to the internal 
standard’s concentration (log[Cex/Cis]). Linear regression analysis was used to interpolate 
area of standards from biological data. 
Animal methods 
 
Broiler chicks were used as a model system for detection of N-acyl amino acids from 
biological matrices. From seven to thirty days of age, chicks were fed diets in which fatty 
acids were provided from flaxseed oil, canola oil, fish oil, or lard, each of which has a 
distinctive fatty acid profile.127 At 30d of age, abdominal adipose tissue was harvested 
and snap-frozen from five chicks in each group. Approximately 100 mg samples of 
adipose tissue from each of the chicks was homogenized and subjected to a previously 
described extraction protocol.126 Samples were analyzed via UPLC-HRMS on the 
Exactive Plus (Thermo Fisher Scientific, Waltham, MA). Bile acids are most abundant in 
the intestinal tract of mammals, making this the ideal sample type to validate the 




10% fat. The duodenums from mice were removed and bile acids extracted using the 
acidic acetonitrile method.125 Samples were analyzed as previously described. All tissue 
extracts were spiked with deuterated standard mixture at a final concentration of 50nM 
for quantitation using isotope dilution.  
Results and discussion 
Separation 
 
The chromatographic conditions employed by the described method allow for optimized 
analysis of the 27 N-acyl amino acids by providing well-resolved, discrete peaks with 
preferred gaussian shapes (Table 3-1). Of the 20 bile acid standards analyzed, 17 
spectral features were detected (Table 3-1). Many of the bile acids investigated are 
simple isomers either differing by the location of a single hydroxyl or a change in 
stereochemistry. The chromatographic conditions facilitate the complete resolution of 
several isobaric compounds, which is demonstrated by the three distinct spectral features 
at 407.2803 m/z. CA, aMCA, and bMCA all have the same m/z, thus separation in the 
mass domain was not possible. However, as seen in Figure 3-2, the standards are clearly 
resolved from each other in the time domain. As expected, CA should be retained 
differently than the muricholic acids (α and β) because the hydroxyl changes from the 6th 
position on the B ring to the 12th position on the C ring of the steroid structure (Figure 3-
2). Surprisingly, the two diastereomers aMCA, and bMCA, have the same m/z as CA and 
are well resolved with retention times of 8.2 min and 8.4 min respectively. There are 
additional isomers with an m/z of 407.2803 that were not analyzed, but this separation 
scheme shows great potential in resolving those isomers as well. Conversely, some 
isomers were unable to be separated within the analysis, leading to joint identifications 
seen in Table 1. An example of this can be seen when comparing CDCA (hydroxyl at 7 
position), DCA (hydroxyl at the 12 position), and HDCA (hydroxyl at the 6 position). Even 
though they are all constitutional isomers, CDCA and DCA have identical retention times 
at 10.3 minutes while HDCA has a retention time of 9.2 minutes (data not shown). 
Furthermore, the separation provided by reverse-phase UPLC reduces the risk of 
suboptimal detection of the elmiric acids and bile acids by resolving them from the polar 




Table 3-1: Detection parameters for metabolite standards 
 









N-acyl Amino Acids               
N-dodecanoyl valine C17H33NO3 11.3 [M-H]
- 298.2388 298.2385 1.01 0.005-50.0 
N-dodecanoyl leucine C18H35NO3 11.6 [M-H]
- 312.2544 312.2545 0.32 0.005-50.0 
N-dodecanoyl phenylalanine C21H33NO3 11.7 [M-H]
- 346.2388 346.2385 0.87 0.005-50.0 
N-palmitoleoyl valine C21H39NO3 12.7 [M-H]
- 352.2857 352.2857 0.00 0.005-50.0 
N-palmitoyl valine C21H41NO3 13.6 [M-H]
- 354.3014 354.3014 0.00 0.005-50.0 
N-palmitoleoyl leucine C22H41NO3 13.0 [M-H]
- 366.3014 366.3014 0.00 0.005-50.0 
N-palmitoyl leucine C22H43NO3 13.8 [M-H]
- 368.3170 368.3174 1.09 0.005-50.0 
N-linoleoyl valine C23H41NO3 12.9 [M-H]
- 378.3014 378.3015 0.26 0.005-50.0 
N-oleoyl valine C23H43NO3 13.7 [M-H]
- 380.3170 380.3171 0.26 0.005-50.0 
N-stearoyl valine C23H45NO3 14.6 [M-H]
- 382.3327 382.3327 0.00 0.005-50.0 
N-linoleoyl leucine C24H43NO3 13.3 [M-H]
- 392.3170 392.3168 0.51 0.005-50.0 
N-oleoyl leucine C24H45NO3 13.9 [M-H]
- 394.3327 394.3322 1.27 0.005-50.0 
N-stearoyl leucine C24H47NO3 14.8 [M-H]
- 396.3483 396.3484 0.25 0.005-50.0 
N-eicosapentaenoyl valine C25H39NO3 12.3 [M-H]
- 400.2857 400.2852 1.25 0.005-50.0 
N-palmitoleoyl phenylalanine C25H39NO3 12.9 [M-H]
- 400.2857 400.2857 0.00 0.005-50.0 
N-palmitoyl phenylalanine C25H41NO3 13.8 [M-H]
- 402.3014 402.3014 0.00 0.005-50.0 
N-eicosanoyl valine C25H49NO3 15.6 [M-H]
- 410.3640 410.3641 0.24 0.005-50.0 
N-eicosapentaenoyl leucine C26H41NO3 12.6 [M-H]
- 414.3014 414.3012 0.48 0.005-50.0 
N-eicosanoyl leucine C26H51NO3 16.1 [M-H]
- 424.3796 424.3798 0.47 0.005-50.0 
N-docosahexaenoyl valine C27H41NO3 12.7 [M-H]
- 426.3014 426.3019 1.17 0.010-50.0 
N-linoleoyl phenylalanine C27H41NO3 13.2 [M-H]
- 426.3014 426.3013 0.23 0.005-50.0 
N-oleoyl phenylalanine C27H43NO3 13.9 [M-H]






Table 3-1 continued 
 
  









N-stearoyl phenylalanine C27H45NO3 14.7 [M-H]
- 430.3327 430.3321 1.39 0.005-50.0 
N-docosahexaenoyl leucine C28H43NO3 13.0 [M-H]
- 440.3170 440.3170 0.00 0.005-50.0 
N-eicosapentaenoyl phenylalanine C29H39NO3 12.6 [M-H]
- 448.2857 448.2854 0.67 0.005-50.0 
N-eicosanoyl phenylalanine C29H49NO3 15.8 [M-H]
- 458.3640 458.3636 0.87 0.005-50.0 
N-docosahexaenoyl phenylalanine C31H41NO3 13.0 [M-H]
- 474.3014 474.3012 0.42 0.005-50.0 
Bile acids               
Chenodeoxycholic/ Deoxycholic acid  C24H40O4 10.3 [M-H]
- 391.2854 391.2881 6.90 0.250-100 
Hyodeoxycholic acid C24H40O4 9.2 [M-H]
- 391.2854 391.2879 6.39 0.100-100 
Ursodeoxycholic acid C24H40O4 9.0 [M-H]
- 391.2854 391.2879 6.39 0.025-100 
α-Muricholic acid C24H40O5 8.2 [M-H]
- 407.2803 407.2828 6.14 0.250-100 
β-Muricholic acid C24H40O5 8.4 [M-H]
- 407.2803 407.2831 6.87 0.250-100 
Cholic acid C24H40O5 8.8 [M-H]
- 407.2803 407.2826 5.65 0.025-100 
Glycolithocholic acid C26H43NO4 10.4 [M-H]
- 432.3119 432.3122 0.69 0.001-100 
Glycochenodeoxycholic acid C26H43NO5 9.0 [M-H]
- 448.3068 448.3072 0.89 0.001-100 
Glycodeoxycholic acid C26H43NO5 9.1 [M-H]
- 448.3068 448.3075 1.56 0.001-100 
Glycocholic acid C26H43NO6 8.0 [M-H]
- 464.3018 464.3017 0.22 0.025-100 
Taurolithocholic acid C26H45NO5S 13.4 [M-H]
- 482.2946 482.2952 1.24 0.025-100 
Tauroursdoexycholic acid C26H45NO6S 8.7 [M-H]
- 498.2895 498.2893 0.40 0.025-100 
Taurohyodeoxycholic acid C26H45NO6S 8.9 [M-H]
- 498.2895 498.2898 0.60 0.005-100 
Taurochenodeoxycholic/ 
Taurodeoxycholic acid 
C26H45NO6S 10.7 [M-H]- 498.2895 498.2893 0.40 0.005-100 
Taurocholic acid C26H45NO7S 8.9 [M-H]
- 514.2844 514.2844 0.00 0.001-100 
Tauro-α/β-muricholic acid C26H45NO7S 7.9 [M-H]
- 514.2844 514.2845 0.19 0.005-100 
Tauro-ω-muricholic acid C26H45NO7S 8.3 [M-H]










All N-acyl amino acids were detected as their respective deprotonated molecular ions [M-
H]- with a mass error of less than 2 ppm. However, spectral peaks with exact m/z 
correlating to noncovalent dimers [2M-H]- were also detected for several elmiric acids at 
identical retention times to the parent molecular ion (Figure 3-3).  
Bile acids were all detected as [M-H]- species. The mass accuracy facilitated by Orbitrap 
mass spectrometry allowed mass errors of less than 5 ppm for most standards. CA, 
aMCA, bMCA, UDCA, HDCA, and CDCA/DCA had mass errors between 5 and 7 ppm. 
Calibration curves were generated for all 44 standards to validate a linear relationship 
between area and concentration (shown in Supporting Information). All standards 
displayed good linear fits with average slope equal to 0.86, and average coefficients of 
determination equal to 0.97. Detection information is compiled in Figure 1. The lower limit 
of detection for the bile acids ranged from 1 nM (the lowest standard analyzed) for many 
of the glycine and taurine conjugated bile acids to 250 nM for many of the aliphatic bile 
acids. It is assumed that compounds with structural similarities to GCDCA are more easily 
ionized via ESI, allowing for the detection at lower concentrations. N-acyl amino acids 
displayed linear ranges down to 5.0 nM, except DHAV, which was not detected at 






Figure 3-3: Representative illustration of noncovalent N-acyl amino acid dimers detected by HRMS. 




Two pairs of lipoamino acids (EPAV and PMOF as well as DHAV and LINF) were isobaric; 
and, though the standards had slightly differing retention times, resolution is potentially 
convoluted in biological samples where matrix effects cause subtle changes in 
chromatography. Although chromatographic resolution of both pairs was achieved in the 
present work, tandem MS can provide an additional level of resolution if necessary. To 
illustrate this, PRM was used to isolate the parent ions and fragment them for 
differentiation in the mass domain. Product ions corresponding to the respective amino 
acids were observed as the most prevalent fragments in the PRM experiments. Thus, 
these ions were chosen for quantitation. Surprisingly, the acyl fragments were not 
observed. A summary of the MS/MS data for the two pairs of isobaric lipoamino acids is 









Table 3-2: Differentiation of isobaric N-acyl amino acids using Parallel Reaction Monitoring 
Campound Fragment Formula RT Species Calculated m/z Observed m/z Conc. Range (µM) 
Eicosapentaenoyl valine Eicosapenaenoate C20H29O2- 12.3 [M-H]- 301.2173 not detected N/A 
Eicosapentaenoyl valine 
 
 C5H10NO2- 12.3 [M-H]- 116.0717 116.071 0.05-50 µM 
Palmitoleoyl phenylalanine Palmitoleate C16H29O2- 12.7 [M-H]- 253.2173 not detected N/A 
Palmitoleoyl phenylalanine 
 
C9H10NO2- 12.7 [M-H]- 164.0717 164.072 0.05-50 µM 
Docosahexaenoyl valine Docosahexaenoate C22H31O2- 13.3 [M-H]- 327.2330 not detected N/A 
Docosahexaenoyl valine 
 
 C5H10NO2- 13.3 [M-H]- 116.0717 116.071 0.5-50 µM 
Linoleoyl phenylalanine Linoeleate C18H31O2- 13.0 [M-H]- 279.2330 not detected N/A 
Linoleoyl phenylalanine 
 








Relative quantitation of N-acyl amino acids in biological samples 
 
18 spectral features corresponding to N-acyl amino acids from the synthetic library were 
detected and their peaks were integrated. The data was analyzed using Partial Least 
Squares Differential Analysis (Figure 3-4) and visualized using box and whisker plots and 
stacked bar graphs. Chicks which had been fed lard-supplemented diets displayed the 
highest levels of total N-acyl amino acids in adipose tissue. As expected, the profile of 
elmiric acids was influenced by the fatty acid composition of the various diets. 
Supplementation with fish oil, which is rich in docosahexaenoic acid, resulted in elevated 
levels of N-docosahexaenoyl leucine, N-docosahexaenoyl valine, and N-
docosahexaenoyl phenylalanine. In all other diets, these DHA-conjugated amino acids 
were absent. PLS-DA showed clear separation between the four diets as a function of N-
acyl amino acid profile. DHAV, DHAL, and DHAF are prominent drivers of the separation 
in the PLS model, with Variable Importance in Projection (VIP) scores greater than 1. N-
acyl amino acids were also detected in the serum of chicks from the same study, but the 
tissue extracts garnered better data. This is not surprising, as the enzyme responsible for 
the acylation, PM20D1, has been identified in adipocytes.11  
Detection of N-AAAs and bile acids in serum 
While N-acyl amino acids and bile acids were detected best in their respecitvely ideal 
sample types, both sets of molecules were detected in serum. As previously decribed, 
serum from the broiler chicks was extracted and analyzed via UPLC-HRMS. While the 
peak intensities of N-acyl amino acids from serum were lower than those from tissue, 
most of the compounds were detected in both sample types. Additionally, six bile acids 






Figure 3-4: Detection of metabolites in biological samples from broiler chicks and mice. A) PLSDA of the 
N-acyl amino acids detected in avian adipocytes. Data is grouped by diet. B) Graphic illustrating the 




Absolute quantitation of bile acids in biological samples 
 
Samples were extracted using the acidic acetonitrile protocol.128 After UPLC-HRMS, 
areas of the extracted-ion chromatograms were calculated for all detected bile acids and 
deuterated standards. Using the calibration curves, exact concentrations were calculated 
for 15 compounds. Five of the detected bile acids were above the highest standard 
analyzed and were not quantifiable. Table 3-3 shows the 10 bile acids that were quantified 
with the standard errors for each experimental condition. This biological data shows it is 
possible to simultaneously quantify several bile acids, including some isomeric 







Table 3-3: Calculated concentrations of bile acids extracted from mouse duodenum 
Bile Acid 
Conc.  (µM) 
10% Fat 
chenodeoxycholate/deoxycholate(CDCA)/(DCA) 10.01 ± 4.1 
hyodeoxycholate (HDCA) 0.85 ± 0.58 
ursodeoxycholate (UDCA) 0.35 ± 0.24 
beta-muricholate (bMCA) 22.01 ± 7.4 
alpha-muricholate (aMCA) 22.73 ± 5.31 
glycochenodeoxycholate (GCDCA) 0.02 ± 0.0056 
glycodeoxycholic acic (GDCA) 0.04 ± 0.011 
taurolithocholate (TLCA) 0.16 ± 0.030 
taurochenodeoxycholate (TCDCA) 86.67 ± 20. 




In conclusion, a single method using reverse-phase UPLC and electrospray high-
resolution mass spectrometry was developed for detection of both N-acyl amino acids 
and bile acids. The method provides desirable chromatographic resolution of many bile 
acid isomers and can provide additional resolution of isobaric N-acyl amino acids if a 
hybrid orbitrap with PRM capability is used. Moreover, the method is suitable for profiling 
both bile acids and N-acyl amino acids in biological systems. In the future, as more 
biologically active N-acyl amino acids are discovered, the synthetic library of standards 
and the analytical method can be readily expanded to become more comprehensive. 






Chapter 3B: Expression of N-acyl amino acids is influenced by fasting-induced 
lipolysis and dietary supplementation with exogenous fatty acids 
Introduction 
Investigation of adaptive thermogenesis has been recently reinvigorated, since energy 
expenditure pathways are a promising target for therapy of metabolic diseases.10 Brown 
adipose tissue (BAT) and, to some extent, beige adipose tissue are the primary organs 
responsible for thermogenesis. These adipocytes can promote energy expenditure 
through a number of molecular mechanisms, which are being revealed by emergent 
research. Uncoupling protein 1 (UCP1) dependent means of thermogenesis have 
classically attracted much of the attention, but UCP1-independent mechanisms are 
gaining awareness. Several classes of small molecule thermogenic stimulators have 
been studied, and the elucidation of their mechanisms is underway.129 One such family 
of metabolites, N-acyl amino acids (N-AAAs), recently demonstrated mitochondrial 
uncoupling activity—promoting thermogenesis and glucose homeostasis in mice.11, 130 As 
endogenously-expressed modulators of energy expenditure, N-AAAs possess potential 
for the safe combat obesity and pathological metabolic disease.8 While peptidase M20 
domain containing 1 (PM20D1) is known to regulate N-AAAs in vivo by both hydrolysis 
and synthesis, the expression of N-AAAs is not well understood. For instance, they entail 
a diverse assortment of amino acid-bound fatty acids, but the selectivity of their synthesis 
has not been described. Likewise, it is not known whether PM20D1 is solely responsible 
for the acylation or if enzyme expression is even the most prominent way of regulating N-
AAA synthesis. 
Considering these questions, we hypothesized that lipolysis, through release of free fatty 
acid substrates, may regulate abundance of N-acyl amino acids. To study this, circulating 
N-AAAs can be measured during a period of induced lipolysis. Avians represent a suitable 
animal model, given the relative ease of inducing lipolysis via acute food withdrawal. In 
addition, they lack BAT, suggesting that UCP1-independent mechanisms of 
thermogenesis may be particularly active. If, indeed, circulating fatty acids are readily 
incorporated into N-AAAs, diet may have a direct impact on N-AAA profile and 




compositions can aid in illuminating any selective incorporation of fatty acids into N-AAAs. 
These studies require a method to quickly and generally profile N-AAAs from biological 
samples. Liquid chromatography paired with mass spectrometry provides an apt 
instrumental platform for accomplishing this goal with the desired sensitivity. The high 
degree of specificity afforded by mass spectrometry allows discrimination among N-
AAAs, while the chromatography provides temporal resolution and ease of quantitation.  
Using such a platform, the in vivo expression and regulation of N-AAAs can be monitored 
to provide insight into this UCP1-independent means of promoting thermogenesis. This 
fundamental research provides invaluable precedence for forthcoming attempts to 
improve metabolic health by leveraging endogenous thermogenic mechanisms.  
Materials and methods 
Materials 
HR Series NEFA-HR (2) assay kit was purchased from Wako Diagnostics (FUJIFILM 
Wako Diagnostics, Mountain View, CA). Chloroform, hydrochloric acid, HPLC grade 
methanol, HPLC grade acetonitrile, HPLC grade water, and formic acid were purchased 
from Fisher Scientific (Waltham, MA). 
Animals and diets 
All animal procedures were approved by the University of Tennessee Institutional Animal 
Care and Use Committee. Mixed-sex Cobb 500 broiler chicks were obtained from a local 
hatchery and used for both the sequential fasting and diet studies. For the fasting study, 
chicks were fed a commercial broiler starter diet ad libitum, beginning at hatch. At 21 d of 
age, chicks were randomly allocated to one of five experimental groups: continued ad 
libitum feeding, fasted for four, eight or twelve hours (n=10), or fasted for 12 hrs and then 
returned to ad libitum feeding for two hours (n=5). For the diet study, chicks were fed ad 
libitum a commercial starter diet from hatch until 7 d, then switched to experimental diets 
containing fat (8% wt:wt) from lard (LA), canola oil (CA), flaxseed oil (FL), or fish oil (FO) 
into a commercially formulated starter diet base, as previously described. Chicks were 
fed experimental diets from 7 to 30 d. For both studies, chicks were euthanized by CO2 




transferred to 10 ml serum separator tubes (Fisher Scientific, Pittsburgh, PA), and serum 
was separated by centrifugation. Samples of abdominal adipose tissue were dissected 
and immediately snap-frozen. Serum and tissue samples were stored at -80o C until 
extraction for N-AAA analyses. 
Extraction of N-acyl amino acids 
For each sample, 100 mg of tissue or 0.100 mL of serum was aliquoted into a 2 mL 
microcentrifuge tube. 800 µL of a mixture containing 1:1 0.1 N aqueous hydrochloric acid: 
methanol was added, followed by 400 µL of chloroform.126 Each sample was vortexed for 
1 minute and centrifuged for 5 minutes at 13,000 rpm. The organic (lower) phase was 
isolated and concentrated to dryness under a stream of dry nitrogen gas. Each sample 
was resuspended in 300 µL of 10% chloroform in methanol prior to analysis.  
Measurement of N-acyl amino acids and free fatty acids 
Relative quantitation of N-AAAs was performed via a previously-reported Ultra-
Performance Liquid Chromatography—Mass Spectrometry (UPLC-HRMS) method which 
was developed and validated in-house. In short, reverse-phase chromatography using a 
C-18 column with a solvent system of 0.1% formic acid in water and 0.1% formic acid in 
acetonitrile was employed for separation. The chromatograph was coupled to an Orbitrap 
Exactive Plus mass spectrometer (Thermo Fisher Scientific, Waltham, MA) equipped with 
an electrospray ionization source. Samples were analyzed in negative mode. Using this 
method, serum and tissue samples were screened for 27 N-AAAs featuring hydrophobic 
amino acids valine, leucine, and phenylalanine by matching exact m/z and retention time 
to an in-house standard library.  A commercially available colorimetric assay kit was used 
to measure serum non-esterified fatty acid (NEFA) levels (Wako Chemicals, Neuss, 
Germany).  
Data analysis 
After UPLC-HRMS analysis, data files were converted from .raw to .mzml.121 Peaks for 
all detected N-AAAs were integrated using Metabolomic Analysis and Visualization 
Engine (MAVEN), an open-source software for processing LC-MS data.119 Peak areas of 




R packages (version 3.4.3) were employed for multivariate analysis, statistical power 
analysis, and data visualization.122-124, 131 ANOVA and correlation analyses were 
conducted using MetaboAnalyst version 4.0.132 Microsoft Excel was used to construct bar 
graphs and perform additional statistical tests.  
PM20D1 expression 
Expression of PM20D1 was quantified in abdominal adipose tissue of fed and 12 hr fasted 
chicks (n=6/group). Total RNA was isolated from approximately 200 mg of abdominal 
adipose tissue using InvitrogenTM TRIzolTM (Invitrogen, Carlsbad, CA) and reverse 
transcribed to cDNA using a commercial kit (iScript cDNA Synthesis Kit, Bio-Rad 
Laboratories, Hercules, CA). Primers specific for PM20D1 and TBC1 domain family, 
member 8 (TBC1D8; used as a housekeeper) were designed using PRIMER3 and based 
on Gallus_gallus-5.0 (Ensembl release 94).133 QPCR was performed in triplicate for each 
sample using iQ SYBR Green Master Mix (Bio-Rad Laboratories, Hercules, CA), as 
previously described. 134  
Results 
Fasting-induced lipolysis study 
The pool of 27 N-AAA reference standards included nine fatty acids, in lengths from 12-
22 carbons, combined with three amino acid head groups (valine, leucine, and 
phenylalanine). These head groups were chosen because of the emphasis on 
hydrophobic amino acids in the work published by the Spiegelman lab.11 Of these, 18 
endogenous N-acyl amino acids were detected in serum of broiler chicks that were fed, 
progressively fasted, or fasted and re-fed. The pool of detected N-AAAs included species 
containing eight different fatty acids and the amino acids valine, phenylalanine, and 
leucine. Species containing longer-chain fatty acids (20:0, 20:5, and 22:6) were largely 
absent, with the exception of docosahexaenoyl leucine. Moreover, oleoyl-conjugated 
amino acids accounting for approximately 35-40% of the detected N-AAA pool.  This is 
readily explained by the corn-based diet of the chicks. Effects of progressive fasting on 
the abundance of circulating N-AAAs was evaluated by ANOVA. Fasting significantly 




Partial least squares discriminant analysis (PLS-DA) illustrates the incremental 
separation between fasting durations (Figure 3-5). Total abundance of N-AAAs increased 
(235%) after four hours compared to the fed group (p=0.0577). Levels after eight hours 
of feeding increased by an additional 229% compared to four hours of fasting (p=0.0085) 
and were 464% greater than fed levels (p=0.00005). No further increases were found 
after an additional four hours of fasting (8 vs. 12 levels; p=0.28).  Serum N-AAAs in fasted 
chicks were rapidly restored to those of ad libitum fed chicks by two hours of refeeding 
(Figure 3-6). Levels in the fasted/re-fed group were not different than those from fed 
controls (p=0.24). Total N-AAA and serum NEFA levels were compared across time 
points to assess the relationship free fatty acid availability and N-AAA synthesis. 
Circulating NEFA levels exhibited a similar profile with respect to the fasting state and 
were correlated with total abundance of N-AAAs (r= 0.976 from comparison of mean total 
N-AAA to mean total NEFA). These data support the hypothesis that lipolysis is 










Figure 3-6: Metabolites quantitated in serum of fasted chicks. A) N-AAAs; B) NEFA 
 
 
In addition to the analysis of bulk N-AAA changes across fasting states, relative percent 
composition of individual N-AAA species was evaluated (Figure 3-7). Abundance of each 
individual N-AAA was normalized to the total pool level and analyzed by ANOVA. Six N-
AAAs varied across the duration of fasting (p < 0.05). In general, those containing 
saturated fatty acids decreased with fasting, while those containing unsaturated fatty 
acids increased. This can be observed when comparing percentages of stearoyl (18:0) 
leucine, oleoyl (18:1) valine, and linoleoyl (18:2) phenylalanine among groups. Stearoyl 
leucine displayed a marked percent-of-total decrease over the fasting period, while 
percentages of the two N-AAAs that contained unsaturated 18-carbon acyl chains both 
increased with duration of fast. This may corroborate preexisting literature which suggests 
that unsaturated fatty acids are more freely mobilized than those which are more highly 
saturated.135 The relationship between saturation of the fatty acid tail and abundance 
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Adipose tissue synthesizes and secretes Peptidase M20 domain-containing enzyme 1 
(PM20D1), a bidirectional enzyme that regulates both synthesis and degradation of N-
AAAs.11  The Align tool in UniProt (uniprot.org) was used to determine that conservation 
of the amino acid sequence of PM20D1 is relatively high (56.5 %) between chicken and 
mouse, the species in which PM20D1 was shown to regulate N-AAA levels, and that the 
active sites are perfectly conserved between the two species. Expression of PM20D1 was 
analyzed by QPCR in adipose tissue to determine if fasting coordinately regulated the 
dominant enzyme responsible for N-AAA abundance.  Despite the increase in circulating 
N-AAAs, expression of PM20D1 was decreased in fasted (12 hr) vs. fed controls (p = 
0.03, Figure 3-9). This suggests that the condensation to produce N-AAAs may be more 
dependent on substrate availability than enzyme expression.  In addition, because 
PM20D1 also hydrolyzes N-AAAs, it suggests that downregulation of this enzyme may 
be a mechanism to sustain N-AAA levels during periods of energy restriction. 
Diet study 
Adipose tissue plays a key role in N-AAA synthesis through both expression of the 
PM20D1 enzyme and as the source of fatty acids that are esterified with amino acids.  It 
is also a potential clinically relevant functional target of N-AAAs because of their 
thermogenic effects that are mediated through uncoupling of mitochondrial metabolism. 
However, local synthesis of N-AAAs within adipose tissue has not been reported. 
Abundance of N-AAAs was analyzed in adipose tissue homogenates. Chicks were fed 
diets enriched in different types of fatty acids to determine if N-AAA profiles reflected 
tissue fatty acid composition. A total of 18 N-AAA species, containing 7 different fatty acid 
tails, were detected in adipose tissue homogenates from one or more diet groups. No 
species featuring stearoyl or eicosanoyl tails were detected. Composition of the N-AAA 
pool varied markedly in response to dietary fat source. When combined based on fatty 
acid component, five N-AAA subpools (those containing palmitic, oleic, linoleic 















Figure 3-10: N-AAAs (grouped by fatty acid) detected in chicks fed 4 distinct diets. The inset shows the 






























For example, DHA- and EPA-conjugated amino acids were detected in tissue of chicks 
fed diets enriched with fish oil, and to a lesser extent flaxseed oil, but absent in the canola 
and lard groups. However, these data also suggest that some fatty acids, may be 
preferentially incorporated in N -AAAs. For example, across the four diets, tissue levels 
of linoleic acid were lower in the lard group (~ 4%) than in the other three diets (~ 14-
18%). In contrast, N-AAAs containing linoleic acid were more abundant in lard-fed chicks 
(~ 35%) than in the three other diets (~ 10-25%). Differential effects of diet on N-AAA 
composition relative to tissue fatty acid profile were particularly apparent for species 
containing DHA. This fatty acid comprised ~ 8% of tissue fatty acids in fish oil-fed chicks, 
yet was present in ~ 26 % of N-AAAs .127  In contrast, EPA was also enriched in tissue 
from the fish oil group and in fact represented a greater proportion (~ 13%) of tissue fatty 
acids than did DHA.  However, EPA was markedly less abundant (~ 0.8%) than DHA (~ 
26%) in the N-AAA pool of fish oil chicks, and only one EPA-containing N-AAA species 
(eicosapentaenoyl valine) was detected in adipose tissue. Similarly, while the oleoyl 
(18:1) tails accounted for 28-48 % of neutral lipid in tissue and the linoleoyl (18:2) tails 
accounted for only 4-19%, oleoyl and linoleoyl amino acids were equally represented in 
each of the 4 groups. In combination, these data indicate that while the dietary fatty acid 
profile does influence the composition of the tissue N-AAA pool, there appear to be 
additional, selective mechanisms of N-AAA synthesis in adipose tissue.  
Palmitoleoyl leucine and palmitoleoyl phenylalanine were elevated in the fish-fed group 
as compared to the canola and flaxseed groups. Since fish oils are a dietary source of 
palmitoleic acid (up to 7% of the total fatty acids)136 enrichment in palmitoleoyl-conjugated 
amino acids for FS is expected. However, the mean levels of these two metabolites were 
highest (but highly variable) in LA. As evidenced by the shaded matrix of Pearson 
correlation constants (Figure 2-11), N-AAAs were plainly correlated based on their 
featured fatty acids. For instance, DHA-bound amino acids displayed high positive 
correlations with one another, as well as a less pronounced positive correlation with 
eicosapentaenoyl valine. Oleoyl-bound AAs displayed a decidedly negative correlation 
with DHA-bound AAs, and a positive correlation to linoleoyl, palmitoyl, and dodecanoyl-
bound AAs. This illustrates the expected relationship between dietary abundance of fatty 












As evidenced by the inverted ratios of EPA/DHA and oleate/linoleate in neutral lipid and 
N-AAA pool, there appears to be a preferential incorporation of fatty acids with higher 
degrees of unsaturation. These data suggest that biosynthesis may be selective or 
indirectly regulated by preferential mobilization of certain fatty acids. This trend is 
corroborated by the absence of stearoyl amino acids detected in either sample type, 
despite accounting for 4-9% of neutral lipid from the adipose tissue. However, lauryl 
amino acids were abundant in serum and tissue—a trend which is initially puzzling due 
to the repeatedly demonstrate preference for incorporation of unsaturated tails. It has 
been documented that the mobilization of fatty acids into plasma is not proportional to 
tissue composition. While relative mobilization is positively correlated with unsaturation, 
it is negatively correlated to chain length.135 Previous work showed that polyunsaturated 
species are most readily mobilized, yet EPA exceeds the relative mobilization of DHA due 
to the negative contribution of chain length.135 However, lauric acid was less easily 
mobilized than longer fatty acids.137 This suggests that—while preferential mobilization 
appears to indirectly regulate biosynthesis by biasing the pool of substrates—PM20D1 
does favor the incorporation of certain fatty acids independent of substrate concentration.  
The observation that, in some cases, unsaturated fatty acids are preferentially conjugated 
amino acids is intriguing, given recent findings by Lin and coworkers.130 They observed 
an incremental increase in uncoupling activity based on unsaturation (C18:0-Phe < 
C18:1-Phe < C18:2-Phe) which drops off for polyunsaturated species. This begins to 
reveal a cascade in which diet—by influencing the pool of substrates for N-AAA 
synthesis—can promote differential expression of N-AAAs with greater therapeutic 
impact. 
It is noteworthy that DHA-Leu and DHA-Phe also accounted for a small percentage of the 
detected N-AAAs in the flaxseed group. This is explained by the known mechanism 
through which α-linoleic acid (ALA) is converted to DHA. Linoleic acid (LA) and α-linoleic 
acid compete for a single set of desaturating and elongating enzymes, which generally 
limits an appreciable conversion of ALA to DHA.138, 139 However, when the relative ratio 




abundance of ALA (39.0-60.4%), making it one of the richest dietary sources of ALA.140, 
141 Thus, the presence of DHA-conjugated amino acids in the flax samples is consistent 
with the existing literature on conversion of ALA to DHA.  
It is also notable that certain N-AAAs have demonstrated analgesic and anti-inflammatory 
activities in previous studies.95, 99, 100 Certain N-AAAs, especially those featuring 
polyunsaturated fatty acids, have been shown to increase the ratio of J series 
prostaglandins to E series both in vitro and in vivo.99 Prostaglandin ratios favoring the J 
series have been previously shown to promote the resolution of inflammation.99 Most 
recently, the roles of N-AAAs in nociception were demonstrated by the antinociceptive 
behaviors of PM20D1 knockout mice exposed to chemical and inflammatory pain stimuli 
and the corresponding decrease of some N-AAAs in response to chemical pain 
stimulus.142  This implicates N-AAAs as potential regulators of physiologic nociception. 
Considering the observation that fasting readily induces N-AAA formation, the current 
work may begin to reveal the molecular mechanism of pain attenuation through fasting. 
In several recent studies, fasting has been shown to affect nociception in a way that 
suggests improved pain tolerance relative to postprandial states.143-145 This has been 
demonstrated in both mice and humans. In one case, hunger was shown to selectively 
inhibit inflammatory pain in comparison to acute pain.145 Additionally, previous work has 
implicated caloric restriction as a way to attenuate inflammatory response to reperfusion 
following ischemia.146 More broadly, intermittent fasting and caloric restriction have 
demonstrated an ability to reduce inflammation, especially in metabolically unhealthy 
patients.147-151  
Since N-AAAs have demonstrated these abilities and their abundance has been positively 
correlated with fasting duration, they may be involved in an endogenous process of pain 
and inflammation regulation based on need state. Similarly, considering the known 
vulnerability of cancer cells to nutrient deprivation and the documented ability of some N-
AAAs to inhibit cancer cell proliferation, N-AAAs may partially account for the observed 
benefits of fasting during cancer therapy.96, 152 Given these demonstrated relationships, 




clear influence of diet on their expression, N-AAAs may underpin the hypothesis that the 
benefits of fasting may depend, in part, on the composition of the baseline diet.  
Conclusions 
Parallel experiments demonstrate that lipolysis rapidly increases the total amount of N-
AAAs in serum and that the composition of dietary fatty acids notably influences N-AAA 
profiles in tissue. In the lipolysis study, the correspondence between serum NEFA levels 
and N-AAA abundance suggests that availability of free fatty acids may be a primary 
driver of acylation. In addition, it reveals potential mechanisms for lipolysis induced 
energy expenditure independent of protein uncouplers such as UCP1. In the case of 
exogenous fat supplementation, N-AAA profiles were distinctly influenced by the dietary 
fatty acid composition. When comparing the composition of neutral lipid in tissue, 
enrichment of the N-AAA pool with certain fatty acids was observed.  This begins to 
illuminate a probable complex regulation in which preferential mobilization of certain fats 
manipulates the pool of substrates, which are incorporated into N-AAAs with some 
selectivity. Furthermore, this information about the regulation of N-AAAs by fasting and 
diet may clarify the molecular mechanisms that underly the emerging benefits of calorie 












ZorO (Z-protein often repeated) is a small protein expressed by pathogenic 
enterohemorrhagic Escherichia coli (EHEC E. coli) which was recently discovered 
through bioinformatic searches. While its biological role is still being elucidated, it has 
been demonstrated to exhibit toxic effects on the cell when overproduced. This puzzling 
genetic ability for what, at first glance, appears to be self-destruction may be nuanced 
way for wild strains of bacteria to adapt to host environments or survive stress. This likely 
entails a much more minimal expression of ZorO, initiating subtle cell behavior that is less 
apocalyptic. In order to investigate the localization and function of endogenously-
expressed ZorO, the protein was be synthesized for biophysical experimentation using 
solid-phase peptide synthesis. In addition, several analogs of ZorO were synthesized to 
further enable an investigation of structure-activity relationship. These analogs include 
versions of ZorO with single amino acid mutations, as well as variants with “tags” for 
detection, purification, or capturing transient interactions. In the latter case, an unnatural 
replacement of the amino acid methionine (photo-methionine) was synthesized for 
incorporation into a synthetic peptide analog. This synthesis work required exploration of 
literature and reaction optimization, ultimately leading to a novel synthesis of photo-
methionine. Much of the synthetic groundwork for studying ZorO has now been laid, and 
efforts are underway to develop analytical methods for detecting ZorO in cell extracts—a 
daunting task considering the complex protein composition of the cell and the wide 
concentration ranges spanned by endogenously-expressed polypeptides.  
 
Preface 
The work in this chapter is previously unpublished. It is part of an ongoing collaborative 
project, in partnership with the Fozo microbiology lab at UTK, with more components than 
those described herein. The following account is biased towards the chemical component 
of the project, though ample attention is given to the biological rationale and larger goals. 





The forgotten proteins 
Though many proteins have been extensively studied, there remains a class of proteins 
that has been historically ignored by science. These are small proteins, defined as 
polypeptides that obtain their slight size—often less than 50 amino acids—by translation 
of small open reading frames (ORF).153 In other words, these polypeptides are 
synthesized independently instead of expressed by proteolytic cleavage of precursors. 
Many of these small proteins have been identified either through serendipity or by 
identification of their respective ORFs with bioinformatics.153 While the biological functions 
of some small proteins have been elucidated, many have unknown activity. Several have 
been confirmed to play a role in toxin-antitoxin (TA) loci. More specifically, the type 1 
toxin-antitoxin pair features a small, hydrophobic protein as the toxin and a strand of 
antisense sRNA as the antitoxin.154 These loci have been identified in both gram-positive 
and gram-negative bacteria.154 In some cases, toxicity is only induced when the mRNA 
responsible for encoding the toxin is overexpressed. Toxicity is repressed when the 
antitoxin base-pairs with the toxin mRNA.154  
ZorO, the type-1 toxin 
In recent years, a new type 1 TA family was identified in Escherichia coli through 
bioinformatic searches.13 This locus includes two 29 amino acid proteins, differing by a 
single residue, which are toxic to E. coli when overproduced. These have been termed 
ZorO and ZorP (Z-protein often repeated) and their respective antitoxins, OrzO and OrzP 
(overexpression reduces Z-protein toxicity).13 The focus of this project is the zorO-orzO 
system. Intriguingly, this locus is highly conserved in most pathogenic strains of E. coli 
but absent in common laboratory strains.14 In true type 1 TA fashion, OrzO binds the 5’ 
end of the mRNA encoding ZorO and represses toxicity in a target-specific manner.14 
While the toxin-antitoxin relationship is understood, there are looming and unanswered 
questions regarding the biological function of the ZorO protein including whether or not it 
serves a purpose besides its toxicity.14 Since domesticated strains of bacteria lack the 





An astounding number of these small proteins with known biological roles are membrane-
localized.15 In fact, 65% of small proteins produced by E. coli are predicted to contain a 
trans-membrane domain.15 ZorO follows this trend, as do other type 1 toxins. For 
instance, TisB, a small protein involved in a similar TA locus, has garnered some attention 
due to its function within membranes.155 Experiments show that it aligns antiparallel with 
itself to create dimers via the formation of 4 salt bridges by electrostatic attraction of 
oppositely charged residues. This has been termed a “charge zipper”, which has 
implications in transport (Figure 4-1).156 TisB has been shown to interrupt the proton 
gradient, which may be explained by the ability of the polar charge zipper interface to 
transport water into the hydrophobic bilayer core. This could lower the activation barrier 
for hydroxide ions and protons to pass through the membrane and be neutralized.156 It is 
reasonable to suspect that the biological role of ZorO may also be linked to its probable 
membrane localization. Moreover, preliminary results suggested that ZorO may mimic the 
function of TisB and form membrane-spanning dimers or oligomers. Certain ZorO 
derivatives with charged residues replaced do not confer toxicity (unpublished results, 
Fozo Lab, UTK). Thus, we hypothesized that ZorO may be forming salt bridges and self-
dimerizing to create channels that similarly facilitate the breakdown of proton gradients. 
In this way, it could abolish the link between nutrient synthesis and ATP production by 
uncoupling respiration.  
 
 






The chosen approach for investigating the biological question of ZorO’s mechanism of 
action involves a substantial amount of synthesis. To elucidate ZorO’s putative biological 
action and localization, appreciable amounts of ZorO are desired. Thus, an initial goal is 
the synthesis of native ZorO in milligram quantities, allowing the structure and potential 
oligomerization of ZorO to be probed in vitro. Synthesis is an attractive alternative to 
isolation and enrichment, which can be a significant challenge. 
It is also desirable to obtain analogs of ZorO for investigating structure-activity 
relationship. Analogs with single amino acid mutations can illuminate any influence of 
sequence on toxicity. Specifically, the charge of the 23rd residue, arginine (R) has been 
shown to be essential for ZorO toxicity. When R23 is replaced with a lysine via mutations 
to the zorO gene, positive charge is retained as is toxicity. When R23 is replaced with a 
neutral residue like leucine, the resultant peptide loses toxicity (unpublished results, Fozo 
laboratory, UTK). Thus, it is desirable to synthesize R23K and R23L mutants of ZorO to 
investigate the way that their structure and/or oligomerization may change in relation to 
that of native ZorO.  
If ZorO is indeed forming oligomers or recruiting other proteins to the membrane, then 
understanding these associations could provide invaluable data. To this end, photo-cross-
linking will be employed as a means of capturing protein interactions for study. In short, 
photo-cross-linking is a technique which allows strict temporal control over interactions, 
allowing transient complexes to be covalently captured (Figure 4-2).157 This is 
accomplished by introducing tags that decompose to highly reactive intermediates 
(carbenes, nitrenes, or radicals) when exposed to irradiation. These tags can either be 





Figure 4-2: Photo-cross-linking 
 
 
To allow photo-cross-linking, a variant of ZorO, containing a photoactivatable handle 
which will rapidly react with any molecules in immediate proximity, will be synthesized. 
The modification must be slight enough to avoid interference with the peptide structure 
and function, and stable enough to survive in a biological environment until irradiation. 
For this application, replacement of ZorO’s N-terminal methionine (M1) with a diazirine-
containing unnatural analog should allow the desired activity. This so-called photo-
methionine (Figure 4-3) has been used previously in photo-cross-linking applications with 
success.158, 159 
Attaching a handle for detection and purification of ZorO is another attractive modification. 
While many such tags entail attaching the target polypeptide to a second protein, creating 
a “fusion protein”, this has many disadvantages for the present study.160 These fusions 
often interfere with the folding of the protein, potentially impacting function.160 Especially 
when studying a protein as diminutive as ZorO, care must be taken to alter the molecular 
weight as little as possible to reduce the impact on function or transport. Therefore, low 







Figure 4-3: Structure of photo-methionine 
 
The short polypeptide sequence H-D-Y-K-D-D-D-D-K-OH, termed 1X-FLAG, has been 
successfully used for protein detection and purification. With the complimentary antibody, 
it can be used for immune-affinity purification or detection by western blotting.160 As the 
final synthetic objective, an analog of ZorO bearing this N-terminal 1X-FLAG will be 
made.In addition to these synthesis-heavy aims, a parallel goal includes establishing a 
method of analytically detecting ZorO extracted from cell cultures. This will be 
accomplished by UPLC-HRMS with an objective to optimize ZorO detection for eventual 
measurement of chromosomally-expressed ZorO.  
Overview of solid-phase peptide synthesis 
 
To synthesize the peptide, a traditional solid phase peptide synthesis (SPPS) was 
employed. Pioneered by Robert Bruce Merrifield, who was awarded the Nobel Prize in 
chemistry in 1984, SPPS has become the method of choice, as it boasts many 
improvements over solution phase approaches.161 Most notably, solid-phase synthesis 
allows minimal purification between successive reactions. There are many components 
necessary for SPPS, including a solid support, activating groups, linkers, and protecting 
groups.161 The general workflow is illustrated in Figure 4-4.161 The process begins with 
the C-terminal residue which has a protected N-terminus. It is then anchored to a solid-
support resin containing either by amidation or esterification. Once the C-terminal residue 
is linked to the resin, the N-terminus is deprotected, leaving the free Nα amine. The next 
residue, with an activated C-terminus and protected N-terminus, is added, creating the 
amide bond between residues. Successive deprotections and additions of prepared 














The most common of these strategies relies on fluorenylmethyloxy-carbonyl (Fmoc) and 
tert-butyl (tBu) protecting groups.161 Crosslinked polystyrene (PS) beads are widely used 
as the solid support, but require a low loading to assemble difficult sequences.161 
Liberation of the Fmoc-protected N-terminus is achieved by a brief treatment with 
piperidine and subsequent washing.161 Coupling reactions are carried out by addition of 
excess activated amino acid. Vigorous stirring is unnecessary and potentially detrimental, 
as diffusion phenomena dictate the reaction kitnetics.161 After the entire sequence is 
assembled, a global deprotection liberates the peptide from the solid support and 
simultaneously deprotects the side chains. This is accomplished by the use of an acidic 
cleavage cocktail containing silane scavengers to quench carbocations that are 
generated.161 The cocktail consists of trifluoroacetic acid, water, and triisopropyl silane.161 
This process affords intact peptides which can be isolated by precipitation, centrifugation, 
and lyophilization. This entire process can be accomplished manually, with potential 
intervention at each stop of the process, or automatically, with pre-programmed synthetic 
sequences. Each approach has its unique advantages and disadvantages.  
Precedence for diazirines in photo-cross-linking applications 
 
Diazirines were first synthesized and characterized in the 1960’s.162 Their notable 
attributes include a remarkable stability despite the strained appearance of the three-
membered ring, along with their ability to liberate nitrogen gas and form highly reactive 
carbene species upon photolysis, pyrolysis, or ultrasonication.162 Thus, diazirines make 
ideal functional groups for photo-cross-linking or photoaffinity labelling applications. 
Diazirines have a number of advantages over other commonly used photo-cross-linking 
groups. For example, benzophenone, a classic photoactivatable moiety, requires longer 
irradiation times to produce its reactive triplet state carbonyl.163 This introduces a risk for 
nonspecific labelling163 and could also present more opportunity to negatively affect cell 
viability. Perhaps the greatest advantage of the diazirine for photo-cross-linking 
applications is its compact size. When probing interactions, it is necessary to create a 
suitable mimic of the desired partner163 by choosing a tag that minimally changes its steric 
properties. Diazirines are nearly isosteric with methyl groups164 and among the smallest 




of diazirines is their short half-life, lending them high specificity.159 Their carbene 
intermediates undergo rapid quenching when not poised for crosslinking.164 In the 
absence of nearby molecules, carbenes are quickly quenched either by solvents or by 
internal rearrangement to form alkene species.165  
While aryl azides had been previously employed in crosslinking166, 167, diazirines were not 
used in this application until the early 90’s. In 1992, 3-[3-(3-(trifluoromethyl)diazirin-3-
yl)phenyl]-2,3-dihydroxypropionic acid was developed as a crosslinking reagent by 
Bochkariov and Kogon.168 In 1993, Khorana and coworkers designed and employed a 
diazirine-containing radiolabeled crosslinking reagent to understand the contact between 
Meta II rhodopsin and the retinal GTP binding protein transducin.169 A disulfide in the 
cross-linking reagent allowed it to make disulfide bonds with the cysteine residues in 
rhodopsin, followed by irradiation and cross-linking of the diazirine to transducin.162, 169 
This was followed by cleavage of the disulfide bond to transfer the radiolabel to 
transducin.169  In the years following, several diazirine-containing photo-labile reagents 
were used for cross-linking. For example, In 1998, Girshovich and associates used the 
diazirine reagent reported by Bochkariov and Kogon to investigate the interactions of 
heat-shock chaperone protein GroEL with membrane protein SecA, an integral 
component of translation machinery.170  
Diazirine derivatives of amino acids—specifically photo-methionine and photo-leucine—
for probing protein-protein interactions were introduced in 2005 by Theile and 
coworkers.159 These novel and unnatural amino acids were subjected to tests for toxicity 
and function. Addition of photo-leucine or photo methionine to cell cultures did not affect 
viability (via tryptan blue exclusion) or morphology.159 In addition, the brief irradiation 
required for photoactivation of the diazirines did not affect cell viability. Furthermore, it 
was demonstrated that photo-methionine can, at least partially, functionally replace 
methionine. This was determined by incorporating photo-amino acids into biomolecules 
in vivo, and observing that the fluorescence intensities and localization of 3 separate GFP 
fused GTPases were unchanged and the function of β-galactosidase was not impaired.159 
In the same publication, Theile and coworkers proved the ability of photo-methionine to 




proteins PGRMC1 and SREBP as well as PGRMC1 and Insig-1 using photo-cross-linking 
followed by immunoprecipitation and western blotting.159 
Since this original proof of concept was reported, photo-methionine has been employed 
in several other studies. In 2007, Muir and associates used the site-specific incorporation 
of photo-methionine to capture protein oligomerization of the Smad2 signaling protein.158 
They synthesized Fmoc photo-methionine and used it in a classic solid phase peptide 
synthesis to give a synthetic peptide that was added to a complimentary protein thioester, 
yielding a semi-synthetic protein bearing the diazirine functionality.158 Along with a control 
sample containing the unmodified protein, protein isolates were irradiated and subjected 
to western blotting. These experiments revealed cross-linked species with apparent 
molecular weights corresponding to dimers and trimers of Smad2. These species were 
barely detectable in the irradiated control and non-irradiated samples.158 Moreover, their 
strategic placement of the cross-linker unveiled a transient interaction between MH2 
regions of Smad2 that is dependent on post-translational modification.158 In 2012, Kölbel 
and coworkers employed photo-methionine and photo-leucine to investigate secondary 
peptide structure by interrogating intramolecular interactions.171 In this work, peptides 
containing photo-amino acids were irradiated and digested prior to mass spectrometric 
analysis. This process produced data that corroborated the proposed β-strand structure 
of the peptides in question.171 Recently, Lössl and associates employed photo-methionine 
and photo-leucine as a compliment to other techniques to study the interactions of 
nidogen-1 and laminin γ1.172 Their results were reported in 2014.172 
Methods 
Synthesis and characterization of photo-methionine 
 
Initially, the synthesis of photo-methionine was attempted via a modification of the method 
published by Thiele and coworkers (Figure 4-5).159 4-acetylbutyric acid (2) is allowed to 
stir in ammonium hydroxide at 0°C before the slow addition of hydroxylamine-O-sulfonic 
acid (HOSA).173 This yielded crude diaziridine 3, which is concentrated in vacuo and 
resuspended in methanol. Introduction of catalytic triethylamine, followed by slow addition 





Figure 4-5: Synthesis of photo-methionine by Thiele et. al. 
 
Chromatographic purification of 4 is followed by an attempted α-bromination of the 
carboxylic acid. This step proved problematic, and work to afford the α-halo acid in 
acceptable yield was a lengthy but fruitless endeavor. Despite many attempts at reaction 
optimization (Table 4-1), the pure, halogenated product was never achieved. Prolonged 
stirring of 5 in methanolic ammonia should give photo-methionine in 4 steps, yet this was 
not completed due to issues with the previous step. 
A second possible synthesis for photo-methionine was attempted as a means of 
circumventing the issues encountered during α-halogenation (Figure 4-6). Instead of 
introducing the diazirine at the beginning, this alternate route installs the labile 
functionality at the end. This could clearly be advantageous for protection of the labile 
functional group. This method begins with protected glutamic acid 6, which is subjected 
to Weinreb amidation to afford 7.158 Methylmagnesium iodide is added to 7, giving the 
glutamate-derived ketone 8.158 The ketone can then be subjected to ammonium 
hydroxide and HOSA173 or liquid ammonia and HOSA158, 174 to yield the diaziridine, which 
is subsequently oxidized to the corresponding diazirine to give protected photo-
methionine (9). Deprotection with trifluoroacetic acid (TFA) and HCl was reported to yield 
1.158 Issues with the diaziridination led to the investigation of an amended route based on 
































CCl4 85 °C 1.5 h 
 
NBS, cat. HBr CCL4 70 °C 1.5 h 
 
SOCl2, ICl CCl4 70 °C 1.5 h 
 
1) PBr3, Br2 
2) H2O 
neat 70-80 °C 10-20 h 
 




SOCl2 70 °C 2+ h 
 
NBS, H2SO4 TFA 70-85 °C 16 h 
 
 SOCl2, Br2 SOCl2 50 °C, then RT  ON 
 
SOCl2, Br2 SOCl2 50 °C, then RT  ON 
 
SOCl2, Br2 SOCl2 50 °C, then RT  ON 
 















1-(tert-butyl) 2-methyl 5-oxopyrrolidine-1,2-dicarboxylate (14): The novel synthesis 
of photo-methionine (Figure 4-8) begins with pyroglutamic acid, which was protected as 
described by Huy-Dinh et al.175 In short, 50 μL of concentrated hydrochloric acid was 
added to a solution of pyroglutamic acid (5g) in dry methanol (50 mL) and the mixture 
was stirred for 24 hours. Concentration in vacuo yielded an oil which was sufficiently pure 
in quantitative yield. Boc anhydride (12.0g), triethylamine (3.62g, 500uL), and DMAP 
(0.426g) were added to the resultant methyl ester (5g) in DCM. This mixture was 
permitted to react for 24 hours at room temperature and extracted with ether. The organic 
layer was washed with aqueous NaHSO4, followed by 1M Na2CO3, and finally brine. The 
ethereal solution was dried with MgSO4, filtered, and concentrated in vacuo. The product 
was purified on silica gel with 80:20 ether/petroleum ether to yield N-Boc methyl 
pyroglutamate (98.8%).  1H NMR (300 mHz, CDCl3): δ 1.48 ppm (s,9H), 1.99-2.05 (m, 











Methyl 2-((tert-butoxycarbonyl)amino)-5-oxohexanoate (15): The ketone was formed 
via a Grignard reaction following published conditions.176 A solution of protected 
pyroglutamate (14) in anhydrous THF was stirred under an inert atmosphere in an 
acetonitrile/dry ice bath. MeMgI (1.2eq) in ether was added dropwise. After 2 hours of 
stirring, the mixture was transferred to the freezer overnight. The reaction was then 
quenched with ammonium chloride, acidified to pH 2-3, and extracted into EtOAc. The 
product was purified by flash chromatography with 7:3 hexanes to EtOAc with 1% acetic 
acid (rf = 0.4, vanillin) to give 66.8% yield of the ketone. 1H NMR (300 mHz, CDCl3): δ 
1.42 ppm (s, 9H), 1.82-1.90 (m, 1H), 2.07-2.12 (m, 1H), 2.13 (s, 3H), 2.46-2.60 (m, 2H), 
3.72 (s, 3H), 4.25 (bs, 1H), 5.09 (bs, 1H). 
Methyl 2-((tert-butoxycarbonyl)amino)-4-(3-methyl-3H-diazirin-3-yl)butanoate (16): 
Ketone 15 was dissolved in excess 7N methanolic ammonia and stirred in an ice/salt 
bath. Hydroxylamine-O-sulfonic acid (1 eq) was added portion wise. The mixture was 
allowed to stir in the cooling bath for 1hr, then at room temperature for 1 hr. The resulting 
solution and white precipitate were stored in the refrigerator overnight, after which the 
mixture was concentrated in vacuo, redissolved in MeOH, and filtered. The filtrate was 
stirred at 0° C with triethylamine (0.25 eq). Iodine crystals were added portion wise until 
a deep red hue persisted. The product was concentrated in vacuo and purified via flash 
chromatography with 85:15 hexanes/EtOAc (rf = 0.3). 1H NMR (300 mHz, CDCl3): δ 1.01 
ppm (s, 3H), 1.34-1.40 (m, 1H), 1.44 (bs, 12H), 1.68-1.74 (m, 1H), 3.74 (s, 3H), 4.27 (bs, 
1H), 4.97 (bs, 1H). 
Photo-methionine (1): Molecule 16 (1 eq) was dissolved in MeOH, and LiOH•H20 
(1.5eq) in an equivalent volume of water was added. The mixture was refluxed overnight 
in the dark. The reaction was neutralized with ammonium chloride, and the product was 
extracted in EtOAc. Free acid 17 was obtained in high purity, and no further purification 
was needed.  1H NMR (300 mHz, CDCl3): δ 1.03 ppm (s, 3H), 1.44 (bs, 12H), 1.80 (m, 
2H), 4.28 (bs, 1H), 4.95 (bs, 1H). The free amino acid was obtained by stirring Boc-photo-
methionine in a 50:50 mixture of 4N aqueous HCl:THF at room temperature for 20 hours 




NMR. 1H NMR (300 mHz, D2O): δ 0.91 ppm (s, 3H), 1.33-1.51 (m, 2H), 1.64-1.84 (m, 2H), 
3.93 (t, 1H). 
A successful route to photo-methionine allows synthesis of a diazirine-functionalized 
ZorO analog. However, this requires Fmoc protection of photo-methionine, which is 
achieved according to the methods of Muir and coworkers.158 Specifically, Photo-
methionine (246 mg) and NaHCO3 (207 mg) are dissolved in a minimal amount of water. 
12 mL dioxane is added to the mixture. Fmoc-OSu (517 mg) in dioxane was then added 
over 15 minutes, and the reaction is allowed to proceed in the dark at room temperature 
for 20 hours. The reaction is then acidified to pH 3 with HCl and extracted with EtOAc. 
Organic layers were dried with MgSO4, filtered, and concentrated in vacuo. Flash 
chromatography over silica with 2.5% MeOH in DCM with 1% acetic acid yields Fmoc-
photo-methionine.  
Synthesis and characterization of ZorO and analogs 
 
Peptide synthesis was achieved manually with a wrist-action shaker and 25 mL vessels 
with integral filter frit and 3-way stopcock. Initial difficulties were encountered when 
coupling with 3 equivalents of each successive amino acid. Given the trans-membrane 
domain of ZorO that features a high content of residues with hydrocarbon side-chains, 
this difficulty was not startling. Existing literature suggested that unusually hydrophobic 
peptide sequences are difficult to assemble.161 This is usually due to aggregation of resin-
bound chains leading to insufficient solvation. Sometimes these issues with solvation 
require addition of chaotropic salts to change the polarity of the environment or, in more 
severe situations, incorporation of amino acids with modified protecting groups every 6-7 
residues to prevent aggregation.161 After several failed attempts to construct the desired 
peptide, success was achieved by modification of standard coupling parameters without 
chaotropic agents or modifications.  
The successful protocol for peptide synthesis entailed purchasing a polystyrene-based 
Wang resin with the C-terminal Fmoc-protected lysine residue bound. This resin was 
swollen in minimal amounts of methylene chloride for 10-15 minutes, after which the 




DMF was added to the resin, the vessel was shaken for 1 minute, and the liquid was 
drained under aspirator vacuum. This process was repeated with a 15-minute shaking 
duration. After this two-stage deprotection, the resin was washed 3 times with DMF. 
Couplings were accomplished by solvating 6 equivalents of the subsequent amino acid 
5.9 equivalents of HBTU as a peptide coupling reagent, and 12 equivalents of 
diisopropylethylamine (DIPEA).177 After couplings, the resin was washed 3x with DMF. 
The Kaiser test was used to monitor the success of each coupling. To accomplish this, a 
few beads of the clean resin were placed in a 1-dram glass vial with 3-4 drops of each of 
the following 3 solutions: A) 5%ninhydrin in ethanol; B) 80% phenol in ethanol; C) KCN in 
pyridine (2mL 0.001M KCN in 98 mL pyridine) and heated for 5 minutes at approximately 
110° C.161 Reaction of the ninhydrin with free amines produces a blue color (+), indicating 
incomplete coupling. In the event of a positive Kaiser test, the coupling was repeated until 
the beads were colorless upon testing. Once the full sequence was assembled via cycles 
of deprotection and coupling, a final Fmoc deprotection was accomplished to liberate the 
N-terminus of the resin-bound peptide. Finally, the resin was allowed to stir in excess 
trifluoroacetic acid/water/triisopropyl silane 95:2.5:2.5 for 90-180 minutes.161 The 
cleavage cocktail was filtered, and the filtrate was concentrated under a stream of 
nitrogen. Peptide was achieved by dropping the free peptide solution into cold ether 
(diethyl ether or MTBE), centrifuging, decanting, and lyophilizing from an ACN/H2O 
solution.161, 177  
The synthetic targets of SPPS are the previously-described ZorO analogs (Figure 4-9). 
Detection of ZorO by UPLC-HRMS 
 
Measuring expression of ZorO from cell cultures would provide valuable information, 
especially if the measurement is sensitive enough to monitor chromosomal expression. 
To this end, a method was developed to quantitate ZorO in fractions of E. coli cell lysate. 
Initially, the synthetic standards of native ZorO were used to validate the method and 
confirm experimental mass-to-charge ratios and chromatographic retention time. 
Synthetic ZorO was suspended in a mixture of ACN/H2O with TFA and diluted to the 






Figure 4-9: ZorO and analogs synthesized with SPPS 
 
Samples were analyzed on a Q Exactive Plus Hybrid Orbitrap equipped with a Dionex 
UltiMate 3000 with nano-flow capabilities (Thermo Fisher Scientific, Waltham, MA). An 
Easy-Spray source interfaced the chromatograph with the mass spectrometer. The 
method featured a 10-minute load onto a C18 PepMap 100 µ-Precolumn (5 µm, 100Å, 
300 µm x 5 mm) with an isocratic flow of 2% ACN in H2O with 0.1% formic acid at 10.0 
µL per minute. After loading on the precolumn, valve switching allowed the analytes to be 
back-flushed onto the analytical column. The samples were separated on a PepMap 
RSLC C18 Easy-Spray column (3 µM, 100Å, 75µm x 15 cm) with a solvent system of A) 
0.1% formic acid in H2O; and B) 0.1% formic acid in ACN. The separation gradient was 
as follows: t = 0 min, 100% solvent A, 0% solvent B; t = 10 min, 0% solvent A, 100% 
solvent B; t = 35 min, 0% solvent A, 100% solvent B; t = 45 min, 0% solvent A, 100% 
solvent B; t = 45.1 min, 100% solvent A, 0% solvent B; t = 60 min, 100% solvent A, 0% 
solvent B. The flow rate was a constant 0.200 µL per minute. 
Spectra were collected in full-scan mode with positive polarity, a scan range of 266.7 - 




IT was 200 ms. For ionization, the sheath gas (N2) was set to 25, and the aux gas flow 
was 8. A spray voltage of 4.00 kV with a capillary temp of 320 °C.  
Before the validated method was applied to biological extracts, sample preparation was 
carefully considered. Cell lysates, even when separated into cytoplasmic and membrane 
fractions, are incredibly complex. Therefore, target proteins are typically enriched or 
isolated prior to analysis by mass spectrometry. This can be achieved through 
immunoprecipitation, electrophoresis and excision, affinity chromatography, or other 
emerging technologies. Many of these approaches are costly and may require specific 
antibodies or covalent modification of the target protein with a tag. These options are not 
desirable for studying ZorO, which has unknown function and is diminutive at 3.2 kDa. 
Covalent modification could drastically influence the properties of this small protein, and 
the absence of existing ZorO research has not made immunological isolation techniques 
available. Thus, gel excision was chosen as a method of protein enrichment prior to 
analysis. 
In brief, ZorO was overexpressed in a variant of E. coli MG1655 using a ZorO-encoding 
plasmid and PBAD promoter. Transcription of zorO was initiated by addition of arabinose 
(0.2% maximum) to growing cultures.178 Cell lysates were separated into cytoplasmic and 
membrane fractions, and the two protein fractions we subjected to gel electrophoresis 
using a Tricine gel (containing tris, glycerol, TEMED, ammonium persulfate) designed for 
optimal resolution of low molecular weight proteins. After electrophoresis, bands were cut 
from the gel to target the 3 kDa range. Proteins were recovered from the gel using an 
elution buffer (Tris HCl, NaCl and EDTA).  
Results and discussion 
Small molecule synthesis 
While 2 routes to photo-methionine had been previously described, they entailed their 
unique difficulties when reproduction of the methods were attempted. The synthetic 
scheme afforded by the work of Thiele and coworkers was direct but included an alpha-
bromination that was unable to be duplicated in any notable yield. This is potentially due 




reactions to interfere with the diazirine and create a confounding matrix of unwanted 
products. Figure 4-10 shows stacked NMR spectra displaying the difficulty achieving the 
α-bromination. Even in a pressurized vessel, the intended transformation did not appear 
to occur. Variations of this reaction were attempted many times, and results were mixed. 
The most promising reaction outcomes (Figure 4-10, row 5) were subjected to column 
chromatography in an attempt to achieve purified product. However, none were fruitful.  
  




The scheme by Muir and associates was adopted to avoid the halogenation difficulties. 
This approach was less direct, requiring the synthesis of a Weinreb amide intermediate 
before installing the ketone handle as a precursor to the diazirine. In addition, the bulky 
protecting groups selected for the reaction appeared to hinder a detectable conversion of 
ketone to diazirine. The problem was not remedied by deprotection before diaziridination, 
likely due to the hemiaminal form of the ketone that is favored by the equilibrium.  
Thus, to circumvent all the above issues, a novel synthesis of photo-methionine was 
conducted. Because it begins with a protected pyroglutamate, the newest route avoids 
the Weinreb amide intermediate and is more direct than the one reported by Muir et. al. 
In addition, the use of smaller C-terminal protecting groups enables the diaziridination to 
occur without steric hindrance. The novel scheme eliminates the need for the 
halogenation reaction, avoiding the most dubious reaction in the sequence from the work 
of Thiele et. al. For all these reasons, photo-methionine was afforded in ample yield with 
technical simplicity using the original method described herein. The merits of this method 
were realized when the product was achieved with minimal time lost to investigating or 
optimizing reaction parameters. The success of this novel method led to abandonment of 
the two previous schemes. With a reliable route to photo-methionine established, current 
efforts are underway to afford larger amounts of the Fmoc-protected product for use in 
SPPS. 
Peptide synthesis  
Solid-phase peptide synthesis is commonly used to assemble products with fewer than 
50 residues. Thus, it should pair nicely with the study of small proteins in bacteria, which 
conventionally have the same size restraint. There is some difficulty; however, with 
practical synthesis of these small proteins. Most small, independently-encoded proteins 
act at the membrane, suggesting an enrichment of hydrophobic residues. This is certainly 
true in the case of ZorO, which has a sequence that is 62.0% composed of residues with 
hydrocarbon side-chains (Leu, Ile, Ala, Val). These highly hydrophobic peptides are more 
difficult to synthesize by SPPS, and issues are intensified as chain length increases. 
While modern automated peptide synthesizers are suitable for high-throughput, many of 




The advantage of manual synthesis is its modularity. In contrast to automated protocols, 
manual synthesis includes monitoring the yield of each individual coupling for 
completeness, providing information about the necessity of recoupling and the location of 
problematic residues.177 This both enables the specialized treatment of problematic 
couplings and drastically decreases the economic and environmental impact as 
compared to automated syntheses which may include second couplings by default 
instead of as needed.177  
Native ZorO, bearing the sequence shown in Figure 4-9, was achieved using the 
previously-described protocol and characterized by mass spectrometry. The 
experimental mass spectrum of synthetic ZorO, in the +2, +3, and +4 charge states, 
perfectly matched the spectra predicted Yergey Algorithm using IsoPro 3.1.179 Of these 
peak clusters, the +3 charge state was the most abundant (Figure 4-11).  
 
 





Likewise, the R23K analog was successfully synthesized. However, the benefits of 
manual synthesis were especially noted when synthesizing the R23K analog of ZorO. 
Repeated issues were encountered when attempting to couple the L8 residue to the resin-
bound chain. Extended coupling times were employed, yet 4 coupling cycles were 
required to achieve a negative Kaiser test. This care would not have been afforded by 
automated synthesis, which could not have enabled identification of problematic residues 
until the completion of the synthesis, wasting resources and opportunity. The mass 
spectra of synthetic R23K ZorO matched the predicted data (Figure 4-12). Again, the +3 
charge state was observed to be the most abundant ion. Unlike that of the other synthetic 
peptides, characterization MS data for 1X-FLAG ZorO did not perfectly match the 
predicted peaks. This could be independent of synthetic success, and simply related to 
the altered ionization parameters caused by the addition of the FLAG. As evidenced in 
the mass spectrum of 1X-FLAG ZorO, a unique mass error is noticed. 
 
 












Based on the mass discrepancy of the most abundant ions, the +3 charge state of 1X-
FLAG ZorO differs from the expected mass by 17/3 m/z, while the +4 charge state differs 
by an error of 17/4 m/z. This seem to indicate that 1X-FLAG ZorO is forming ammonium 
adducts in the ionization source.  
Alternatively, Issues in SPPS may have arisen with the 8 additional residues either 
because of a straightforward relationship between chain length and synthetic ease or 
because of the drastic change in polarity between the hydrophobic ZorO structure and 
the hydrophilic FLAG sequence. Because of the unclear MS characterization data, the 
1X-FLAG ZorO was subjected to detection by electrophoresis and western blotting with 
FLAG-specific antibodies. As seen in Figure 4-14, synthetic FLAG-tagged ZorO runs and 
stains in a similar fashion to the plasmid-expressed 1X-FLAG ZorO, except the obvious 
smearing which could be due overloading the gel with synthetic protein. Detection by 
western blotting indicates that the FLAG head-group of the ZorO analog is intact. 
However, direct infusion mass spectrometry shows potential byproducts of the peptide 
synthesis which may be due to sequence deletions for certain subsets of the peptide 
population. From these data, it becomes evident that 1X-FLAG ZorO must undergo 
further purification and characterization. 
 
 






Analysis of the synthetic standard showed that ZorO elutes at 30.0 minutes under the 
previously-described conditions and that it is detected predominantly in the +3 and +4 
charge states (Figure 4-15). As a method of confirmation, the isotopologue distributions 
of both charge states were matched to the simulated isotope clusters predicted by the 
Yergey Algorithm using IsoPro 3.1.179 
Detection of ZorO from biological sources proved to be a significant undertaking. This is 
likely related to the innate difficulty of studying individual small proteins from bacteria.  
Genome annotation of lab-strain E. coli reveals over 4000 genes that encode for 
proteins.180 Some of these proteins, such as acyl carrier protein, are highly abundant and 
account for a significant percentage of the cellular protein.181 Other classes of proteins, 
including many of these small proteins with emerging research focus, regulate their 
respective biological functions at low concentrations. Given the fact that ZorO is toxic 
when highly expressed, the natural abundance is surely low.  
 
 





Detecting a single lowly-abundant protein from cell extracts is akin to finding the 
proverbial needle in the haystack. In addition to the inherent concentration concerns 
raised by sample complexity, issues of ion suppression, dynamic range limitations, and 
instrument sensitivity can hinder identification of individual species. 
While the nominal mass of the +3 charge state of ZorO was detected in cellular 
subfractions, the peak was low in intensity and lacked the characteristic isotopic spread 
of a polypeptide. It is possible that ZorO may be forming adducts in the electrospray 
source with counterions that are specific to the sample preparation process. Thus, the 
data is currently being mined to deconvolute the myriad of peaks observed in the 
chromatograph of gel-excised E. coli lysate to identify any possible species of ZorO that 
differ from the m/z of the synthetic standard. 
Conclusions and future work 
There are other issues that are specific to an analysis of this nature, as most current 
biochemical protocols and assays are biased against small proteins. For instance, it is 
difficult to raise antibodies against a hydrophobic polypeptide the size of ZorO.12 
Moreover, most experiments targeted at understanding interactions of small proteins 
have included tagging small proteins with tags that surpass their molecular weight.12 
While analogs such as Photo-met ZorO and 1X-FLAG ZorO are promising proxies for 
studying ZorO’s structure and fuction, there is a significant challenge posed by future 
biophysical characterization of ZorO’s interactions.  
These limitations of the field also impact mass spectrometric detection. Enrichment of 
target proteins prior to analysis is a preferred way to isolate the desired protein analytes. 
However, for reasons described above, small polypeptides lack a precedence for 
immunoprecipitation compared to larger proteins. Gel excision was employed in the 
current study to enrich ZorO prior to UPLC-HRMS analysis. However, it lacks the 
specificity of immunoaffinity based methods. An added layer of complication comes from 
the probable low relative abundance of ZorO in cell lysates. Even overexpression of ZorO 
yielded spectra that were unclear. Only once ZorO detection is achieved at maximal 
expression can the arabinose can be titrated back to create a biological calibration curve 




While the investigation of ZorO is only beginning, a significant groundwork of synthetic 
and analytical methods has been laid. A reliable and reproducible route to photo-
methionine has been established. Likewise, a method for the manual synthesis of ZorO 
and analogs has been optimized and employed to create a small library of modified ZorO 
derivatives for future study. With this optimization, the possibility of synthesizing new 
analogs arises. For instance, the D26 position of native ZorO may also feature a negative 
charge that is necessary for the putative oligomerization. In order to investigate this, D26E 
and D26N analogs of ZorO will be made. Concerning other potential analogs with 
unnatural amino acids, there remains opportunity. Incorporation of an alkyne-bearing 
amino acid (for which work is underway) will allow copper-catalyzed “Click” cycloadditions 
with azides. This provides the opportunity to attach tags for affinity purification or 
fluorescent labelling using bio-orthogonal chemistry. In addition to continued synthesis, 
means of probing structure and function must be optimized. This includes biophysical 
tests for quantifying oligomerization of ZorO mutants relative to the native peptide and 
characterizing any oligomers that can be captured with the photo-cross-linking of 
diazirine-functionalized ZorO. In parallel, efforts to allow UPLC-HRMS detection of ZorO 
from cell matrices will continue.  
The field of small protein analysis is evolving, yet still presents challenges to overcome. 
The techniques and approaches described in this chapter are building blocks for both the 
hopeful characterization of ZorO’s function and interactions and the advancement of small 




CHAPTER FIVE: DESIGN AND INCEPTION OF INTERDISCIPLINARY 









A final component of this interdisciplinary work focuses on efforts to incorporate 
interdisciplinarity into higher education. While research endeavors are becoming 
increasingly collaborative across disciplines, typical undergraduate classes maintain 
marked boundaries between departments and, therefore, disciplines. While students of 
science are briefly exposed to the interplay of chemistry and biology in molecular biology 
courses, there remains important areas that are untouched; namely, the immediate 
applications of classic chemical techniques towards the understanding of biological 
systems. With this void in mind, a new laboratory course was designed in which 
undergraduate chemistry majors would exert the tools of a chemist to explore biological 
systems. In the design phase, this course had several primary objectives: 1) expose 
students to every major class of biomolecules; 2) incorporate classical techniques applied 
directly towards biological questions; 3) feature both qualitative (presence/absence) 
analyses as well as quantitative; 4) encourage engagement with the scientific literature; 
and 5) introduce students to the interface of disciplines in a way that highlights the 
contributions of both fields. To accomplish these goals, a novel 300-level chemical biology 
laboratory course was designed and implemented. This course relies on organic 
chemistry (a suggested prerequisite) and analytical chemistry (a suggested corequisite) 
and is intended to become a core requirement of a chemistry major. By design, this 
provide a unique experience that is distinguished from molecular biology courses by the 
heavy emphasis on applied chemistry. In each experiment of the semester-long 
sequence, continued emphasis is placed on the tools and rationales that are rooted in 
pure chemistry, and the answers they facilitate when applied to biological systems 
(Figure 5-1). 
The central dogma expanded 
Most molecular biology courses emphasize the central dogma of molecular biology: 
genes are transcribed to RNA, which is translated to proteins. This cascade of biological 
macromolecules is certainly foundational; however, it excludes the diverse array of small 





Figure 5-1: Concept map of the course scope: firmly rooted in chemistry to answer biological inquiries 
 
This is the first crossroads at which this novel course diverges from a standard 
biochemistry lab. While ample attention is given to deoxyribonucleic acids and 
polypeptides, additional emphasis will bring small molecules into the spotlight. 
Saccharides, important players in energy storage and structural composition of cells, will 
be emphasized. Lastly, small lipophilic signaling molecules will be investigated in the final 
experimental sequence of the semester. This provides the four major classes of 
biomolecules which will be examined (Table 5-1).  
A chemical arsenal 
This course is designed to include methodologies which are mainstays of chemistry. 
Techniques for synthesis, separation, and instrumentation are some of the primary 
contributions that chemists have made to the scientific community. Thus, they are amply 
represented in the following materials. In addition to metabolite synthesis, solid-phase 
peptide synthesis (SPPS) will be introduced and employed. Similarly, the essential 
synthesis-based technique of polymerase chain reaction (PCR) is introduced as an 
avenue for exploiting natural enzymes to assist with desired syntheses. Both techniques 
are Nobel-winning innovations that are prime examples of using chemistry to facilitate 
biology. On the separations front, gel electrophoresis will be taught and implemented for 
separation of charged biopolymers. Other techniques such as peptide precipitation and 
liquid-liquid extractions will be incorporated into later experiments. Concerning 
instrumentation, fluorescence and luminescence spectroscopy will be employed. In 
addition, students will be introduced to means of sequencing polypeptides using mass 
spectrometry. These techniques are intentionally paired with the four previously-





Course outline and schedule 
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detecting genes for 
antibiotic resistance, 
including design of 
specific primers for 
PCR 
Sequencing peptides 
with tandem mass 
spectrometry, 
synthesizing fluorogenic 
peptides and using them 
to determine protease 
specificity 
Assessing structural 
features of sugars by 
leveraging reactivity, 
then determining the 




them to modulate 
luminescence in 
bacterial colonies, and 





Table 5- 2: Semester schedule. Weeks marked with an asterisk are part of a multi-week sequence. 





Lab week Experiment Agenda 
0 Orientation 
Complete chemical and biological safety training, introduce chemical biology via 
instructor, establish goals and expectations for the semester, practice 
micropipette techniques. 
1*ǂ 
Genes part 1: 
PCR design 
Design PCR primers given the sequence of target (ampicillin resistance gene). 
Use internet-based tools to explore the gene sequence, identify possible 
primers, and evaluate their properties. Extract DNA for use the following week. 
2* 
Genes part 2: 
amplification182 
Using primers very similar to the ones designed in week one and the DNA 
extracted previously, the target gene is amplified using polymerase chain 
reaction. 
3* 
Genes part 3: 
detection183 
The amplified DNA from week 2 is subjected to gel electrophoresis and 





In this dry lab, MS/MS spectra of polypeptides are provided. They are interpreted 





SPPS is introduced, with C-terminal coumarin-modified tripeptides as the 




SPPS resumes, allowing the completion of tripeptide synthesis, culminating in 




The synthetic fluorogenic peptides are combined with various proteases, and the 
changes in fluorescence are recorded with a microplate spectrometer to 




Known saccharide solutions are assessed with colorimetric reaction-based 
assays to distinguish sugars based on molecular features. Using these same 
tests, unknown sugars will be identified.  
9* 
Chemical 
signaling part 1187 
Acyl homoserine lactones (AHLs), common bacterial signaling molecules, are 
synthesized using a microwave reactor.  
10* 
Chemical 
signaling part 2188 
AHL synthesis is completed, and the resulting AHLs are used to modulate 
luminescence in V. fisheri cultures using luminescence spectroscopy.  
11 Lab final/ practical 
Using an inquisition-based approach, experiments are proposed (or executed) 





Methods of evaluation and material reinforcement 
As appropriate for a mid-to-upper level science course, this novel chemical biology lab 
encourages scientific writing. Thus, student evaluation is primarily comprised of formal, 
typed lab reports for each experiment. These reports consist of the following structure: 
Introduction  
Background, objectives, biological questions/systems, and 
chemical tools/understanding 
Materials and methods 
 List of instrumentation, chemicals, glassware, and supplies 
 Experimental procedure using actual amounts and values 
Observations and results  
 Raw data (graphs, pictures of gels, yields, spectra, etc…) 
Discussion and conclusion  
 Re-introduce the objectives and describe the way they were 
 addressed 
 Interpret the data and results 
 Conclude the success of the experiment 
 
In addition to the typed lab reports, concept maps are completed and turned in for every 
experiment. This serves as a simple way to reinforce the interplay between the chemical 
tools employed and the driving biological motivation. These concept maps are a single 
page chart similar in structure to Figure 5-1 but containing information specific to the 
present experiment. These will be graded, but ultimately serve to evaluate student 
understanding and train students to produce a condensed overview of each experiment 
that preserves the important experimental rationales. Lastly, intermittent questions or in-
lab quizzes will be interspersed into the course to continually engage students in between 
the due dates of formal lab reports.  
For each sequence of experiments students will be required to read peer-reviewed 
publications that establish precedence for the current techniques. These publications are 
chosen because of their foundational content, historical significance, or scientific 




laboratory, students will mature in their abilities to both digest and produce scientific 
writing.  
Week 11 ends the semester with a culminating assignment. To promote inquiry-based 
experimental design, students are presented with a biological question that can be 
answered using techniques and protocols like the ones employed earlier in the semester. 
In its initial iteration, this experimental design prompt took the form of a written 
examination, requiring students to propose experiments on paper. While this encouraged 
students to identify the purpose and explanatory power of the various data generated 
during the semester, it fell short of its ultimate potential. Thus, the assignment transitioned 
to presentation-based experiment proposal format. This allows students to work 
collaboratively with their lab partners to create thorough experimental plans, and propose 
specific workflows, and defend their rationales. By requiring students to engage their 
inquiry and creativity, these mock research proposals help immerse upper-level 
undergraduates in the methods of the scientific community. While a presentation-based 
assignment serves these goals, an ultimate objective is to facilitate a lab practical in which 
students can design their own experiments and be supplied to resources to perform them. 
Objectives: Learning outcomes 
Over the course of the semester, students will apply a myriad of techniques. For the 
course to function as designed, these experiences are framed in a way that reinforces 
three central learning outcomes: A) Students will digest interdisciplinary work, learning to 
identify the predominant contributions of chemistry in each application; B) Guided by 
principles of metacognition, students will develop a mature comprehension of 
experimental design rationales; and C) Drawing from specific model cases, students will 
learn to creatively propose biological applications of chemical techniques. The final of 
these three objectives is a culminating outcome that draws from the former two.  
To keep these outcomes central, instruction for this course should continually reiterate 
the ways that chemistry has facilitated explorations in molecular biology. For instance, 
while PCR is widely considered to be a tool of molecular biologists, it is fundamentally 




will encourage appreciation for the historical contributions of chemistry and highlighting 
the ways it has enabled answers will foster an appreciation for interdisciplinarity. These 
themes are reinforced throughout the semester with the introduction of each new 
technique.  
Course material 
A comprehensive collection of course material for this semester-long sequence was 
produced de novo, with significant inspiration from the scientific literature. Lab handouts 
were written for each experiment and assembled to yield an in-house lab manual. In 
addition, pre-lab lecture materials were conceived and constructed. All of this material is 
contained in Appendix D.  
Discussion 
Selected experiments from this sequence warrant further discussion to understand their 
feasibility, cost, benefit, and novelty. Most notable are the two multi-week sequences that 
use solid-phase synthesis and culminate with microplate assays. 
The peptide synthesis and protease specificity sequence relies on the ability to synthesize 
ACC-modified peptide substrates beginning with an ACC-functionalized resin. This resin, 
while commercially available from limited suppliers, is quite expensive. It can be 
synthesized in larger quantities for reduced cost. However, this requires extensive time 
cost and considerable synthetic skill. This should be noted, as maintaining an internally-
supplied source of the ACC-functionalized Rinke Amide resin presents opportunity costs 
that should be evaluated. Either cost is outweighed by the benefit. By performing this 
multi-week experiment, students are introduced to SPPS, which has both historical and 
technical significance. Also, it allows for a single polypeptide experiment which explores 
structure and function of both small tripeptides and entire enzymes 
Initially, the chemical signaling sequence culminated with observing the quorum sensing 
response to AHLs using biosensor strains of Chromobacterium violaceum and/or 
Agrobacterium tumefaciens in petri dish-based assays. These approaches relied on the 




previously incorporated into an undergraduate educational laboratory, they failed to give 
reliable results in the pilot semesters of the currently-described course. More importantly, 
they yield only qualitative data from which presence or absence of AHLs can be inferred. 
To streamline the technical workflow and allow for the generation of numerical data, these 
petri dish-based assays are being replaced with a quantitative quorum-induced 
luminescence assay in Vibrio fischeri DC22. The preparation of the DC22 biosensor 
assay is more straightforward, necessitating only liquid cultures. In addition, it replaces 
visual observation with chemical instrumentation and result in quantitative data which can 
be accessed via statistical analyses. For these three reasons, it is preferred over the petri 
dish-based assays. 
Most of the experiments in this sequence were originally conceived, drawing from 
collaborative experience and adapting protocols from research literature. This facilitates 
the desired innovation level of the course and can be especially recognized in the case 
of the tandem synthesis/assay experiments. However, the carbohydrate analysis 
laboratory is more straightforward. It relies on well-established colorimetric tests that are 
commonly used in undergraduate laboratories. For instance, Florida Institute of 
Technology (Melbourne, Florida), Boğaziçi University (Istanbul, Turkey), Amrita Vishwa 
Vidyapeetham (Coimbatore, India), and King Saud University (Riyadh, Saudi Arabia) all 
employ very similar experiments in their curriculum. These institutions have made their 
lab procedures available online, which provided the template for the carbohydrate lab for 
the present sequence. While this unit may lack the innovation and adaption of research 
literature that typifies the course as a whole, it affords a well-rounded sequence by the 
insertion of these straightforward qualitative tests between synthesis and instrumentation-
heavy modules. Nonetheless, this presents an avenue for continued course evolution to 
incorporate higher-level problem solving into the carbohydrate analysis unit.  
Dry labs were conceived with intentionality, exposing students to experimental design (in 
the case of week 1) and data analysis (in the case of week 4). These are vital components 
of successful laboratory science, which can be easily overlooked in technique-driven 
courses. By incorporating two dry labs into a sequence that otherwise relies on bench 




holistic experience, breeding a familiarity that should equate to improved research 
preparedness.   
Outlook 
In summary, a semester-long laboratory course was designed with the intent to explore 
applications of chemical methodologies while simultaneously introducing undergraduates 
to the biological rationales that often facilitate interdisciplinary science. The conception of 
curriculum for this course was deliberate, intended to create a cohesive set of laboratory 
sessions that introduces students to 4 major classes of biomolecules, encourages them 
to understand biological rationales, and reinforces the value of prominent chemical 
techniques.  
Many undergraduate chemistry majors gravitate either towards mathematics, with limited 
exposure to the life sciences, or towards the health sciences, with plans to attend health 
professional schools following graduation. This course serves the chemistry program in 
two regards, by the intentional incorporation of biology that makes the mathematically-
oriented chemistry majors increasingly well-rounded and simultaneously bridges the gaps 
between the physical and life sciences for those who intend to pursue health professions 
with a background in chemistry.  
This course was piloted for 3 semesters and is undergoing optimization to accommodate 
larger class sizes and become a core component of the chemistry program at the 
University of Tennessee. With the completion of this foundational work, opportunities for 
course evolution are facilitated. Efforts will continue to make this sequence cohesive and 
highlight the complementarity. Eventually, a multi-faceted lab practical will be 
incorporated into this curriculum, allowing the semester to culminate in a way that 
challenges students to engage in creative and wholistic thinking to investigate 










In conclusion, a breadth of experience in chemical methodology was applied to facilitate 
interdisciplinary science and improve interdisciplinary education. Bridging analytical 
chemistry and environmental science, mass spectrometry was used in conjunction with 
biological metadata to demonstrate that microbial communities without previous exposure 
to hydraulic fracturing removed the fracturing biocide glutaraldehyde from the 
environment more rapidly than previously unexposed communities. In a separate 
vignette, synthesis and mass spectrometry were used to institute and validate a method 
of measuring N-acyl amino acids (N-AAA) from biological samples. Subsequently, it was 
demonstrated that N-AAA expression is highly correlated to lipolysis via fasting and 
regulated by dietary fat composition. This allowed the generation of new hypotheses 
about molecular health benefits of fasting and diet. Later, in a synthesis-heavy endeavor, 
the toxic small protein ZorO was investigated. These efforts were slowed by 
methodological setbacks, but ultimately yielded several tools to enable the future study 
of ZorO and other small proteins, including a novel and improved synthesis of photo-
methionine. Lastly, an original and innovative laboratory course was designed and 
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A3: pH changes over time in the microcosms 
 
 Day 0- No GA Day 14 Day 21 Day 28 Day 35 Day 49 
Group pH / SD pH / SD pH / SD pH / SD pH / SD pH / SD 
HF+ 5.3 / 0.6 7.8 / 0.2 6.9 / 0.9 8.4 / 0.0 6.2 / 1.0 4.2 / 0.1 
HF- 6.5 / 0.3 7.7 / 0.3 7.4 / 0.2 8.1 / 0.2 5.2 / 0.5 4.1 / 0.1 
HF- biotic 5.3 / 0.6 7.5 / 0.2 8.4 / 0.0 7.9 / 0.4 8.2 / 0.7 5.7 / 0.5 
HF- abiotic 6.5 / 0.3 7.7 / 0.2 7.6 / 0.1 7.6 / 0.3 8.4 / 0.1 6.7 / 0.3 
 
 
The pH each group n=9 was averaged and standard deviation (SD) calculated. Day 0-No 
GA was measured prior to the start of the experiment. The other samples were measured 





Appendix B: Supporting information for chapter 3 
B1: Characterization data for synthetic N-acyl amino acids 
 
Dodecanoyl phenylalanine: 1H NMR (500 MHz, CDCl3) δ 0.88 (t, 3H), 1.24 (m, 14H), 
1.55 (m, 2H), 2.17 (t, 2H), 3.11-3.27 (dq, 2H), 4.85 (m, 1H), 5.81 (d, 1h), 7.17 (m, 2H), 
7.31 (m, 3H). 13CNMR (500 MHz, CDCl3): δ 13.86, 22.43, 25.27, 28.88, 29.04, 29.08, 
29.19, 29.35, 31.65, 36.20, 36.95, 52.89, 127.00, 128.42, 129.07, 135.37, 173.72, 
174.36. HRMS (ESI) m/z calculated for C21H33NO3 [M-H]- 346.2388, found: 346.2385. 













Dodecanoyl leucine: 1H NMR (300 MHz, CDCl3) δ 0.88 (t, 3H), 0.97 (m, 5H), 1.26 (m, 
17H), 1.30-1.62 (m, 6H), 2.25 (t, 2H), 4.57 (m, 1H), 5.76 (m, 1H), 7.17. 13CNMR (600 
MHz, CDCl3): δ14.09, 21.86, 22.66, 22.82, 24.88, 25.60, 29.19, 29.30, 29.32, 29.48, 
29.59, 31.89, 36.48, 41.18, 50.87, 174.06, 176.56. HRMS (ESI) m/z calculated for 














Dodecanoyl valine: 1H NMR (300 MHz, CDCl3) δ 0.88 (t, 3H), 0.99 (m, 5H), 1.26 (m, 
18H), 1.65 (t, 2H), 2.26 (m, 3H), 4.57 (m, 1H), 5.92 (d, 1H). 13CNMR (600 MHz, CDCl3): 
δ 14.10, 17.69, 19.01, 22.67, 25.67, 29.20, 29.29, 29.31, 29.46, 29.58, 30.82, 31.89, 
36.68, 56.99, 173.84, 175.06. HRMS (ESI) m/z calculated for C17H33NO3 [M-H]- 













Stearoyl phenylalanine: 1H NMR (500 MHz, CDCl3) δ 0.88 (t, 3H), 1.25 (m, 28H), 1.55 
(m, 3H), 2.17 (t, 2H), 3.15 (dd, 1H), 3.25 (dd, 1H), 4.82 (m, 1H), 5.77 (d, 1H) 7.18 (m, 
2H), 7.31 (m, 3H). 13CNMR (500 MHz, CDCl3): δ 13.86, 22.43, 25.29, 28.90, 29.05, 
29.11, 29.22, 29.38, 29.41, 29.42, 29.45, 31.67, 36.20, 36.99, 52.86, 126.97, 128.38, 
129.09, 135.41, 173.74, 174.37. HRMS (ESI) m/z calculated for C27H45NO3 [M-H]- 
















Stearoyl leucine: 1H NMR (300 MHz, CDCl3) δ 0.88 (t, 3H), 0.96 (m, 5H), 1.25 (m, 
30H), 1.63 (m, 5H), 2.24 (t, 2H), 4.59 (m, 1H), 5.83 (m, 1H). 13CNMR (500 MHz, CDCl3): 
δ 13.85, 21.61, 22.42, 22.58, 24.64, 25.37, 28.96, 29.07, 29.10, 29.26, 29.37, 29.40, 
29.42, 29.44, 31.66, 36.23, 40.95, 50.63, 173.86, 176.32. HRMS (ESI) m/z calculated 














Stearoyl valine: 1H NMR (300 MHz, CDCl3) δ 0.88 (t, 3H), 0.98 (m, 6H), 1.25 (m, 28H), 
1.65 (t, 2H), 2.26 (m, 4H), 4.56 (m, 1H), 5.86 (d, 1H). 13CNMR (500 MHz, CDCl3): δ 
13.86, 17.48, 18.77, 22.43, 25.40, 28.96, 29.05, 29.10, 29.22, 29.34, 29.38, 29.40, 
29.42, 29.44, 30.43, 31.66, 36.42, 56.78, 173.55. HRMS (ESI) m/z calculated for 

















Palmitoyl phenylalanine: 1H NMR (500 MHz, CDCl3) δ 0.88 (t, 3H), 1.25 (m, 24H), 
1.55 (m, 3H), 2.17 (t, 2H), 3.15 (dd, 1H), 3.24 (dd, 1H), 4.83 (m, 1H), 5.77 (d, 1H) 7.16 
(m, 2H), 7.31 (m, 3H). 13CNMR (500 MHz, CDCl3): δ 13.88, 22.45, 25.32, 28.91, 29.07, 
29.12, 29.23, 29.39, 29.43, 29.46, 31.68, 36.22, 37.02, 52.87, 126.97, 128.38, 129.11, 
135.43, 173.78, 174.45. HRMS (ESI) m/z calculated for C25H41NO3 [M-H]- 402.3014, 














Palmitoyl leucine: 1H NMR (300 MHz, CDCl3) δ 0.88 (t, 3H), 0.95 (m, 6H), 1.25 (m, 
25H), 1.66 (m, 5H), 2.24 (t, 2H), 4.58 (m, 1H), 5.78 (m, 1H). 13CNMR (500 MHz, CDCl3): 
δ 13.85, 21.60, 22.43, 22.55, 24.60, 25.28, 28.92, 29.04, 29.10, 29.21, 29.34, 29.39, 
29.41, 29.43, 31.66, 36.22, 40.53, 50.66, 173.93, 174.35. HRMS (ESI) m/z calculated 
















Palmitoyl valine: 1H NMR (300 MHz, CDCl3) δ 0.88 (t, 3H), 0.97 (m, 6H), 1.25 (m, 
25H), 1.64 (t, 2H), 2.26 (m, 3H), 4.56 (m, 1H), 5.94 (d, 1H). 13CNMR (500 MHz, CDCl3): 
δ 13.85, 17.43, 18.73, 22.43, 25.47, 28.97, 29.06, 29.10, 29.23, 29.36, 29.40, 29.44, 
30.71, 31.66, 36.42, 56.76, 173.85, 175.14. HRMS (ESI) m/z calculated for C21H41NO3 















Oleoyl phenylalanine: 1H NMR (300 MHz, CDCl3) δ 0.88 (t, 3H), 1.26 (m, 20H), 1.55 
(m, 2H), 2.00 (m, 4H), 2.17 (t, 2H), 3.14 (dd, 1H), 3.24 (dd, 1H), 4.83 (m, 1H), 5.34 (m, 
2H), 5.80 (d, 1H), 7.17 (m, 2H), 7.31 (m, 3H). 13CNMR (500 MHz, CDCl3): δ 13.87, 
22.44, 25.28, 26.94, 26.99, 28.88, 28.98, 29.08, 29.28, 29.47, 29.53, 31.66, 36.20, 
37.00, 52.86, 126.98, 128.39, 129.10, 129.48, 129.78, 135.49, 173.54, 174.22. HRMS 














Oleoyl leucine: 1H NMR (300 MHz, CDCl3) δ 0.86- 0.96 (m, 9H), 1.26 (m, 20H), 1.42 
(m, 1H), 1.63 (m, 4H), 2.01 (m, 3H), 2.23 (m, 1H), 2.32 (m, 1H), 4.21 (m, 1H), 4.58 (q, 
1H), 5.34 (m, 2H), 5.79 (m, 1H), 5.80 (d, 1H). 13CNMR (500 MHz, CDCl3): δ 10.90, 
14.01, 21.91, 22.61, 22.78, 22.92, 23.77, 24.91, 25.54, 27.14, 27.19, 28.91, 29.10, 
29.15, 29.18, 29.25, 29.28, 29.47, 29.64, 29.66, 29.72, 30.38, 31.85, 36.48, 38.78, 
41.26, 68.17, 127.89, 128.77, 129.97, 130.80, 132.48, 167.70, 173.76. HRMS (ESI) m/z 















Oleoyl valine: 1H NMR (300 MHz, CDCl3) δ 0.88 (t, 3H), 0.97 (m, 6H), 1.27 (m, 20H), 
1.65 (m, 3H), 2.02 (m, 4H), 2.26 (m, 3H), 4.56 (m, 1H), 5.34 (t, 2H), 5.86 (d, 1H). 
13CNMR (500 MHz, CDCl3): δ 14.37, 17.98, 19.29, 22.94, 25.91, 27.43, 27.48, 29.39, 
29.46, 29.48, 29.58, 29.78, 29.96, 30.03, 31.06, 36.94, 57.25, 129.99, 130.27, 174.00, 
175.00. HRMS (ESI) m/z calculated for C23H43NO3 [M-H]- 380.3170, found: 380.3173. 















Eicosanoyl phenylalanine: 1H NMR (300 MHz, CDCl3) δ 0.88 (t, 3H), 1.25 (m, 32H), 
1.46 (m, 3H), 2.16 (t, 2H), 3.15 (dd, 1H), 3.24 (dd, 1H), 4.27 (t, 2H), 4.84 (m, 1H), 7.18 
(m, 2H), 7.30 (m, 2H). 13CNMR (600 MHz, CDCl3): δ 11.08, 14.03, 14.10, 22.68, 22.95, 
23.97, 25.57, 28.97, 29.36, 29.66, 29.71, 30.56, 31.92, 38.89, 67.78, 128.54, 129.30, 
129.48, 134.22. HRMS (ESI) m/z calculated for C29H49NO3 [M-H]- 458.3640, found: 
















Eicosanoyl leucine: 1H NMR (300 MHz, CDCl3) δ 0.88 (t, 3H), 0.96 (m, 6H), 1.25 (m, 
32H), 1.62 (m, 6H), 2.24 (m, 2H), 4.58 (m, 1H), 5.76 (m, 1H). 13CNMR (500 MHz, 
CDCl3): δ 13.86, 21.61, 22.56, 24.63, 25.30, 28.93, 29.05, 29.10, 29.23, 29.35, 29.40, 
29.44, 31.67, 36.24, 40.70, 50.63, 173.83, 175.57. HRMS (ESI) m/z calculated for 

















Eicosanoyl valine: 1H NMR (300 MHz, CDCl3) δ 0.88 (t, 3H), 0.99 (m, 6H), 1.24 (m, 
32H), 1.70 (m, 5H), 2.23 (m, 3H), 4.54 (m, 1H), 6.64 (d, 1H). 13CNMR (500 MHz, 
CDCl3): δ 13.86, 17.49, 18.77, 22.48, 25.40, 28.96, 29.05, 29.10, 29.22, 29.35, 29.40, 
29.44, 30.44, 31.67, 36.43, 56.76. HRMS (ESI) m/z calculated for C25H49NO3 [M-H]- 















Linoleoyl phenylalanine: 1H NMR (300 MHz, CDCl3) δ 0.88 (t, 3H), 1.26 (m, 14H), 
1.56 (m, 2H), 2.04 (m, 4H), 2.17 (t, 2H), 2.77 (t, 2H), 3.14 (dd, 1H), 3.24 (dd, 1H), 4.86 
(m, 1H), 5.36 (m, 4H), 5.80 (d, 1H), 7.17 (m, 2H), 7.31 (m, 3H). 13CNMR (500 MHz, 
CDCl3): δ 14.06, 22.56, 25.62, 27.19, 29.10, 29.60, 31.51, 36.43, 37.24, 53.09, 127.21, 
127.88, 128.06, 128.63, 129.32, 130.01, 130.23, 135.67, 173.83, 174.68. HRMS (ESI) 














Linoleoyl leucine: 1H NMR (300 MHz, CDCl3) δ 0.89 (t, 3H), 0.96 (m, 6H), 1.31 (m, 
14H), 1.64 (m, 1H), 1.73 (m, 2H), 2.04 (m, 4H), 2.24 (m, 2H), 2.77 (t, 3H), 4.26 (t, 2H), 
4.59 (m, 1H), 5.35 (m, 4H), 8.09 (s, 1H). 13CNMR (500 MHz, CDCl3): δ 10.83, 13.78, 
22.70, 23.73, 28.72, 29.44, 30.31, 38.65, 67.52, 129.22, 133.98, 165.71. HRMS (ESI) 















Linoleoyl valine: 1H NMR (300 MHz, CDCl3) δ 0.91 (m, 9H), 1.31 (m, 16H), 1.64 (m, 
4H), 1.80 (m, 4H), 2.03 (m, 5H), 2.22 (m, 3H), 2.76 (t, 2H), 3.05 (t, 2H), 4.29 (q, 1H), 
5.33 (m, 4H), 6.24 (d, 1H). 13CNMR (500 MHz, CDCl3): δ 13.81, 17.78, 19.10, 22.21, 
22.31, 22.36, 25.36, 25.56, 26.94, 28.92, 29.03, 29.05, 29.08, 29.38, 30.78, 31.25, 















Eicosapentaenoyl phenylalanine: 1H NMR (300 MHz, CDCl3) δ 0.97 (t, 3H), 1.66 (m, 
3H), 2.08 (m, 4H), 2.19 (m, 2H), 2.84 (m, 8H), 3.16 (m, 1H), 3.22 (m, 1H), 4.84 (m, 1H), 
5.37 (m, 10H), 5.78 (d, 1H), 7.18 (m, 2H), 7.29 (m, 3H). 13CNMR (500 MHz, CDCl3): δ 
14.27, 20.55, 25.61, 26.56, 29.68, 35.79, 37.28, 53.11, 127.00, 127.16, 127.85, 128.07, 
128.18, 128.28, 128.58, 128.60, 128.83, 128.90, 129.32, 132.04, 135.81, 173.49, 













Eicosapentaenoyl leucine: 1H NMR (300 MHz, CDCl3) δ 0.98 (m, 9H), 1.26 (m, 1H), 
1.73 (m, 5H), 2.08 (m, 6H), 2.83 (m, 8H), 4.60 (m, 1H), 5.38 (m, 10H), 5.77 (d, 1H). 
13CNMR (500 MHz, CDCl3): δ 14.26, 20.54, 21.82, 22.81, 24.89, 25.32, 25.53, 25.61, 
26.58, 29.68, 35.76, 40.96, 50.82, 126.99, 127.86, 128.08, 128.18, 128.19, 128.29, 
128.59, 128.89, 128.93, 132.06, 173.68, 175.36. HRMS (ESI) m/z calculated for 













Eicosapentaenoyl valine: 1H NMR (300 MHz, CDCl3) δ 0.97 (m, 9H), 1.73 (m, 3H), 
2.07 (m, 4H), 2.24 (m, 4H), 2.83 (m, 7H), 4.58 (m, 1H), 5.37 (m, 9H), 5.97 (d, 1H). 
13CNMR (500 MHz, CDCl3): δ 14.26, 17.69, 19.02, 20.54, 25.52, 25.61, 26.63, 30.88, 
35.99, 56.97, 126.99, 127.85, 128.07, 128.17, 128.18, 128.27, 128.57, 128.84, 128.95, 
129.47, 132.04, 173.53, 174.68. HRMS (ESI) m/z calculated for C26H39NO3 [M-H]- 
















Docosahexaenoyl phenylalanine: 1H NMR (300 MHz, CDCl3) δ 0.97 (t, 3H), 2.07 (m, 
2H), 2.25 (m, 2H), 2.35 (m, 2H), 2.83 (m, 10H), 3.13 (m, 1H), 3.23 (m, 1H), 4.85 (m, 
1H), 5.38 (m, 12H), 5.90 (d, 1H), 7.17 (m, 2H), 7.28 (m, 3H). 13CNMR (500 MHz, 
CDCl3): δ 14.26, 20.54, 23.12, 25.52, 25.56, 25.62, 29.68, 36.11, 37.24, 53.14, 127.00, 
127.17, 127.81, 127.86, 127.98, 128.07, 128.08, 128.27, 128.28, 128.33, 128.57, 
128.61, 129.34, 129.53, 132.03, 135.76, 172.92, 174.04. HRMS (ESI) m/z calculated for 













Docosahexaenoyl leucine: 1H NMR (300 MHz, CDCl3) δ 0.95 (m, 9H), 1.25 (m, 1H), 
1.56 (m, 1H), 1.70 (m, 2H), 2.07 (m, 2H), 2.33 (m, 2H), 2.41 (m, 2H), 2.85 (m, 10H), 
4.62 (m, 1H), 5.38 (m, 12H), 5.90 (d, 1H). 13CNMR (500 MHz, CDCl3): δ 14.26, 20.54, 
21.84, 22.82, 23.20, 24.86, 25.52, 25.62, 29.68, 36.13, 41.05, 50.84, 127.00, 127.86, 
127.89, 127.98, 128.06, 128.08, 128.27, 128.28, 128.33, 128.57, 129.55, 132.04, 
173.16, 175.78.  HRMS (ESI) m/z calculated for C28H43NO3 [M-H]- 440.3170, found: 















Docosahexaenoyl valine: 1H NMR (300 MHz, CDCl3) δ 0.97 (m, 9H), 1.25 (m, 1H), 
2.07 (m, 2H), 2.23 (m, 1H), 2.35 (m, 2H), 2.42 (m, 2H), 2.84 (m, 10H), 4.59 (m, 1H), 
5.38 (m, 12H), 5.94 (d, 1H). 13CNMR (500 MHz, CDCl3): δ 14.10, 17.71, 19.03, 20.55, 
22.67, 25.62, 29.34, 29.68, 30.84, 31.91, 36.32, 57.02, 92.01, 127.01, 127.87, 127.98, 
128.00, 128.08, 128.09, 128.26, 128.28, 128.32, 128.57, 129.56, 132.04, 163.11, 
174.66. HRMS (ESI) m/z calculated for C27H41NO3 [M-H]- 426.3014, found: 426.3019. 















Palmitoleoyl phenylalanine: 1H NMR (300 MHz, CDCl3) δ 0.88 (t, 3H), 1.26 (m, 16H), 
1.56 (m, 2H), 2.00 (m, 4H), 2.17 (m, 2H), 2.36 (m, 1H), 3.17 (dd, 1H), 3.23 (dd, 1H), 
4.85 (m, 1H), 5.35 (m, 2H), 5.83 (d, 1H), 7.18 (m, 2H), 7.29 (m, 3H). 13CNMR (500 MHz, 
CDCl3): δ 13.85, 22.40, 25.23, 26.92, 26.97, 28.84, 28.95, 29.44, 31.52, 31.67, 36.19, 
58.64, 126.97, 128.41, 129.05, 129.47, 129.76, 173.58. HRMS (ESI) m/z calculated for 













Palmitoleoyl leucine: 1H NMR (300 MHz, CDCl3) δ 0.88 (m, 9H), 1.29 (m, 17H), 1.62 
(m, 5H), 2.00 (m, 4H), 2.24 (m, 2H), 4.57 (m, 1H), 5.34 (m, 3H). 13CNMR (500 MHz, 
CDCl3): 14.09, 21.79, 22.64, 22.91, 24.89, 25.61, 27.18, 27.21, 28.97, 29.17, 29.21, 
29.26, 29.71, 31.77, 36.48, 40.94, 51.29, 113.91, 172.78, 129.70, 129.99. HRMS (ESI) 















Palmitoleoyl valine: 1H NMR (300 MHz, CDCl3) δ 0.88 (m, 3H), 0.98 (m, 6H), 1.31 (m, 
16H), 1.65 (m, 3H), 2.02 (m, 4H), 2.26 (m, 3H), 4.55 (m, 1H), 5.34 (m, 2H), 5.86 (d, 1H). 
13CNMR (500 MHz, CDCl3): δ 14.09, 17.69, 19.00, 22.64, 25.65, 27.15, 28.97, 29.10, 
29.18, 29.20, 29.68, 29.71, 30.83, 31.77, 36.66, 129.73, 129.99, 173.75, 175.11. HRMS 






































Log (Concentration µM) 
N-stearoyl valine      




























































































































































































Log (Concentration µM) 
N-oleoyl valine




































































































































































































































































































































































































































































































N-docosahexaenoyl valine PRM (426.3014-
116.071)
































































































































2.0000 8.4683 8.3895 8.2976 8.8337 8.8632 8.6429 8.7059 7.3937 8.7569 8.5393 8.5611 8.2531 8.6464 8.5679 8.6419 8.6279 8.4039 8.0660 9.0149 7.9436 8.6452 8.3649 8.5941 8.3664 8.0884
2.0000 8.5302 8.3988 8.2612 8.8525 8.9104 8.6343 8.7197 7.4774 8.7807 8.5528 8.5469 8.3328 8.6544 8.6282 8.7695 8.6255 8.4320 8.0786 9.0808 7.9724 8.6576 8.4060 8.6137 8.4530 8.1137
2.0000 8.5276 8.4195 8.2687 8.8258 8.8592 8.5926 8.7057 7.3592 8.7780 8.5468 8.5400 8.3260 8.6459 8.5870 8.6969 8.6312 8.4886 8.0906 9.0785 8.0626 8.6586 8.4356 8.6120 8.3843 8.0609
1.6990 8.4843 8.3201 8.1816 8.7018 8.8056 8.5405 8.6844 7.1829 8.6053 8.4242 8.4010 8.0686 8.5403 8.3850 8.5589 8.4678 8.2969 7.8429 8.9084 7.6681 8.6043 8.2793 8.4840 8.2076 7.8135 8.6760 9.3855
1.6990 8.3856 8.2769 8.1550 8.6681 8.7549 8.5166 8.6569 7.0501 8.5512 8.4094 8.3762 7.9919 8.5469 8.3541 8.5074 8.5008 8.2432 7.7929 8.8582 7.6692 8.5300 8.2245 8.4515 8.2194 7.7067 8.8479 9.4923
1.6990 8.4564 8.3223 8.2199 8.6343 8.7455 8.6255 8.6442 6.9885 8.6385 8.4034 8.4601 7.9877 8.5725 8.4488 8.4405 8.4340 8.2845 7.9231 8.8243 7.7758 8.5420 8.2347 8.4937 8.2642 7.8600 8.9448 9.6228
1.0000 8.0531 7.9442 7.9663 8.3682 8.5392 8.1907 8.3911 6.6967 8.1714 8.1661 8.0544 7.4716 8.2435 7.8654 8.1048 8.1901 7.8524 7.4915 8.5875 7.1432 8.4055 7.8342 8.1129 7.6606 7.0819
1.0000 8.1461 7.9785 7.8946 8.3317 8.4666 8.3202 8.4235 6.6022 8.3077 8.1197 8.1154 7.5144 8.2138 7.9715 8.0369 8.1257 7.8369 7.5641 8.5497 7.1950 8.3827 7.8243 8.1255 7.7522 7.2430
1.0000 8.1271 7.9831 7.8953 8.2404 8.4793 8.2831 8.4016 6.5691 8.2109 8.0771 8.0664 7.4094 8.1809 7.9177 7.9799 8.0328 7.8012 7.5443 8.4655 7.0871 8.3395 7.7729 8.1073 7.7109 7.1489
0.6990 7.8476 7.7520 7.6909 8.0252 8.2513 8.0778 8.2032 6.4349 7.9810 7.8456 7.8357 7.1598 7.8877 7.6718 7.7643 7.8145 7.4627 7.1962 8.2862 6.7546 8.2405 7.4505 7.7219 7.4607 6.9297 7.7280 8.5837
0.6990 7.8195 7.7523 7.5796 8.1336 8.2651 7.9574 8.2595 6.3299 7.9030 7.7733 7.7358 7.2444 7.8003 7.5009 7.8453 7.6949 7.3436 7.1143 8.3736 6.5691 8.2621 7.3153 7.6360 7.3094 6.6892 7.8820 8.7592
0.6990 7.8710 7.8063 7.7084 7.9486 8.1520 8.0025 8.1678 6.2123 7.9191 7.9387 7.8313 7.0778 7.9913 7.5705 7.6220 7.8799 7.5961 7.3520 8.2150 6.8375 8.1490 7.5293 7.8465 7.3666 6.7745 7.9858 8.8880
0.0000 7.3118 7.3162 7.1885 7.2679 7.5774 7.5250 7.5976 5.4778 7.3544 7.2853 7.2226 6.4139 7.2413 6.9364 6.9857 7.0647 6.6740 6.5842 7.5630 5.8899 7.6654 6.6595 7.0240 6.7014 6.0456
0.0000 7.4472 7.3833 7.3262 7.1576 7.5127 7.6206 7.5997 5.4051 7.5110 7.3466 7.2790 6.2977 7.3369 7.0171 6.8821 7.2030 6.8201 6.7750 7.5120 6.0926 7.5718 6.8710 7.1898 6.8200 6.2010
0.0000 7.3365 7.4164 7.3488 7.3660 7.6689 7.6120 7.7382 5.5648 7.4801 7.4392 7.2520 6.4728 7.4017 7.0674 7.0412 7.2156 6.9325 6.7924 7.6593 6.1309 7.7186 6.8894 7.1921 6.8164 6.1703
-0.3010 7.1673 7.0609 6.9743 7.0389 7.4301 7.4211 7.5280 5.2032 7.2127 7.1592 7.0420 6.1871 7.1152 6.8397 6.7248 6.8802 6.5337 6.3728 7.4148 5.7223 7.4997 6.5351 6.8989 6.5057 5.8227 6.6446 7.6517
-0.3010 7.3010 7.2410 7.0109 6.9583 7.3198 7.5436 7.4495 5.2382 7.4231 7.2969 7.1181 6.0316 7.2635 6.9995 6.6540 7.0078 6.7065 6.5368 7.2876 5.8472 7.3869 6.6765 7.0149 6.6439 6.0289 6.7012 7.7517
-0.3010 7.2529 7.1218 7.0082 7.0393 7.3542 7.4610 7.5365 5.4007 7.2867 7.0654 7.0455 6.1481 7.1460 6.8027 6.6917 6.9537 6.5826 6.4820 7.3524 5.8717 7.3247 6.6255 6.9245 6.5863 5.9134 6.8137 7.9576
-1.0000 6.4594 6.4082 6.4814 6.2651 6.7366 6.6813 7.1234 4.3700 6.5736 6.6804 6.2795 5.3104 6.7254 5.9647 5.9081 6.3835 6.0543 5.8048 6.5767 5.2177 6.6527 6.0978 6.3720 5.7667 5.1075
-1.0000 6.5762 6.5080 6.3390 6.2829 6.7302 6.7713 7.1434 4.7005 6.5930 6.6095 6.4235 5.4045 6.5598 6.2287 5.9254 6.2830 5.9593 5.6517 6.6329 5.2439 6.6771 5.9731 6.3039 5.9050 5.2439
-1.0000 6.4706 6.5311 6.3361 6.3870 6.8306 6.7815 7.2269 4.6131 6.6716 6.5426 6.3030 5.4935 6.6339 6.0437 6.0301 6.3123 6.0133 5.7301 6.7132 5.2274 6.7893 6.0416 6.3547 5.8347 5.1521
-1.3010 6.2465 6.1688 5.9461 6.0521 6.4006 6.5560 7.0492 4.4099 6.3757 6.1783 6.0574 5.1544 6.2896 5.8452 5.6561 5.9523 5.5214 5.2927 6.2707 4.8666 6.3573 5.6846 6.0077 5.5844 4.9385 5.6569 6.7698
-1.3010 6.2842 6.1224 5.8945 5.9875 6.4400 6.5448 7.0117 4.2673 6.4019 6.0842 6.0675 5.0714 6.1461 5.8859 5.6721 5.7825 5.4355 5.2214 6.3211 4.8472 6.4163 5.5222 5.8318 5.6053 4.9784 5.7326 6.8679
-1.3010 6.2152 6.0868 5.9244 6.0055 6.4207 6.4876 7.0684 4.3589 6.4084 6.1392 6.0325 5.0772 6.1826 5.8883 5.5896 5.8537 5.5982 5.2070 6.2744 4.8632 6.3323 5.6171 5.9370 5.6771 4.9023 5.9471 6.9948
-2.0000 5.3371 5.2849 5.4150 5.3707 5.7256 5.6087 7.0607 3.6017 5.2926 5.5282 5.2683 4.4601 5.5239 4.9160 4.8997 5.2329 4.9075 4.7932 5.6723 4.6407 5.8061 5.0423 5.1574 4.7052 3.7956
-2.0000 5.5027 5.4830 5.2534 5.3151 5.8044 5.7289 7.0661 3.9727 5.4710 5.4595 5.3887 4.4370 5.3690 5.0520 5.0754 5.1478 4.7632 4.5937 5.6787 4.5343 5.8166 4.8119 5.1346 4.7464 3.9201
-2.0000 5.4084 5.4372 5.3622 5.3174 5.6579 5.7053 7.0001 3.6617 5.4652 5.5750 5.2466 4.5456 5.4260 4.8576 5.0169 5.1710 4.7710 4.6614 5.6503 4.5460 5.7971 4.8308 5.1700 4.6962 3.4515
-2.3010 5.0100 5.1707 4.9980 4.9924 5.3842 5.3602 6.9461 3.5042 5.2733 5.2298 4.8768 3.9278 5.1808 4.4601 4.6841 4.8343 4.2998 4.1991 5.2793 4.2883 5.4633 4.4851 4.8063 4.5592 #NUM! 4.6621 5.8855
-2.3010 4.8984 5.0350 4.9268 4.9188 5.2275 5.3554 6.9167 3.9527 5.1105 5.1073 4.8498 3.4979 5.1200 4.7160 4.5295 4.7925 4.4802 4.2123 5.2485 4.2290 5.3860 4.3787 4.7615 4.1766 #NUM! 4.7211 6.1137
-2.3010 5.0069 5.0722 5.0367 4.9456 5.3254 5.3891 6.9243 3.5772 5.0727 5.1275 4.8927 4.0752 5.0835 4.5802 4.4334 4.8842 4.4987 4.2587 5.2680 4.3783 5.3760 4.5181 4.8812 4.4845 #NUM! 4.8416 6.2180
-3.0000 4.3712 4.4479 4.1948 4.7515 4.8572 6.6227 3.9543 4.4556 4.5452 4.3834 4.3508 #NUM! #NUM! 3.6324 #NUM! 3.1101 4.4563 4.0238 4.7147 #NUM! #NUM! #NUM! #NUM!
-3.0000 4.4919 4.4953 4.0325 3.8678 4.7177 4.8024 6.8155 3.6236 4.5994 3.9070 4.0930 4.0279 3.8611 #NUM! 3.5078 3.4696 3.1616 4.5278 4.0013 4.7529 #NUM! 3.5575 3.5672 #NUM!














































































































































































































































































































































































































































log (Conc/IS)CDCA/DCA HDCA UDCA aMCA bMCA CA GLCA GCDCA GDCA GCA TLCA TUDCA THDCA TCDCA/TDCATCA Ta/bMCA TwMCA
-1.69897 2.061549 1.291834 4.936562 0.557784 0.44174 -0.63837 -1.90671 -2.01447 -1.50285 3.53364 3.215055 6.089721 0.387581 -2.54432 -1.26514 -0.21055 5.177999
-1.69897 1.934273 1.192529 5.050733 0.464156 0.478596 -0.64295 -1.84404 -1.85193 -1.5103 3.554461 2.487105 5.255419 -0.37261 -2.39106 -1.50504 -0.96956 4.525954
-1.69897 2.285369 1.311113 5.054098 0.453399 0.411575 -0.68337 -1.73597 -1.75337 -1.59839 3.4661 3.246484 4.585176 -1.03536 -2.33081 -1.6575 -1.15481 4.054612
-1 2.139919 1.260654 4.97654 0.447699 0.408374 -0.65725 -0.99022 -1.06475 -0.83844 3.426025 4.196224 4.587472 -1.11613 -1.14542 -1.01895 -1.02584 4.103345
-1 2.136675 1.348237 5.077999 0.366911 0.342868 -0.67755 -0.99872 -1.02699 -0.81513 3.475145 4.255996 4.500273 -1.16386 -1.10686 -0.99664 -1.00639 3.923778
-1 2.13634 1.342496 5.047725 0.493127 0.395866 -0.62696 -0.95915 -0.96881 -0.85275 3.402518 4.274449 4.528088 -1.15646 -0.92576 -1.01062 -1.04785 4.087695
-0.30103 2.042518 1.279993 4.947524 0.360121 0.355176 -0.67326 -0.31237 -0.30997 -0.16178 3.463542 5.302292 5.197278 -0.52626 -0.27156 -0.36704 -0.62428 4.602338
-0.30103 2.110533 1.117402 4.988151 0.340047 0.337218 -0.70732 -0.28532 -0.24893 -0.14642 3.501813 5.336804 5.190742 -0.51463 -0.27182 -0.36333 -0.60343 4.638714
-0.30103 2.13543 1.244465 4.949313 0.38261 0.33868 -0.67418 -0.31352 -0.28299 -0.13176 3.480111 5.362707 5.208728 -0.51711 -0.28486 -0.34987 -0.6074 4.624786
0 2.131737 1.353962 4.959916 0.276967 0.277103 -0.66488 0.021573 0.032635 0.128177 3.474185 5.686838 5.505079 -0.23522 0.051319 -0.03065 -0.34075 4.91738
0 2.087328 1.189093 4.894921 0.310986 0.346211 -0.64658 0.000705 0.03134 0.121568 3.677419 5.703423 5.524322 -0.19237 0.043465 -0.00854 -0.32931 4.903131
0 2.061806 1.183272 4.874971 0.260664 0.264302 -0.67824 0.04904 0.017522 0.135058 3.593949 5.723721 5.544178 -0.22667 0.100916 -0.01179 -0.32757 4.903316
0.30103 2.101633 1.103246 4.891796 0.238356 0.277716 -0.50393 0.314118 0.327314 0.477105 3.634097 6.018661 5.834332 0.104604 0.336439 0.225349 -0.04248 5.21263
0.30103 2.115152 1.242678 4.949001 0.25853 0.250795 -0.47936 0.306791 0.351731 0.473531 3.610388 6.048766 5.837545 0.117413 0.35984 0.248697 -0.01497 5.230111
0.30103 2.099049 1.201706 4.959151 0.224052 0.265198 -0.45658 0.296437 0.338196 0.488345 3.660664 6.082633 5.827793 0.135205 0.345169 0.230831 -0.03535 5.2387
0.69897 1.973486 1.199988 4.963023 0.293514 0.301404 -0.12845 0.723296 0.807719 0.904135 3.7886 6.492577 6.248372 0.52887 0.730159 0.634922 0.339955 5.62705
0.69897 2.18937 1.229179 4.993761 0.34462 0.34157 -0.12215 0.720468 0.739901 0.894193 3.706718 6.509929 6.268306 0.567198 0.783449 0.655849 0.359375 5.64767
0.69897 2.249319 1.261812 4.903756 0.329944 0.377103 -0.15172 0.712065 0.765249 0.890711 3.797861 6.519846 6.271982 0.544317 0.766842 0.672346 0.370009 5.653961
1.30103 2.184107 1.496463 0.680031 0.657059 0.389174 1.349483 1.3769 1.468179 1.117188 1.368283 1.287538 0.948162
1.30103 2.250375 1.361118 0.725994 0.708941 0.389539 1.368836 1.39626 1.489709 1.156322 1.442045 1.308211 0.968263
1.30103 2.082861 1.319449 0.702676 0.646884 0.370791 1.341555 1.349806 1.49849 1.158959 1.421628 1.313905 0.969932
1.69897 2.265211 1.611716 5.08424 1.048165 0.991443 0.83145 1.756037 1.795311 1.945096 4.522144 7.821931 7.320776 1.590848 1.8379 1.715736 1.429013 6.677097
1.69897 2.220159 1.675844 5.368491 1.046407 1.064684 0.832127 1.755291 1.773257 1.937405 4.494728 7.691655 7.266153 1.631912 1.871604 1.719076 1.427255 6.608406
1.69897 2.165547 1.695461 5.293018 1.022788 1.046615 0.820109 1.755111 1.779075 1.917807 4.460812 7.641858 7.235828 1.629221 1.859117 1.741862 1.433964 6.561709
2.30103 2.320513 1.900512 5.781278 1.40221 1.425285 1.260996 2.141254 2.235969 2.355227 5.118507 8.22841 7.857564 2.129927 2.33649 2.209283 1.940939 7.200616
2.30103 2.350462 1.887456 5.678831 1.422139 1.431333 1.259375 2.147057 2.273461 2.323841 5.088863 8.24303 7.866914 2.169094 2.38653 2.223995 1.934994 7.211098
2.30103 2.333381 1.942191 5.648778 1.427742 1.427181 1.272111 2.151875 2.275303 2.340012 5.067379 8.256082 7.872256 2.156586 2.409216 2.223926 1.941661 7.203625
2.60206 2.864654 2.128362 5.878563 1.659828 1.768156 1.563377 2.445453 2.626792 2.658258 5.470269 8.543031 8.187047 2.554402 2.74746 2.556907 2.318533 7.568549
2.60206 2.766666 2.149522 5.887471 1.690519 1.720627 1.519126 2.422387 2.604906 2.618967 5.440759 8.609311 8.216684 2.572629 2.766128 2.591306 2.367786 7.545447
2.60206 2.815619 2.24615 5.852139 1.726876 1.742778 1.561501 2.478119 2.621104 2.637534 5.359096 8.600249 8.200935 2.567428 2.812132 2.561516 2.348022 7.521068
3.30103 3.121772 2.309614 6.292235 2.290989 2.219269 1.986101 2.90532 3.049464 3.072469 6.357246 9.385569 8.926366 3.278438 3.809477 3.415052 3.011474 8.297135
3.30103 3.301912 2.276663 6.113176 2.245725 2.23263 2.026941 2.849728 3.109934 3.123496 6.38486 9.336742 8.934414 3.297277 3.786352 3.405443 2.998876 8.345405




B8: Pairing of bile acids with appropriate internal standards 
 































B10: Raw data for N-acyl amino acids detected in biological samples 
 
 
Specimen BC16 BC5 BC4 BC9 BC6 BC1 BC11 BC8 BC12 BC7 BC2 BC13 BC14 BC15 BC10
Fat Content 10% Fat 10% Fat 10% Fat 10% Fat 10% Fat 10% Fat 10% Fat 10% Fat 10% Fat 10% Fat 10% Fat 10% Fat 10% Fat 10% Fat 10% Fat
chenodeoxycholate(CDCA)/ deoxycholate(DCA) 8.600 3.501 0.078 3.323 0.003 0.471 0.143 0.030 39.551 3.353 50.349 20.561 0.004 0.000 20.285
Hyodeoxycholate (HDCA) 0.021 0.045 0.001 0.139 0.002 0.003 0.001 0.000 3.295 0.086 8.454 0.218 0.000 0.000 0.554
Ursodeoxycholate (UDCA) 0.044 0.004 0.001 0.022 0.002 0.003 0.002 0.000 1.501 0.003 3.462 0.063 0.000 0.000 0.248
cholate  (CA) 2491.320 503.046 121.694 1359.863 34.620 327.572 162.876 192.048 4434.263 734.088 5651.631 2382.554 103.868 163.172 3985.769
beta-muricholate (bMCA) 63.400 105.653 1.496 39.796 2.036 4.368 4.139 10.445 12.764 8.945 21.225 21.930 2.774 4.144 27.177
alpha-muricholate (aMCA) 66.356 51.215 9.281 54.018 1.657 10.728 5.243 10.038 17.899 14.526 26.456 37.564 2.521 7.055 26.517
glycochenodeoxycholate (GCDCA) 0.052 0.025 0.039 0.015 0.024 0.012 0.019 0.023 0.002 0.043 0.026 0.075 0.007 0.063 0.004
glycodeoxycholic acic (GDCA) 0.161 0.015 0.041 0.040 0.026 0.019 0.017 0.016 0.010 0.058 0.106 0.109 0.027 0.072 0.017
glycocholate (GCA) 283.552 318.322 201.624 146.063 99.842 38.530 85.818 251.803 28.004 324.460 160.877 344.878 98.682 1015.406 29.746
taurolithocholate (TLCA) 0.394 0.053 0.162 0.073 0.101 0.107 0.114 0.162 0.057 0.273 0.217 0.430 0.124 0.195 0.081
taurochenodeoxycholate (TCDCA) 275.126 25.978 50.033 39.130 40.653 40.993 35.745 56.967 17.644 80.087 163.205 222.734 86.556 99.430 35.780
taurohyodeoxycholate (THDCA) 514.890 44.554 88.360 95.533 69.119 71.489 54.798 74.688 41.015 125.254 396.908 364.018 187.378 158.715 85.844
tauroursdoexycholate(TUDCA)/ taurodeoxycholate 
(TDCA)
64.290 5.781 15.248 12.002 8.997 9.288 8.983 13.561 6.640 18.411 45.461 44.947 31.300 22.280 11.650
taurocholate (TCA) 1917.063 213.712 206.913 248.259 197.388 173.874 203.005 386.484 147.183 500.203 1236.998 2648.459 542.156 643.811 221.964














compoundId 12 hr fast 12 hr fast 12 hr fast 12 hr fast 12 hr fast 12 hr fast 12 hr fast 12 hr fast 12 hr fast 12 hr fast 8 hr fast 8 hr fast 8 hr fast 8 hr fast 8 hr fast 8 hr fast 8 hr fast 8 hr fast 8 hr fast 8 hr fast 4 hr fast 4 hr fast 4 hr fast 4 hr fast 4 hr fast 4 hr fast 4 hr fast 4 hr fast 4 hr fast 4 hr fast fed fed fed fed fed fed fed fed fed fed 12 hr fast 2 hr fed12 hr fast 2 hr fed12 hr fast 2 hr fed12 hr fast 2 hr fed12 hr fast 2 hr fed
stearoyl valine 20423.19 33300.27 71978.06 32580.4 22828.04 19692.24 61214.66 22106.39 33276.79 18307.49 56630.44 26443.44 29354.05 50214.89 10690.92 56917.15 56941.5 64652.24 82379.33 37939.99 5585.229 3051.849 21920.84 748.4656 641.9033 43657.46 47901.53 38133.64 57224.02 50767.75 8269.914 7947.473 3038.581 7829.066 17936.35 1397.989 9602.962 50365.38 3334.058 20133.54 10596.12 6607.277 4109.207 9767.779 5295.836
stearoyl leucine 77647.37 110148.6 146059.4 94059.58 79750.59 61431.12 130602.5 79656.53 100711.8 55729.2 110101.7 70634.07 88158.74 130570.4 62094.41 170475.8 160833.7 156608.5 224814.9 107933.6 24883.42 19341.98 62492.37 12435.47 14871.96 100862.6 152092.4 88321.58 158037.2 140334.6 44830.88 36578.18 9206.284 21326.05 43587.64 11837.49 34350.09 139474.2 9828.036 38603.32 24359.27 27416.83 10581.05 28982.38 27120.13
stearoyl phenylalanine 49092.99 86214.61 80849.82 70182.61 58975.54 41894.94 52515.79 30515.63 72128.3 41897.65 65733.5 52300.78 72351.59 80108.31 55985.17 103587.6 74443.69 113102.2 95400.84 61769.31 19153.75 8273.827 49308.06 4448.373 11699.16 75186.81 80011.45 60201.96 118649.4 114036.7 33388.64 22210.45 5156.412 5778.401 18960.77 5721.218 19567.84 75664.55 9744.188 24890.91 8986.136 12711.8 9114.647 15682.11 10692.88
palmitoleoyl valine 20686.22 76009.11 75784.75 58149.68 36479.17 60567.79 44989.09 20309.13 44354.85 18313.75 73782.91 44133.21 51466.18 48251.93 10574.09 116536.9 54148.07 60725.75 109849.8 64642.18 17421.24 7304.439 36850.99 1219.857 1769.016 54999.98 43155.49 65725.71 79865.57 69093.27 14962.51 5126.168 0 4224.754 5757.811 0 1699.842 60272.84 728.9133 8999.776 1539.277 3980.975 905.4637 1185.043 1314.977
palmitoyl valine 46466.92 87496.3 120409.9 85588.7 48863.98 70199.2 132943.8 30762.92 41066.13 27348.48 89439.33 69531.57 73525.3 75832.09 18706.04 101510.1 88295.92 77082.59 152587 54542.63 11374.79 4884.078 25868.05 2377.975 11021.06 52827.31 88129.19 37844.06 65158.72 56552.04 14141.07 11029.85 4521.637 11170.29 22301.4 6148.938 14050.63 68688.62 5096.101 15839.55 7220.175 11156.15 9527.013 9225.863 9231.312
palmitoyl phenylalanine 104657.9 193652.9 167606.4 181041.2 161124.5 145819.2 166756.6 77698.39 127528.4 94302.88 202182.1 154843.9 203922 163236.9 68074.57 272972.5 159589 175531.3 256458.3 102097.6 29770.3 30559.41 97560.95 12006.01 19376.89 114883.9 140133.9 123351.2 200971 191115.6 41095.2 19763.58 12488.16 11966.81 31925.56 7962.073 31180.11 157529.2 12749.81 32226.82 21374.88 18035.56 11326.92 22142.28 24707.13
palmitoly leucine 128353.1 259029.3 257784.1 217754.3 168181 146713.6 311351.1 104437.1 144551.8 100919.7 204734.5 164916.9 199583 183606.9 76115.04 300101.2 241522.3 201687.2 406705 157058.9 35028.26 32599.65 104521.7 17456.56 24443.63 147367.9 240335.4 138927.8 186930.1 183589.7 58552.16 32194.44 13158.1 26818.25 47367.69 20212.61 37158.92 254983.2 13288.03 44869.23 29658.54 35005.54 15715.9 32601.33 35026.04
oleoyl valine 66261.38 156871.5 224743.6 157492 92359.12 93503.8 220404.6 54713.57 72356.81 49663.79 112784.2 97208.65 119995 124602.3 30386.64 171233.7 137398.5 143599.4 194607.9 77063.99 3908.458 6139.046 50434.15 2886.287 7617.953 77108.09 117894.7 65207.86 102209.7 100839.4 17615.4 6684.806 2241.182 2630.002 22985.62 0 9786.027 116885.1 4516.255 21449.48 6159.382 13569.76 4593.604 10171.26 10354.83
oleoyl phenylalanine 171838.8 353011.2 315715.9 365635 325737.9 243784 300922.8 137901.7 292066.6 184904.5 306821 258841.2 394597.5 266052.2 106169.1 533673.3 291644.4 355833.7 409446.3 191266.8 37516.8 36319.55 188063.9 22062.71 18733.88 222920.3 232302.1 234225.3 359024 332396 61113.61 42116.39 6905.381 26569.24 45314.7 3270.459 36297.7 274396.7 13179.99 48655.42 28203.88 33179 8581.641 34441.23 27212.7
oleoyl leucine 215301 439466.6 476843.3 418646.6 332269.4 255829.8 568318.3 194421.6 295375.8 187718.5 324630.2 307630.4 416915.8 356466.6 118437.8 546058.4 487458.6 453544.9 773408.9 298251 41031.11 37588.93 193578.6 24575.67 28977.68 251321.8 396561.7 270679.6 391775.3 365109.1 85249.97 45113.4 26606.57 48427.67 76538.48 11238.2 55335.48 472252.5 18266.25 67135.47 46000.81 43428.96 24353.63 49165.71 36607.43
linoleoyl valine 13731.73 42879.15 74619.68 53310.25 24394.68 33780.02 69634.66 24533.15 25129.23 17761.63 47767.38 40586.24 26332.68 44458.95 12512.81 57047.85 42530.73 60021.2 92315.62 33982.89 7215.492 7522.472 19705.23 6939.436 8360.78 44696.38 45663.41 21507.82 26839.77 38202.12 10898.93 4813.872 2594.071 7356.417 14638.01 8325.779 5185.295 34393.77 5051.61 9846.032 7345.01 12731.79 8151.048 7860.691 9368.054
linoleoyl phenylalanine 49983.98 145914.3 156576.2 100818.4 102089 78114.04 88480.8 45049.21 85922.18 49654.72 96024.45 95027.99 106850.8 90933.96 44917.02 207204.7 104530.7 120148.3 183738.8 57896.3 12603.49 9368.485 52361.59 806.6263 3416.221 84828.64 83783.27 76258.86 80650.63 79889.76 24515.87 13030.7 5502.942 9259.294 13444.49 3261.046 15829.95 61439.3 7345.773 13511.49 8622.922 14187.68 0 11384.98 10411.31
linoleoyl leucine 76377.85 179023.6 202627.8 116053.1 102597.7 73447.67 164411 58160.82 83078.74 74069.8 121884 117264.8 106704.5 109664.5 36289.47 217544.8 151583.1 152893.6 304993.9 97147.31 13706.36 9418.202 58187.25 0 10196.51 84815.66 128566.1 82806.19 82219.67 97042.16 34190.07 20158.45 4558.673 14017.91 26468.28 2542.188 16872.11 92365.26 8011.588 22263.31 15839.33 15762.34 5892.311 12164.11 19754.55
dodecanoyl phenylalanine 18473.66 54235.21 60554.18 12126.11 6946.283 3414.861 4733.458 41920.94 9962.247 6050.929 41547.52 86284.77 12960.02 8820.636 7743.186 6901.337 105760.1 8983.038 11773.36 25373.04 13631.45 25564.54 1464.917 2432.871 6102.114 5393.083 7017.04 7384.666 6925.241 6388.246 4983.087 7099.269 6344.271 1432.435 13769.69 4419.465 2973.746 4432.729 4296.123 1951.115 0 5546.805 2486.479 7184.024 8022.591
dodecanoyl leucine 179020.5 357579.3 343071.4 259821.2 148694.3 251481.1 258536.7 156676.6 121462.9 140888.1 380148 233893.4 141428.1 318838.5 73494.27 222446.5 234915.1 166548.9 460224.9 244803.8 45016.62 47263.92 115206.1 26480.28 27970.67 156176.8 267301.9 133467 141143.6 221240.1 69617.03 37924.89 32710.17 88133.64 72359.7 55219.21 63626.08 112839.6 35123.38 59729.38 40236.7 45910.04 38103.46 51317.06 45993.27
docosahexaenoyl leucine 7496.992 22027.6 16192.08 8933.185 6655.835 11306.81 15841.56 8960.886 7200.211 3032.384 28729.04 6905.197 3120.949 4975.944 2715.608 17016.65 12640.89 6898.965 42502.95 5621.253 1199.44 1381.711 2331.301 878.8221 976.32 8755.234 37712.95 17040.97 15872.98 13145.69 12255.11 0 1215.282 0 0 0 1830.149 9953.288 0 0 2575.943 1018.854 1826.736 1041.062 1136.971
palmitoleoyl leucine 0 12519.62 23965.28 6946.888 10609.71 13487.22 22573.93 4026.417 3244.371 8128.415 9786.844 10604.71 20326.94 13903.96 3108.593 20323.17 9669.648 7286.889 47935.05 7180.971 1166.358 4976.649 953.3542 0 0 3508.165 15589.92 4830.092 15502.47 6069.826 1876.391 0 0 2939.488 1810.065 2721.341 0 9553.263 0 0 0 0 947.8567 0 0
palmitoleoyl phenylalanine 0 21582.21 7511.358 7091.518 1109.55 8047.766 14293.66 1536.604 3954.464 3194.32 8872.649 6802.093 17694.38 4286.894 0 25345.07 8396.67 2397.833 14618.13 5926.406 0 1046.003 1075.276 0 0 6287.805 5822.043 3286.725 6962.28 7723.217 0 0 0 0 0 0 0 5215.873 0 0 0 0 0 0 0
compoundId 12 hr fast 12 hr fast 12 hr fast 12 hr fast 12 hr fast 12 hr fast 12 hr fast 12 hr fast 12 hr fast 12 hr fast 8 hr fast 8 hr fast 8 hr fast 8 hr fast 8 hr fast 8 hr fast 8 hr fast 8 hr fast 8 hr fast 8 hr fast 4 hr fast 4 hr fast 4 hr fast 4 hr fast 4 hr fast 4 hr fast 4 hr fast 4 hr fast 4 hr fast 4 hr fast fed fed fed fed fed fed fed fed fed fed 12 hr fast 2 hr fed12 hr fast 2 hr fed12 hr fast 2 hr fed12 hr fast 2 hr fed12 hr fast 2 hr fed
stearoyl valine 20423.19 33300.27 71978.06 32580.4 22828.04 19692.24 61214.66 22106.39 33276.79 18307.49 56630.44 26443.44 29354.05 50214.89 10690.92 56917.15 56941.5 64652.24 82379.33 37939.99 5585.229 3051.849 21920.84 748.4656 641.9033 43657.46 47901.53 38133.64 57224.02 50767.75 8269.914 7947.473 3038.581 7829.066 17936.35 1397.989 9602.962 50365.38 3334.058 20133.54 10596.12 6607.277 4109.207 9767.779 5295.836
stearoyl leucine 77647.37 110148.6 146059.4 94059.58 79750.59 61431.12 130602.5 79656.53 100711.8 55729.2 110101.7 70634.07 88158.74 130570.4 62094.41 170475.8 160833.7 156608.5 224814.9 107933.6 24883.42 19341.98 62492.37 12435.47 14871.96 100862.6 152092.4 88321.58 158037.2 140334.6 44830.88 36578.18 9206.284 21326.05 43587.64 11837.49 34350.09 139474.2 9828.036 38603.32 24359.27 27416.83 10581.05 28982.38 27120.13
stearoyl phenylalanine 49092.99 86214.61 80849.82 70182.61 58975.54 41894.94 52515.79 30515.63 72128.3 41897.65 65733.5 52300.78 72351.59 80108.31 55985.17 103587.6 74443.69 113102.2 95400.84 61769.31 19153.75 8273.827 49308.06 4448.373 11699.16 75186.81 80011.45 60201.96 118649.4 114036.7 33388.64 22210.45 5156.412 5778.401 18960.77 5721.218 19567.84 75664.55 9744.188 24890.91 8986.136 12711.8 9114.647 15682.11 10692.88
palmitoleoyl valine 20686.22 76009.11 75784.75 58149.68 36479.17 60567.79 44989.09 20309.13 44354.85 18313.75 73782.91 44133.21 51466.18 48251.93 10574.09 116536.9 54148.07 60725.75 109849.8 64642.18 17421.24 7304.439 36850.99 1219.857 1769.016 54999.98 43155.49 65725.71 79865.57 69093.27 14962.51 5126.168 0 4224.754 5757.811 0 1699.842 60272.84 728.9133 8999.776 1539.277 3980.975 905.4637 1185.043 1314.977
palmitoyl valine 46466.92 87496.3 120409.9 85588.7 48863.98 70199.2 132943.8 30762.92 41066.13 27348.48 89439.33 69531.57 73525.3 75832.09 18706.04 101510.1 88295.92 77082.59 152587 54542.63 11374.79 4884.078 25868.05 2377.975 11021.06 52827.31 88129.19 37844.06 65158.72 56552.04 14141.07 11029.85 4521.637 11170.29 22301.4 6148.938 14050.63 68688.62 5096.101 15839.55 7220.175 11156.15 9527.013 9225.863 9231.312
palmitoyl phenylalanine 104657.9 193652.9 167606.4 181041.2 161124.5 145819.2 166756.6 77698.39 127528.4 94302.88 202182.1 154843.9 203922 163236.9 68074.57 272972.5 159589 175531.3 256458.3 102097.6 29770.3 30559.41 97560.95 12006.01 19376.89 114883.9 140133.9 123351.2 200971 191115.6 41095.2 19763.58 12488.16 11966.81 31925.56 7962.073 31180.11 157529.2 12749.81 32226.82 21374.88 18035.56 11326.92 22142.28 24707.13
palmitoly leucine 128353.1 259029.3 257784.1 217754.3 168181 146713.6 311351.1 104437.1 144551.8 100919.7 204734.5 164916.9 199583 183606.9 76115.04 300101.2 241522.3 201687.2 406705 157058.9 35028.26 32599.65 104521.7 17456.56 24443.63 147367.9 240335.4 138927.8 186930.1 183589.7 58552.16 32194.44 13158.1 26818.25 47367.69 20212.61 37158.92 254983.2 13288.03 44869.23 29658.54 35005.54 15715.9 32601.33 35026.04
oleoyl valine 66261.38 156871.5 224743.6 157492 92359.12 93503.8 220404.6 54713.57 72356.81 49663.79 112784.2 97208.65 119995 124602.3 30386.64 171233.7 137398.5 143599.4 194607.9 77063.99 3908.458 6139.046 50434.15 2886.287 7617.953 77108.09 117894.7 65207.86 102209.7 100839.4 17615.4 6684.806 2241.182 2630.002 22985.62 0 9786.027 116885.1 4516.255 21449.48 6159.382 13569.76 4593.604 10171.26 10354.83
oleoyl phenylalanine 171838.8 353011.2 315715.9 365635 325737.9 243784 300922.8 137901.7 292066.6 184904.5 306821 258841.2 394597.5 266052.2 106169.1 533673.3 291644.4 355833.7 409446.3 191266.8 37516.8 36319.55 188063.9 22062.71 18733.88 222920.3 232302.1 234225.3 359024 332396 61113.61 42116.39 6905.381 26569.24 45314.7 3270.459 36297.7 274396.7 13179.99 48655.42 28203.88 33179 8581.641 34441.23 27212.7
oleoyl leucine 215301 439466.6 476843.3 418646.6 332269.4 255829.8 568318.3 194421.6 295375.8 187718.5 324630.2 307630.4 416915.8 356466.6 118437.8 546058.4 487458.6 453544.9 773408.9 298251 41031.11 37588.93 193578.6 24575.67 28977.68 251321.8 396561.7 270679.6 391775.3 365109.1 85249.97 45113.4 26606.57 48427.67 76538.48 11238.2 55335.48 472252.5 18266.25 67135.47 46000.81 43428.96 24353.63 49165.71 36607.43
linoleoyl valine 13731.73 42879.15 74619.68 53310.25 24394.68 33780.02 69634.66 24533.15 25129.23 17761.63 47767.38 40586.24 26332.68 44458.95 12512.81 57047.85 42530.73 60021.2 92315.62 33982.89 7215.492 7522.472 19705.23 6939.436 8360.78 44696.38 45663.41 21507.82 26839.77 38202.12 10898.93 4813.872 2594.071 7356.417 14638.01 8325.779 5185.295 34393.77 5051.61 9846.032 7345.01 12731.79 8151.048 7860.691 9368.054
linoleoyl phenylalanine 49983.98 145914.3 156576.2 100818.4 102089 78114.04 88480.8 45049.21 85922.18 49654.72 96024.45 95027.99 106850.8 90933.96 44917.02 207204.7 104530.7 120148.3 183738.8 57896.3 12603.49 9368.485 52361.59 806.6263 3416.221 84828.64 83783.27 76258.86 80650.63 79889.76 24515.87 13030.7 5502.942 9259.294 13444.49 3261.046 15829.95 61439.3 7345.773 13511.49 8622.922 14187.68 0 11384.98 10411.31
linoleoyl leucine 76377.85 179023.6 202627.8 116053.1 102597.7 73447.67 164411 58160.82 83078.74 74069.8 121884 117264.8 106704.5 109664.5 36289.47 217544.8 151583.1 152893.6 304993.9 97147.31 13706.36 9418.202 58187.25 0 10196.51 84815.66 128566.1 82806.19 82219.67 97042.16 34190.07 20158.45 4558.673 14017.91 26468.28 2542.188 16872.11 92365.26 8011.588 22263.31 15839.33 15762.34 5892.311 12164.11 19754.55
dodecanoyl phenylalanine 18473.66 54235.21 60554.18 12126.11 6946.283 3414.861 4733.458 41920.94 9962.247 6050.929 41547.52 86284.77 12960.02 8820.636 7743.186 6901.337 105760.1 8983.038 11773.36 25373.04 13631.45 25564.54 1464.917 2432.871 6102.114 5393.083 7017.04 7384.666 6925.241 6388.246 4983.087 7099.269 6344.271 1432.435 13769.69 4419.465 2973.746 4432.729 4296.123 1951.115 0 5546.805 2486.479 7184.024 8022.591
dodecanoyl leucine 179020.5 357579.3 343071.4 259821.2 148694.3 251481.1 258536.7 156676.6 121462.9 140888.1 380148 233893.4 141428.1 318838.5 73494.27 222446.5 234915.1 166548.9 460224.9 244803.8 45016.62 47263.92 115206.1 26480.28 27970.67 156176.8 267301.9 133467 141143.6 221240.1 69617.03 37924.89 32710.17 88133.64 72359.7 55219.21 63626.08 112839.6 35123.38 59729.38 40236.7 45910.04 38103.46 51317.06 45993.27
docosahexaenoyl leucine 7496.992 22027.6 16192.08 8933.185 6655.835 11306.81 15841.56 8960.886 7200.211 3032.384 28729.04 6905.197 3120.949 4975.944 2715.608 17016.65 12640.89 6898.965 42502.95 5621.253 1199.44 1381.711 2331.301 878.8221 976.32 8755.234 37712.95 17040.97 15872.98 13145.69 12255.11 0 1215.282 0 0 0 1830.149 9953.288 0 0 2575.943 1018.854 1826.736 1041.062 1136.971
palmitoleoyl leucine 0 12519.62 23965.28 6946.888 10609.71 13487.22 22573.93 4026.417 3244.371 8128.415 9786.844 10604.71 20326.94 13903.96 3108.593 20323.17 9669.648 7286.889 47935.05 7180.971 1166.358 4976.649 953.3542 0 0 3508.165 15589.92 4830.092 15502.47 6069.826 1876.391 0 0 2939.488 1810.065 2721.341 0 9553.263 0 0 0 0 947.8567 0 0
palmitoleoyl phenylalanine 0 21582.21 7511.358 7091.518 1109.55 8047.766 14293.66 1536.604 3954.464 3194.32 8872.649 6802.093 17694.38 4286.894 0 25345.07 8396.67 2397.833 14618.13 5926.406 0 1046.003 1075.276 0 0 6287.805 5822.043 3286.725 6962.28 7723.217 0 0 0 0 0 0 0 5215.873 0 0 0 0 0 0 0
raw areas Tcanola20 Tcanola29 Tcanola39 Tcanola48 Tcanola59 Tfish6 Tfish8 Tfish15 Tfish21 Tfish49 Tflaxseed12Tflaxseed30Tflaxseed51Tflaxseed52Tflaxseed53Tlard4 Tlard13 Tlard14 Tlard41 Tlard60
docosahexaenoyl leucine 0.00E+00 0.00E+00 0.00E+00 6.91E+03 2.48E+03 2.91E+05 1.52E+05 1.35E+05 4.08E+05 3.67E+04 8.52E+03 5.88E+03 3.37E+03 0.00E+00 4.57E+03 0.00E+00 7.55E+03 0.00E+00 0.00E+00 0.00E+00
docosahexaenoyl phenylalanine 3.07E+03 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1.93E+05 1.84E+04 0.00E+00 1.35E+05 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1.39E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00
linoleoyl phenylalanine 2.21E+04 3.44E+04 1.92E+04 5.73E+03 2.94E+04 3.54E+03 6.19E+03 1.80E+03 0.00E+00 0.00E+00 6.11E+03 0.00E+00 4.42E+03 3.34E+03 1.47E+04 1.64E+04 3.81E+05 5.19E+05 3.00E+03 5.73E+04
dodecanoyl leucine 1.70E+05 1.91E+05 1.32E+05 2.05E+05 1.31E+05 1.82E+05 1.28E+05 1.37E+05 2.03E+05 7.63E+04 1.15E+05 1.00E+05 6.71E+04 6.76E+04 1.16E+05 1.86E+05 9.93E+05 8.86E+05 5.18E+04 1.88E+05
dodecanoyl valine 1.68E+04 1.60E+04 4.59E+03 4.37E+04 1.06E+04 5.46E+04 0.00E+00 1.08E+04 3.03E+04 3.38E+03 0.00E+00 1.02E+04 0.00E+00 6.73E+03 3.57E+04 2.02E+05 3.26E+04 2.70E+04 3.58E+04 3.05E+04
linoleoyl leucine 2.33E+05 3.80E+05 2.55E+05 2.49E+05 2.32E+05 1.25E+05 6.57E+04 6.13E+04 1.21E+05 4.69E+04 1.15E+05 7.52E+04 8.00E+04 2.03E+04 1.46E+05 5.70E+05 3.15E+06 4.36E+06 1.25E+04 5.82E+05
linoleoyl valine 5.08E+04 5.02E+04 6.58E+04 4.56E+04 4.07E+04 2.50E+04 3.64E+04 2.48E+04 2.33E+04 2.81E+04 1.72E+04 1.90E+04 1.37E+04 1.49E+04 4.46E+04 4.09E+04 1.63E+05 4.01E+05 1.38E+04 5.73E+04
oleoyl leucine 3.15E+05 3.34E+05 2.62E+05 2.22E+05 2.01E+05 1.54E+05 6.30E+04 5.38E+04 9.24E+04 2.46E+04 1.52E+05 8.76E+04 7.41E+04 2.07E+04 1.56E+05 5.47E+05 1.70E+06 2.73E+06 1.22E+04 5.22E+05
oleoyl phenylalanine 2.93E+04 7.01E+04 4.85E+04 3.46E+04 2.70E+04 7.01E+03 2.30E+03 1.89E+03 5.80E+03 0.00E+00 1.29E+04 3.13E+03 0.00E+00 2.82E+03 1.95E+04 3.68E+04 2.50E+05 2.24E+05 0.00E+00 6.12E+04
oleoyl valine 5.15E+04 5.38E+04 4.72E+04 3.36E+04 4.11E+04 6.51E+03 4.65E+03 5.67E+03 5.93E+03 1.55E+03 1.64E+04 5.90E+03 6.84E+03 4.32E+03 1.77E+04 4.20E+04 3.56E+05 2.91E+05 0.00E+00 6.91E+04
palmitoleoyl leucine 8.25E+04 1.04E+05 4.27E+04 3.66E+04 5.00E+04 3.68E+05 1.66E+05 9.61E+04 3.24E+05 4.66E+04 3.62E+04 3.42E+04 2.01E+04 7.18E+03 4.74E+04 1.52E+05 6.10E+05 1.15E+06 8.72E+03 1.72E+05
palmitoly leucine 1.87E+05 1.73E+05 1.45E+05 1.50E+05 1.13E+05 2.29E+05 1.34E+05 1.19E+05 1.43E+05 8.24E+04 1.77E+05 7.95E+04 6.70E+04 4.52E+04 1.34E+05 3.70E+05 1.09E+06 1.24E+06 6.66E+04 2.92E+05
palmitoyl phenylalanine 1.42E+04 4.20E+04 1.68E+04 2.50E+04 3.93E+03 2.42E+04 1.44E+04 3.14E+03 1.07E+04 0.00E+00 1.64E+04 6.77E+03 1.30E+04 8.15E+03 9.35E+03 1.23E+04 1.57E+05 1.93E+05 2.32E+03 4.64E+04
palmitoyl valine 5.77E+04 6.86E+04 6.14E+04 8.48E+04 5.88E+04 4.27E+04 2.24E+04 4.76E+04 4.94E+04 2.14E+04 3.87E+04 3.53E+04 2.80E+04 1.93E+04 4.44E+04 1.01E+05 4.63E+05 8.25E+05 3.45E+04 8.12E+04
palmitoleoyl valine 8.22E+04 1.70E+05 8.53E+04 8.61E+04 7.91E+04 4.61E+04 4.05E+04 2.86E+04 6.07E+04 1.31E+04 2.37E+04 2.75E+04 1.72E+04 1.61E+04 5.90E+04 9.74E+04 6.94E+05 1.26E+06 8.01E+03 1.37E+05
docosahexaenoyl valine 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 8.28E+03 3.18E+03 1.59E+03 1.32E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 6.17E+03 0.00E+00 0.00E+00
palmitoleoyl phenylalanine 0.00E+00 8.25E+03 0.00E+00 0.00E+00 0.00E+00 3.02E+04 0.00E+00 1.92E+03 2.04E+04 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 4.24E+03 3.06E+03 8.65E+04 1.36E+05 0.00E+00 1.16E+04




Appendix C: Supporting information for chapter 4 
C1: Characterization data for photo-methionine synthesis 
4,4-azohexanoic acid (4): 1H NMR (300 mHz, CDCl3): δ 1.01 ppm (s, 3H), 1.38-1.43 (m, 








Tert-butyl N2-(tert-butoxycarbonyl)-N5-methoxy-N5-methylglutaminate aka Weinreb 
amide (7): 1H NMR (300 mHz, CDCl3): δ 1.44 ppm (s, 9H), 1.47 (s, 9H), 1.89-1.96 (m, 
1H), 2.12-2.19 (m, 1H), 2.45-2.60 (m, 2H), 3.17 (s, 3H), 3.67 (s, 3H), 4.20 (bs, 1H), 5.19 








Tert-butyl 2-((tert-butoxycarbonyl)amino)-5-oxohexanoate (8): 1H NMR (300 mHz, 
CDCl3): δ 1.43 ppm (s, 9H), 1.46 (s, 9H), 1.77-1.89 (m, 1H), 2.03-2.12 (m, 1H), 2.15 (s, 








2-amino-5-oxohexanoic acid (10): 1H NMR (300 mHz, D2O): δ 2.21-2.31 ppm (m, 1H), 
2.41 (s, 3H), 2.51-2.64 (m, 1H), 3.08 (t, 2H), 5.00 (bs, 1H). Solvent residual peak for D2O 







Methyl pyroglutamate (13): 1H NMR (300 mHz, CD3OD): δ 2.17-2.25 ppm (m, 1H), 2.45-
2.60 (m, 3H), 3.76 (s, 3H), 4.42 (t, 1H). Solvent residual peak for CD3OD at 3.3 ppm. 







1-(tert-butyl) 2-methyl 5-oxopyrrolidine-1,2-dicarboxylate (14): 1H NMR (300 mHz, 
CDCl3): δ 1.48 ppm (s,9H), 1.99-2.05 (m, 1H), 2.27-2.35 (m, 1H), 3.77 (s, 3H), 4.60 (dd, 







Methyl 2-((tert-butoxycarbonyl)amino)-5-oxohexanoate (15): 1H NMR (300 mHz, 
CDCl3): δ 1.42 ppm (s, 9H), 1.82-1.90 (m, 1H), 2.07-2.12 (m, 1H), 2.13 (s, 3H), 2.46-2.60 
(m, 2H), 3.72 (s, 3H), 4.25 (bs, 1H), 5.09 (bs, 1H). Solvent residual peak for CDCl3 at 7.3 







Methyl 2-((tert-butoxycarbonyl)amino)-4-(3-methyl-3H-diazirin-3-yl)butanoate (16): 
1H NMR (300 mHz, CDCl3): δ 1.01 ppm (s, 3H), 1.34-1.40 (m, 1H), 1.44 (bs, 12H), 1.68-
1.74 (m, 1H), 3.74 (s, 3H), 4.27 (bs, 1H), 4.97 (bs, 1H). Solvent residual peak for CDCl3 







2-((tert-butoxycarbonyl)amino)-4-(3-methyl-3H-diazirin-3-yl)butanoic acid (17): 1H 
NMR (300 mHz, CDCl3): δ 1.03 ppm (s, 3H), 1.44 (bs, 12H), 1.80 (m, 2H), 4.28 (bs, 1H), 







Photo-methionine (1): 1H NMR (300 mHz, D2O): δ 0.91 ppm (s, 3H), 1.33-1.51 (m, 2H), 







Appendix D: Course content for chapter 5 

























































Polymerase chain reaction (PCR) is a technique that is used to amplify a region of DNA 
by rapidly synthesizing thousands to millions of copies. To perform PCR, several basic 
components are needed: the DNA template to be amplified, deoxynuclotide triphosphate 
monomers (dNTPs), a DNA polymerase enzyme that performs the polymerization 
reactions, and DNA “primers” to serve as a starting point for the synthesis. The entire 
process is carried out in a thermo cycler, a piece of equipment that subjects the reactions 
to repeated cycles of heating. The procedure can be subdivided into different steps, each 
with corresponding temperatures. In the first step, the DNA that is intended for 
amplification must be denatured into a single strand. This is accomplished by heating at 
94-98 °C. In the second step, the temperature is dropped to 50-60 °C so the primers can 
be annealed to the single-stranded DNA template. Next, the temperature is raised to 70-
80 °C and the DNA is elongated by the enzyme. The cycles are represented by the figure 
below.  
Primers allow the initiation of the DNA polymerization by providing short sections of 
double-stranded DNA which can be elongated. They are essential for DNA replication, 
since the polymerase enzymes are only capable of elongating existing DNA chains.  
Objectives 
A crucial part of performing a PCR experiment is primer design. Since the primer signals 
the start position of the DNA synthesis, it controls the specificity of the reaction. In other 
words, if the primer does not bind exclusively to the intended area of the DNA sequence, 
then unwanted segments of DNA can be unintentionally amplified. In this lab period, the 
process of primer design will be explored. Starting from a gene that will serve as the DNA 
template, primers will be designed and assessed based on several criteria for successful 
PCR. 
Materials 
• Laptop/notebook computers  





1. Open web browser and navigate to www.addgene.org.  
2. Enter “pUC19” in the “search for plasmids” query and select the top hit. The pUC19 
plasmid is isolated from E. coli and contains 3 genes, including the gene for 
resistance to the antiobiotic ampicililin, AmpR. The AmpR gene will be the DNA 
template of this multi-week PCR experiment. The goal is to detect ampicillin 
resistance in E. coli pUC19 DNA. This will be accomplished by PCR amplification 
of AmpR and electrophoresis to resolve the PCR products. 
3. The sequence map should be visible in the top left corner of the pUC19 page. Click 
on “view all sequences” just below the map image.  
4. On the new page, click “analyze sequence” near the map image.  
5. On the resulting screen, select the “sequence” tab.  
6. Scroll down until you see the AmpR portion of the sequence. 
7. Using the select tool (shaped like +), carefully select the entire AmpR gene. 
8. Once the entire gene is highlighted, a clipboard window will appear with the text 
sequence of the AmpR portion of pUC19. Copy the sequence.  
9. Open a new window of Microsoft Word and paste the sequence into it. 
10. With the sequence highlighted, click on the word count in the lower left corner to 
bring up the info window. The sequence should be 861 bases in length. This can 
be confirmed by the character count. If the character count is not 861, repeat steps 
7-9.  
11. Sequences with fewer than 1000 nucleotides are the easiest to amplify. It is 
possible to amplify partial genes, but since the entire AmpR sequence is 861 
bases, the entire gene can be easily amplified. Remember that the template DNA 
is not a single strand, but rather a double strand. Next, the complimentary strand 
will be generated so both strands of the DNA can be visualized.  
12. Open a new web browser tab.  
13. Navigate to http://molbiol.edu.ru/eng/scripts/01_12.html. You should see a page 
with the heading “Sequence Utilities.”       
14. Copy the AmpR sequence from Microsoft Word and paste it into the sequence box.  




16. Copy and paste the resulting text in another page of the Microsoft Word document.  
17. Both forward and reverse primers are necessary. Recall that the double-stranded 
DNA will be denatured before annealing and elongation. The forward primer will 
bind at the 5’ end of one strand of the DNA that will be copied, and the reverse 
primer will bind at the 5’ of complimentary strand. There are several initial 
guidelines for primers that will inform design. Primers should be approximately 18 
-25 nucleotides in length. Additionally, primers should both begin and end with 
G/C. This is due to the added advantage of the third hydrogen bond between G/C 
base pairs. With these guidelines in mind, choose sections of AmpR DNA that 
could be ideal primers. In Microsoft Word, highlight the potential primer areas in 
yellow.  
18. Copy the portion of the sequence that was chosen as the forward primer. Paste it 
on a new page of the same Word document and label it “forward primer”. Do the 
same for the reverse primer. Denote the 5’ and 3’ ends of each primer.  
19. Navigate to www.idtdna.com. 
20. Under the “tools” dropdown menu, select “OligoAnalyzer Tool” 
21. Copy the sequence of the forward primer and paste it into the “sequence box”. 
Click the “analyze” button.  
22. The software should generate several parameters that are useful for determining 
whether or not the primer is suitable. For instance, the GC content should be 
between 30 and 60 %. Likewise, the Tm (melt temp) should be between 56 and 62 
°C. Copy and paste the length, GC content, and Tm into the existing Word 
document.  
23. Repeat steps 20 -22 for the reverse primer.  
24. Lastly, it is crucial that primers are highly selective. To ensure that a primer will 
only bind to the intended sequence, it must be compared against all DNA present. 
If a primer sequence is repeated elsewhere in the pUC19 plasmid, it could cause 
amplification of unwanted genes. To confirm selectivity, return to 
www.addgene.org and navigate to the page for pUC19.  




26. Copy and paste the entire 2686 base pUC19 sequence into a new, blank Word 
document. Using the “find” function (Ctrl + F or Command + F) search both the 
forward and reverse primers and ensure they only occur once in pUC19. 
27. If primers do not meet the given criteria, consult earlier steps and re-design them.  
28. Once primers meet all criteria, save the original document containing the AmpR 
sequence, double stranded DNA sequence, and selected primers with their 
properties. Include a short write-up (1 paragraph) describing why the chosen 
primers are suitable for PCR. Ensure that the document is formatted in an orderly 
way. Name the file based on the following model: 
“YYMMDD_LastNamePartner1_LastNamePartner_2_Primer_Design”. Upload the 
file to Canvas. This will serve as a lab report for week 1 and will be graded.  
29. Once you have completed the primer design exercise, see TA to begin DNA 
extraction. 
30. Extract PUC19 DNA using an Invitrogen Plasmid Mini Kit using the supplied 
instructions (below). 
Use a microcentrifuge capable of centrifuging at >12,000 × g. Perform all centrifugation steps at 
room temperature using a microcentrifuge.  
• Optional: Preheat an aliquot of TE Buffer (TE) to 65–70°C for eluting DNA. Heating is optional 
for eluting 1–30 kb plasmid DNA but is recommended for eluting DNA >30 kb.  
• Caution: Buffers contain hazardous reagents. Use caution when handling buffers. Isolate 
miniprep plasmid DNA  
1. Harvest. Centrifuge 1–5 mL of the overnight LB-culture. (Use 1–2 × 109 E. coli cells for each 
sample.) Remove all medium.  
2. Resuspend. Add 250 μL Resuspension Buffer (R3) with RNase A to the cell pellet and 
resuspend the pellet until it is homogeneous.  
3. Lyse. Add 250 μL Lysis Buffer (L7). Mix gently by inverting the capped tube until the mixture 
is homogeneous. Do not vortex. Incubate the tube at room temperature for 5 minutes.  
4. Precipitate. Add 350 μL Precipitation Buffer (N4). Mix immediately by inverting the tube, or for 
large pellets, vigorously shaking the tube, until the mixture is homogeneous. Do not vortex. 




5. Bind. Load the supernatant from step 4 onto a spin column in a 2-mL wash tube. Centrifuge 
the column at 12,000 × g for 1 minute. Discard the flow-through and place the column back into 
the wash tube.  
6. Optional Wash. (Recommended for endA+ strains). Add 500 μL Wash Buffer (W10) with 
ethanol to the column. Incubate the column for 1 minute at room temperature. Centrifuge the 
column at 12,000 × g for 1 minute. Discard the flowthrough and place column back into the wash 
tube.  
7. Wash and remove ethanol. Add 700 μL Wash Buffer (W9) with ethanol to the column. 
Centrifuge the column at 12,000 × g for 1 minute. Discard the flowthrough and place the column 
into the wash tube. Centrifuge the column at 12,000 × g for 1 minute. Discard the wash tube with 
the flow-through.  
8. Elute. Place the Spin Column in a clean 1.5-mL recovery tube. Add 75 μL of preheated TE 
Buffer (TE) to the center of the column. Incubate the column for 1 minute at room temperature.  
9. Recover. Centrifuge the column at 12,000 × g for 2 minutes. The recovery tube contains the 
purified plasmid DNA. Discard the column. Store plasmid DNA at 4°C (short-term) or store the 





Week 2: Genes: Amplification with PCR 
 
Pre-lab material 
Review slides from week 1 
 
Required reading 
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase 










Polymerase chain reaction (PCR) is a technique that is used to amplify a region of DNA 
by rapidly synthesizing thousands to millions of copies. To perform PCR, several basic 
components are needed: the DNA template to be amplified, deoxynuclotide triphosphate 
monomers (dNTPs), a DNA polymerase enzyme that performs the polymerization 
reactions, and DNA “primers” to serve as a starting point for the synthesis. The entire 
process is carried out in a thermal cycler, a piece of equipment that subjects the reactions 
to repeated cycles of heating. The procedure can be subdivided into different steps, each 
with corresponding temperatures. In the first step, the DNA that is intended for 
amplification must be denatured into a single strand. This is accomplished by heating at 
94-98 °C. In the second step, the temperature is dropped to 50-60 °C so the primers can 
be annealed to the single-stranded DNA template. Next, the temperature is raised to 70-
80 °C and the DNA is elongated by the enzyme. 
The most common polymerase employed in PCR is isolated from the thermophilic 
bacterium Thermus aquatus, which lives in hot springs and hydrothermal vents. Often 
abbreviated Taq Pol or simply Taq, this enzyme is unique among polymerases as it can 
withstand the high temperatures required for DNA denaturation in the initial step of a PCR 
cycle. To function properly, Taq must be buffered. It has optimal activity at a pH of 9. 
Once the primers are annealed to the denatured DNA, Taq will extend the primers until 
the end of the elongation step. Then, the process of denaturation, annealing, and 
elongation will be repeated sequentially until all cycles are complete. This should yield 
millions of exact copies of the target sequence. This makes PCR an extremely powerful 
tool, as endogenous levels of DNA can be very difficult to detect using common laboratory 
techniques. 
Objectives 
In this experiment, the gene for ampicillin resistance in the pUC19 plasmid isolated from 
Escherichia coli (E. coli) will be amplified using primers like the ones that were designed 
in the previous exercise. Each pair of students will be responsible for running two PCRs: 




the reactions are being performed in the thermal cycler, the concepts of PCR will be 
solidified by completing a series of short-answer questions.  
Materials 
• pUC19 plasmid isolate 
• Solution of forward primer (20 uM) 
• Solution of reverse primer (20 uM) 
• IllustraTM Ready-to-GoTM PCR beads 
• Milli-Q water 
• Thermal cycler 
Methods 
1. On the thermal cycler, program the following conditions (the bolded steps are the 
repeated cycles, which should be performed 30 times): 
a) Hold at 95 °C for 3 minutes 
b) Hold at 95 °C for 45 seconds 
c) Hold at 55 °C for 45 seconds 
d) Hold at 72 °C for 1 minute 
e) Final hold at 10-12 °C indefinitely 
 
 
2. To each IllustraTM Ready-to-GoTM PCR bead in a 500 μL Eppendorf tube, add 




3. To each tube, add 1 μL forward primer and 1 μL of reverse primer.  
4. Add 1 μL Puc19 sample to one tube, and 1 μL negative control to the other. Label 
the tubes appropriately with your name and the contents of the tube.  
5. Place to tubes in the thermal cycler and start the reaction cycles.  
6. While reactions are occurring, answer the questions below. 
7. After the questions have been completed, proceed to the gel loading station and 
practice loading gels.  
8. Once amplification is finished, remove vial and return it to the refrigerator. 
 
Questions 
1. The IllustraTM Ready-to-GoTM PCR beads are pre-packaged for fast and 
convenient PCR. In order to perform a successful PCR, the beads must contain 3 




2. Assume that there is a sufficient amount of primer in each reaction vial such that 
each cycle produces a perfect copy of every available DNA strand. How many 
single strands of DNA can be produced from one fragment of double-stranded 







3. The initial cycle of copies of the DNA template are different from all subsequent 





4. Predict the results of a PCR experiment in which the following temperatures are 
too low. Discuss how the products would be altered. 
 

















































PCR, an incredibly beneficial tool for molecular biology, is widely used for amplification of 
DNA. However, it does not yield useful data unless it is paired with another technique. A 
common method of detecting PCR products is gel electrophoresis—a technique which 
separates biopolymers in a gel matrix by their charge and size. Electrophoresis can be 
employed for the separation of proteins, as well as DNA and RNA. For nucleic acid 
polymers (DNA and RNA), the gel matrix is usually comprised of agarose, a 
polysaccharide polymer extracted from algae. In DNA electrophoresis, the sample is 
loaded into a small well in the agarose gel, which is immersed in a buffered electrolyte 
solution. An electric field is applied to the chamber via an external power supply. As the 
negatively-charged DNA migrates towards the positive terminal of the chamber, the 
fragments are slowed by their movement through the pores in the agarose, a 
phenomenon called “sieving”. Since the smallest fragments of DNA are least hindered on 
their path through the gel, they move the fastest—and therefore the furthest in a given 
amount of time. For the data to be meaningful, the migration of unknown DNA must be 
compared to a reference mixture of known DNA fragments known as a “ladder”. A 
visualization reagent (dye) must be used, as the DNA is not detectable without some kind 
of dye or combination of dye and UV light. These dyes can either be incorporated into the 
gel matrix itself or introduced during a staining procedure after electrophoresis. Together, 
the ladder and visualization reagent allow the size of a DNA fragment to be estimated 
with a surprising level of precision.  
Objectives 
The PCR product from the previous lab exercise will be detected using agarose gel 
electrophoresis. Ethidium bromide (EtBr) will be used as an in-gel dye that must be 
visualized under ultraviolet light. It works by inserting between planar bases of DNA 
(intercalating) and, upon exposure to UV light, fluorescing with an orange color. A 1 
kilobase DNA ladder will be used as a reference for determining the size of the amplified 
DNA fragment. Since the size of the AmpR gene is known, a successful PCR can be 







• TAE buffer 
• 1% Ethidium bromide (EtBr) solution 
• Electrophoresis cells 
• Power supply 
• Quick-Load Purple 1 kb DNA ladder 
• Loading dye 
• PCR products from week 2 
• UV gel imaging system 
 
Methods 
1. Pour the gel (done as a group under close TA guidance): 
a) Measure 30 mL of TAE buffer using a graduated cylinder and add it to a 
250 mL erlenmeyer flask.  
b) Using the analytical balance, weigh out 300 mg of agarose on weigh paper. 
c) Add the agarose to the flask of water and microwave until clear, swirling 
occasionally. Total microwave time should not exceed 1 minute. 
d) Add 1 uL of a 1% ethidium bromide solution to the warm agarose solution. 
CAUTION: ethidium bromide is mutagenic and should be handled with 
extreme caution.  
e) Insert the comb into the electrophoresis well. 
f) Pour the mixture into the well and let solidify (approximately 30 minutes). 
g) Once solidified, fill the chamber with TAE buffer until the top of the gel is 
completely covered. 
h) Remove the comb.  




3. One group at a time (following instructions given by the TA), proceed to the gel 
loading station.  
4. Load 5 uL of 1 kb DNA ladder into lane 1. 
a) Using careful pipetting techniques, fill the pipet tip with 5 uL of ladder 
solution. 
b) Insert the tip into the well. Be careful not to disrupt the gel or poke the bottom 
of the chamber. 
c) Slowly dispense the solution into the well. Unlike normal pipette use, do not 
depress the plunger to the second stop! This could cause air to force the 
ladder solution out of the well. 
5. Obtain a small square of parafilm. 
6. Dispense a 5 uL drop of the loading dye onto the parafilm. 
7. Dispense 5 uL of the PCR product onto the parafilm and mix it with the drop of 
loading dye.  
8. Load 5 uL of the mixture of DNA/loading dye into the appropriate lane. 
9. Repeat steps 5-8 for the negative control sample.  
10. Connect the electrodes of the electrophoresis chamber to the power supply using 
the included cables. 
11. Run the gel at 100 V for 45 minutes to 1 hour, or until the purple loading dye 




12. While the gel is running, answer the questions at the end of the procedure. 
13. Once the gel has finished running, carefully remove it from the chamber while 




14. Use the UV lamp to visualize the gel. 
15. Take a picture of the gel under the UV lamp, such that the bands are clearly visible 
in the image. Take care to avoid contamination by disposing of gloves before 
touching cell phones.  





















1. The Quick-Load Purple 1 kb DNA ladder is shown below in lane 1 with all the bands 
labelled. (Notice that the 3 kb band is intentionally more intense than the other 
bands. This will aid in the correct annotation of the ladder bands in the 
experimental gel.) In lane two, draw the expected band(s) for the PCR product(s) 
of the AmpR gene amplification from pUC19. In lane 3, draw the expected band(s) 
for the PCR product(s) of the negative control sample. 
 
 
2. Imagine that you performed this PCR experiment and discovered, to your dismay, 
that your primers were not specific enough. Looking back at the sequence of the 
entire plasmid, you notice that there is a sequence identical to your forward primer 
and another identical to your reverse primer with 520 bases in between. In lane 4 



























Mass spectrometry of peptides and proteins 










Tandem mass spectrometry (MS/MS) can be used to elucidate the sequence of proteins 
and peptides, due to the predictable fragmentation of their amide backbone. Large 
proteins are commonly digested into peptides before analysis, so that each peptide can 
be fully sequenced (termed “bottom-up” proteomics). Most complex proteins require 
search algorithms and reference databases for efficient sequencing. However, in simpler 
cases, MS/MS spectra of peptides can be manually annotated for effective sequence 
elucidation. This is accomplished by observing the difference between prominent peaks 
in MS/MS spectra of peptides and correlating those differences to the masses of 
individual amino acid residues. Additionally, MS/MS sequencing can illuminate post-
translational modifications (PTMs) of known peptides by highlighting residues with a mass 
shift.   
Goals 
Initially, the expected b-type and y-type ions of a known peptide will be predicted. Once 
this is accomplished, an unknown peptide will be identified from an MS/MS spectrum 
using the manual annotation method. Lastly, a mass spectrum of a known sequence 
containing a PTM on one or more residues will be analyzed. Both the identity and the 
location of the modification(s) will be determined from the MS/MS data.  
Materials 
• Spectra packets 
• Reference packets containing lists of residue masses, as well as masses of PTMs 
and possible sites of modification 
• List of strategies for determining sequence from MS/MS spectra 
• Calculators 
• Pens/pencils 




1. In general, the most commonly used mass spectrometers for peptidomics create 
b-type and y-type ions. Y-type ions are usually more abundant than b-type.  
2. Estimate the number of redsidues by dividing the parent mass by the average 
mass of an amino acid residue (110 Da). This is an approximate calculation, and 
will be subject to some error based on the peptide in question. For example, if the 
parent mass of the peptide is 1023.5 Da, then there will be 1023.5/110 or 9.3 
residues (8-10 residues, to be safe).  
3. Identify the y-type ion with the largest m/z and subtract from the parent mass.  This 
will give the mass of the N-terminal residue. (Do not forget to account for the 
proton). 
4. Identify subsequent y-type ions and determine the m/z difference between each 
successive peak.  
5. Using the chart of masses corresponding to amino acid residues, assign an amino 
acid to each difference in m/z between y-ions.  
6. Find the b-type ion with the smallest m/z. This should give you the mass of the N-
terminal residue.  
7. Continue through the spectrum and find the difference in m/z between each 
subsequent b-type ion.  
8. Using the chart of masses corresponding to amino acid residues, assign an amino 





Problem 1: Consider the following peptide. On the sequence, annotate and label all 
possible b-type and y-type ions. In the spaces below, write the sequences of the b-type 






















Problem 2: Based on these b-type and y-type ions from problem 1, draw the expected 
MS/MS spectrum of the peptide. Make sure to include all axis labels. Remember to 
























Problem 3: Below is the MS/MS spectrum of an unknown peptide with an [M+H] 
molecular ion of 792.37 Da. Annotate the spectra and determine the sequence. Show all 































































Problem 4: Consider the following peptide sequence. It has undergone a post-
translational modification, the location and identity of which are unknown. Using the 
experimental MS/MS spectra below, determine the location and identity of the post-



















Location of Modification: ___________________________________ 
 
 












































A Ala 71.0 
R Arg 156.1 
N Asn 114.0 
D Asp 115.0 
C Cys 103.0 
E Glu 129.0 
Q Gln 128.1 
G Gly 57.0 
H His 137.1 
I Ile 113.1 
L Leu 113.1 
K Lys 128.1 
M Met 131.0 
F Phe 147.1 
P Pro 97.1 
S Ser 87.0 
T Thr 101.0 
W Trp 186.1 
Y Tyr 163.1 
V Val 99.1 
 
*Note that these are the masses of the internal residues, not the terminal ones. 
 
Common Protein Modifications 
Modification Affected Residues Mass Shift 
Phosphorylation Ser (common), Thr, Tyr (rarely) + 80 Da 
Sulfation Tyr + 80 Da 
Methylation Lys + 14 Da 
Hydroxylation Lys, Pro + 16 Da 












































Methods and Protocols of Modern Solid Phase Peptide Synthesis 











Modified peptides containing coumarin moieties have previously been employed as a 
means of probing protease specificity through simple fluorescence assays. A common 
approach is to test protease activity on small peptides bearing c-terminal 7-amino-4-
carbamoyl methylcoumarin (ACC) moieties. Cleavage of the appropriate peptide bond 
releases a free ACC which can be detected through basic excitation /emission 
fluorescence. By testing two peptidases against several peptide-ACC substrates, the 
specificity of proteolytic cleavage can be ascertained. In order to facilitate this type of 
assay, modified peptides must be synthesized. The most common reliable means of 
accomplishing this is solid-phase peptide synthesis (SPPS), a technique for which the 
Nobel prize was awarded to Robert Bruce Merrifield in 1984. This approach begins by 
anchoring the C-terminal amino acid to a polymer resin and elongating through 
successive amidation 
Goals 
Tripeptide analogs with C-terminal ACC moieties will be synthesized with SPPS using an 
ACC-modified resin. These will be designed to strategically serve as substrates for the 
proteases trypsin and chymotrypsin by incorporating the appropriate amino acid in 
position next to the scissile bond (the P1 position). In short, peptides which have either 
lysine (sensitive to trypsin), tyrosine (sensitive to chymotrypsin), or alanine (inert) in the 
P1 position relative to the ACC moiety will be made using SPPS. After successful 
synthesis, these peptides will be used to determine protease activity via ACC 
fluorescence using a microplate fluorimeter. Fluorescence will be recorded after addition 
of enzymes trypsin, chymotrypsin, or neither (control) to the synthesized peptide 
substrates. The change in fluorescence of each well will be monitored and the data will 
be plotted and analyzed in Microsoft Excel.  
Materials 
• ACC Resin 




• HBTU (coupling reagent) 
• Diisopropylethylamine (DIPEA) 
• Dimethylformamide (DMF) 
• Dichloromethane (DCM) 






• Kaiser test solution A [5% ninhydrin in ethanol (w/v)] 
• Kaiser test solution B [80% phenol in ethanol (w/v)] 
• Kaiser test solution C [KCN in pyridine (2 mL 1 mM KCN in 98 mL pyridine)] 
• Micropipettes  
• ½ Dram to 1 Dram glass vials 
• Bath for heating vials (Sand in evaporating dish, or metal beads in a heating 
mantle) 
Schedule 
Week 1: Consider the possible proteases, design the two substrates that each group will 
synthesize, and complete the first week of synthesis.  
Week 2: Complete the second week of synthesis of their peptides. 
Week 3: Complete fluorescence assay as described in Protease Specificity Lab Hand-
out 
Design of tripeptide-ACC substrates 
• Each student will choose ACC coupled amino acid to begin.  




• Then, each group chooses two more “inert” residues to couple, either alanine, 
glycine, leucine, or valine.  
 




• Record your choices and make note of how many grams to use and how these 
choices affect your synthesis timeline.  
 
Draw the chemical structure of your tripeptide-ACC final product and answer the following 
questions: 
1) Which protease, if either, will cleave your tripeptide? 
2) At what bond will the protease enzyme cut? 
 
 
Proteases used in lab and their specificities 
 
 
Protease  Cleavage Site 
Trypsin C-Terminal side of Lysine and Arginine 




Experiment Synthesis Flowchart 
Stockroom Preparation: Coupled First FMOC Protected Amino Acid to Resin. P1AA = 




Experiments in Lab: 
Week 1: 
1) Swell Resin 
2) Deprotect  
 
 
3) Couple Second FMOC Protected Amino Acid to Resin 
P2AA = Val, Ala, Gly, or Met 
 
4) Run Kaizer Test. If bad results, go back to step 3 and redo coupling. If good results, 
continue. 



















3) Couple Third FMOC Protected Amino Acid to Resin 
P3AA = Val, Ala, Gly, or Met 
 
 
4) Run Kaizer Test. If bad results, go back to step 3 and redo coupling. 
 If good results, continue. 
5) Final FMOC Deprotection 
 
 
6) Cleavage of Amino Acid protecting groups and linker/resin. 
 
 
Peptide synthesis steps 











1. Add DCM to the peptide vessel until the resin is barely covered 
2. Let the resin sit for 10-15 minutes so it swells to maximal surface area 
Deprotection: 
1. Fill peptide vessel ¼ full with a 20% piperidine/DMF solution 
2. Mix carefully to ensure that there are no clumps of beads (to facilitate access to all 
bead surfaces) 
3. Shake/stir for 1 minute, and drain the solution 
4. Fill the peptide vessel ¼ full with a 20% piperidine/DMF solution 
5. Mix carefully to ensure that there are no clumps of beads (to facilitate access to all 
bead surfaces) 
6. Shake intermittently over 15 minutes 
7. Drain the solution 
8. Rinse 3x with DMF 
Coupling: 
1. Weigh out the appropriate amount of amino acid and place it in a test tube 
2. Weigh out 101 mg of HBTU and place it in the same test tube  
3. Add DMF to the test tube and mix until all contents are dissolved 
4. Add the activated amino acid to the peptide vessel containing the resin and shake 
to ensure adequate dispersion of beads 
5. Add 94 uL of DIPEA 
6. Shake intermittently over 30 minutes 
7. Drain the solution 
8. Rinse 3X with DMF 
Kaiser test: 
1. Remove a few clean beads from the peptide vessel and place in a small vial. Add 
3-4 drops of each Kaiser test solution (A, B, and C) 
2. Heat at 90 – 110 °C for 5 minutes 
3. With adequate lighting, determine if any of the beads maintain a blue color. Kaiser 





Cleavage and final side-chain deprotection: 
1. Dry the resin 
2. Add to round-bottom flask equipped with a stir bar 
3. Add 5-10 mL of cleavage solution 






Week 7: Polypeptides: Probing protease specificity 
 
Pre-lab material 
Review slides from weeks 5 & 6. 
Required reading 
Rapid and general profiling of protease specificity by using combinatorial fluorogenic 
substrate libraries 
Jennifer L. Harris, et. al. 








Enzymes are powerful biological catalysts that are responsible for the chemical reactions 
of metabolism, among other functions. Enzymes are folded proteins with specific shapes 
that are able to bind other molecules and alter them in precise ways. A subset of enzymes 
called proteases are responsible for digesting proteins into smaller peptides. They 
accomplish this by cleaving the amide bond between amino acid residues in the protein. 
Many proteases are specific, and preferentially cleave bonds adjacent to certain amino 
acids based on the ways they interact with the binding “pocket” of the enzyme. This 
function will be assesed through the current experiment. 
Goal 
The Tripeptide-ACC molecules made during previous lab sessions will be employed in 
this experiment. The cleavage of the peptide-ACC bond liberates the ACC molecule, 
which fluoresces. When excited at 365 nm, it fluoresces with an emission wavelength of 
445 nm. Microplate fluorimeters can constantly excite samples at a given wavelength, 
and motitor emission over time to give quantitative data. Using this instrument and the 
peptide-ACC substrates, it is possible to differentiate proteases based on their cleavage 
sites. The synthetic peptides have either lysine (sensitive to trypsin), tyrosine (sensitive 
to chymotrypsin), or alanine (inert) in the P1 position relative to the ACC moiety. 
Fluorescence will be recorded after addition of enzymes trypsin, chymotrypsin, and the 
absence of either using the fluorescence of peptide-ACC substrates. These experiments 
should be run at saturating substrate concentrations to give maximum rates, allowing the 
results to be observed within a short minute time span. 
Materials 
• Microplate fluorimeter 
• 96-well plates 
• Synthetic tripeptide-ACC substrates from previous experiment 
• DMSO 




• Buffered solution of trypsin 
• Buffered solution of Chymotrypsin 
• ACC standard 
• Micropipettes  
• Microsoft Excel 
Methods 
A. Calculations 
Begin by creating stock solutions of the synthetic tripeptide-ACC substrates in DMSO. 
Answer the following questions to help guide you through the dilution calculations. 
Have TA check calculations before creating the solution. 
 
a. Write the abbreviated name and chemical structure of the tripeptide-ACC 
molecules your group designed and synthesized. 
 
b. What is the molecular weight of your tripeptide-ACC compound? Tip: an online 
peptide mass calculator can accelerate the process. 
 
c. Based on the mass of tripeptide-ACC you synthesized, how many moles are 
present?  
 
d. Using this amount of peptide, what total volume of solution is required to yield 
10 mM tripeptide-ACC in DMSO?  
 
Using these concentrations as the stock solutions, calculate the volume needed to aliquot 





e. How many μL of the 10 mM stock solution and how many μL of buffer/protease 
mixture should you add to each well to yield 500 µM tripeptide-ACC in each 
100 μL well? 
 
 
µL of 10 µM stock:___ ______                  µL of buffer solution:_________ 
 
B. Fluorescence assay 
 
a. Fill each well with a total volume of 100 µL.  
b. To each well, add 95 µL buffer/protease mixture. 
c. To each well, add 5 µL of the 10mM tripeptide-ACC in DMSO stock solution, 
such that the total concentration of substrate is 500 µM, as calculated 
previously.   
d. In addition to the wells containing both enzyme and substrate, prepare wells 
for each substrate without enzyme, so that any uncatalyzed hydrolysis of the 
tripeptides can be monitored. Also prepare wells of only ACC standard, only 
DMSO solution, only enzyme, and only tripeptide-ACC to be used as controls.  
e. Fluorescence (excitation, 360 nm; emission, 445 nm) will be measured at 25° 
C for 21 readings (approximately 1 minute each).  
 
C. Data analysis 
 
Using Microsoft Excel, analyze data for all Tripeptide-ACC variants and enzyme 
conditions, (not just the two peptides designed by your group).  
a. Once the excel data has been distributed, compare the cells and well 




b. Since samples were run in triplicate, average the triplicates to get the mean 
value for each time point. It is important to note that there are two versions of 
each Tripeptide-ACC type.  
c. Create fluoresence (y) vs time (x) scatterplots from the fluoresence data for 
each protease. Graph the flourescence results from all 3 Tripeptide-ACC 
versions (P1-Ala-ACC, P1-Lys-ACC, P1-Tyr-ACC) treated with the same 
protease and the blank on the same graph.  
d. Include legends to identify the data, graph titles, and axis titles with units. Since 
the values plotted are mean readings, include custom error bars for the min 
(difference between the mean and smallest reading in the set) and max 
(difference between the mean and the largest value in the set) for each time 





























A Reagent for the Detection of Reducing Sugars 
Stanley R. Benedict 





The Composition of Reducing Sugars in Solution 
Stephen Angyal 








Carbohydrates assume many central biochemical functions including structural support 
of DNA and RNA, composition of coenzymes, and storage of energy. Monosaccharides, 
the single sugar units, can be polymerized to create larger saccharides ranging from 
disaccharides to high molecular weight polysaccharides. Chemical tests can be used to 
broadly categorize and differentiate carbohydrates based on structural differences. These 
tests are often colorimetric—qualitative tests based on a change in color. For example, 
Fehling’s test is a classic colorimetric test which produces a red-brown cuprous oxide 
precipitate in the presence of aldehydes. Thus, it can be used to quickly differentiate 
reducing sugars from nonreducing sugars.  
Objectives 
The purpose of this experiment is to observe the outcomes of various chemical tests on 
carbohydrate substrates and employ those tests to determine the identity of two unknown 
carbohydrate samples. Initially, each of the known saccharide compounds will be tested 
with each qualitative test, and observations should be recorded appropriately. 
Observations should be related to the structure of the saccharide tested. Once a 
familiarity with the tests is established, two unknowns will be tested and identified as 
specifically as the data allows.  
Materials 
• Saccharide knowns: 1 M glucose, 1 M fructose, 1 M maltose, 1 M sucrose, 1 M 
ribose, and soluble starch 
• Molisch’s reagent (10% α-naphthol in ethanol) 
• Concentrated sulfuric acid 
• Fehling’s solution A (aqueous CuSO4) 
• Fehling’s solution B (aqueous solution of potassium sodium tartrate) 
• Barfoed’s reagent (cupric acetate in acetic acid) 
• Seliwanoff’s reagent (resorcinol in HCl/H2O) 
• Bial’s reagent (Orcinol, HCl, ferric chloride) 
• Concentrated HCl 
• Litmus paper 




• Iodine solution 
• Hot water bath (150 mL beaker half full of water on hotplate with 2 boiling chips) 
• Unknown carbohydrates 
• Small test tubes and rack 
• Pasteur pipettes 
• Rubber pipet bulbs 
• Graduated cylinder 
Methods 
1. Obtain approximately 10-15 mL of each known saccharide from the dispensing 
area.  
2. Label clean, dry test tubes and place them in the test tube rack. 
3. Perform each of the following tests on each of the unknowns, as indicated in the 
data table. NOTE: exceptions are marked with an “X”, and do not need to be 
performed 
4. It is crucial to perform a control for each test. This should be done by using water 
instead of the saccharide solutions for each test. Use this control as a comparison 
for each colorimetric test.  
5. After testing all the known compounds, acquire 2 unknown saccharide solutions to 
identify.  
6. Perform all necessary tests on the unknown compounds. It is not necessary to 
perform every test, but make sure to collect enough data to have ample evidence 
for the identification of each unknown.  
7. Answer all discussion questions.  
 
Molisch’s Test: 
A sensitive test for all carbohydrates (and some compounds functionalized with 
carbohydrates), Molisch’s test is a tandem acid-catalyzed dehydration followed by 
condensation of the resulting aldehyde with naphthol to produce a red to purple color. 
NOTE: The appearance of a brown color is due to charring. In the case of charring, repeat 




1. Add 1 mL DI water and 5 drops of known sugar solution to each respective test 
tubes. 
2. Add 1 drop of Molisch’s reagent.  
3. Carefully pour 1 mL of concentrated sulfuric acid (CAUTION: corrosive) down the 
side of the tube. It should form a layer at the bottom of the tube. 
4. Observe the color at the interface between the layers, and record results.  
Fehling’s Test: 
Together, Fehling’s solutions A and B react with reducing sugars to produce a red-brown 
precipitate of copper(I) oxide. The sugars are oxidized in the process of reducing Cu2+ to 
Cu+, acting as a reducing agent like their names suggest. 
1. Add approximately 1 mL of solution B to 1 mL of solution A in a small test tube.  
2. To this mixture, add 1 mL DI water and 1 mL of each sugar solution. 
3. Observe the reaction for a few minutes, then record the results in the data table.  
Barfoed’s Test: 
Barfoed’s reagent is balanced so that it can only be reduced by monosaccharides. Some 
disacchrades may also be reduced, but the reaction takes much longer. The reaction 
reduces copper (II) acetate to copper(I) oxide. Since the product is the same as Fehliing’s 
test, a positive reaction should produce a brick red precipitate.  
1. Add 2 mL of Barfoed’s reagent, 1 mL DI water, and 1 mL sugar solution to each 
test tube. 
2. Heat in a water bath (100° C) for 5 minutes and let stand.  
3. Observe the color and record.  
Seliwanoff’s test: 
Seliwanoff’s test is a simple way of distinguishing aldoses from ketoses. It relies of the 
fact that ketoses more rapidly dehydrate than aldoses when heated. Ketoses should 
quickly produce a red color, while aldoses may slowly form a lighter pink hue.  
1. Add 1 mL of saccharide solution to 3 mL Seliwanoff’s reagent. 
2. Heat in a water bath (100° C). 
3. Ketoses will produce the red color within 1 minute. If the red color does not appear, 




4. Make observations and record them in the data table. 
Bial’s Test: 
Pentoses can be identified with Bial’s test, which relies on the dehydration of pentoses to 
dehydrate to furfural and then react with orcinol. A positive test will result in a blue color, 
and potentially a precipitate. 
1. Add 2 or 3 drops of saccharide solution to 5 mL Bial’s reagent. 
2. Heat in a water bath (100° C) for approximately 1 minute. 
3. Record observations.  
Inversion of Sucrose:  
Sucrose, a disaccharide, can be hydrolyzed into a mixture of its monosaccharide 
constituents. This hydrolysis can be accomplished with only water and heat but is 
accelerated by acid.  Once inverted, the mixture of monosaccharides can be subjected to 
other colorimetric tests. 
1. Obtain clean test tubes and add 1 mL DI water and 2 mL sugar solution to each.  
2. Add 3 drops of concentrated HCl.  
3. Heat in a water bath (100° C) for 10 minutes. 
4. Cool solution and add 1 M NaOH until neutral. Monitor the pH with litmus paper.  
5. Perform Barfoed’s test on the resulting solutions. 
6. Record results. 
Iodine Test: 
Iodine can indicate the presence of starch (polysaccharides) by producing a blue-black 
color.  
1. Add 1-2 drops of iodine solution to 2-3 mL of saccharide solution.  














































































































































1. What are the identities of your two unknowns? Make sure to explain your 
reasoning and to avoid making assumptions. Be as specific as possible based on 





2. Draw the chemical structure of maltose and use it to explain the result that 





3. Could sucrose be differentiated from lactose based on these colorimetric tests 





4. In the required reading, you learned about Benedict’s test for reducing sugars. 






























Structural identification of autoinducer of Photobacterium fischeri luciferase 









N-acyl-L-homoserine lactones (AHLs) are a class of signaling molecules involved in 
various signal transduction pathways across many species of bacterial microorganisms.  
 
They are responsible for signaling many changes in gene expression that can impact 
various phenotypes including biofilm formation, bioluminescence, and production of 
pigments. The AHL signaling pathways are an example of quorum sensing, a 
stimuli/response system that depends on population density. As the bacteria grow, they 
produce AHL signaling molecules (also called autoinducers) and release them into the 
environment. Once microbial communities achieve the population density threshold, 
which is determined by the extracellular concentration of the autoinducers, the pathways 
are activated and the signaling cascade produces the desired phenotype. Generally, 
these phenotypes are expressed through quorum sensing because they are 






Synthetic AHLs can be used to artificially modulate these phenotypes, and to help study 
the signaling pathways. The synthesis of the homoserine lactone portion of the AHL can 
be achieved through the proteolytic action of cyanogen bromide (CNBr) on the methionine 
residue of a peptide. The acyl tail of the AHLs can be added with traditional amide-forming 
chemistry identical to those used in solid-phase peptide synthesis.  
Objectives 
The C8 AHL will be synthesized, and later used to modulate the expression of 
luminescence in bacterial cultures. The synthesis protocol is unique for two reasons: it 
features a solid support and uses a microwave synthesizer. The use of a solid support 
allows the purification steps between reactions to be minimized. Additionally, the use of 
a microwave synthesizer drastically cuts reaction times and may allow milder conditions. 
Both techniques also serve to alleviate the environmental impact of the synthesis.   
Materials 
• Aminomethyl polystyrene resin 
• Fmoc-L-methionine 
• Chloroform (CHCl3) 
• Diisopropyl carboimide (DIC) 
• Hydroxybenzotriazole (HOBT) 




• Dimethylformamide (DMF) 
• Octanoic acid 
• 1.5 M cyanogen bromide (CNBr) in chloroform (cleavage solution A) 
• 1% trifluoroacetic acid (TFA) in water (cleavage solution B) 
• 25% piperidine in DMF 
• Diisopropylethylamine (DIPEA) 
• Microwave (MW) synthesis vials 
• Filter funnels and filter flasks 
• Ethanol (EtOH) 
• Magnesium sulfate 
• Deuterated chloroform (CDCl3) for NMRs 
• NMR Tube 




1. Weigh 100 mg of aminomethyl resin and place it in a reaction vial. 
2. Add a few drops of CHCl3 (such that the resin is just covered by solvent) and allow 
the resin to swell for 10 minutes.  
3. To a separate round-bottom flask, add approximately 3 mL DMF along with 129 
mg Fmoc-L-methionine, 54 mg HOBT, and 73 µL DIC. Allow activation by stirring 
for 10 minutes at room temperature.  
4. Add the activated solution of Fmoc-L-methionine to the swelled resin. 
5. Equip the reaction vial with a stir bar and cap it. 
6. Irradiate the reaction according to the following parameters: 10 min at 50 °C. 
7. Filter the resin and wash with approximately 5 mL each of DMF, water, EtOH, and 
DCM and dried in vacuo.  
8. To deprotect, place the dried resin into a clean MW flask in 1-1.5 mL of 25% 




9. Filter the resin and wash with 3 times with 5 ml of DMF. 
10. To a clean microwave vial with stir bar, add the dried resin (approx. 100 mg) and 
swell with a minimal amount of CHCl3 (approximately 0.5 mL) for 5 min. 
11. In a separate vial, prepare a mixture of 0.344 mmol fatty acid (49.6 mg or 54.5 µL 
octanoic acid), and 0.5 mmol DIC (78 uL) in 2 mL DMF.  
12. Activate by stirring at room temperature for 5 minutes.  
13. Add the activated solution of fatty acid to the swelled resin and irradiate (hold for 
10 minutes at 50 °C). 
14. Filter the resin and wash 2x with 20 mL each of DMF, Water, EtOH, and DCM.  
15. Dry the resin in vacuo (stop here at the end of week 9). 
16. To cleave the AHL from the resin, 3 mL of cleavage solution (5:2 1.5M CNBr to 1% 
TFA) is added to the resin in a clean MW vial. 
17. Irradiate (30 min at 60 °C). 
18. Filter the resin and collect the filtrate.  
19. Add 5 ml CHCl3 and wash the organic layer 3x with water 10 mL each). Dry over 
magnesium sulfate.  
20. Concentrate in vacuo to yield the AHL as a white powder.  
21. Once the product is dry, dissolve a small amount in CDCl3 and transfer to NMR 
tube. 







Week 10b: Chemical signaling: Modulation of luminescence using synthetic 





Shedding light on bioluminescence regulation in Vibrio fischeri 





Modeling Analysis of Signal Sensitivity and Specificity by Vibrio fischeri LuxR Variants 









N-acyl-L-homoserine lactones (AHLs) are a class of signaling molecules involved in 
various signal transduction pathways across many species of bacterial microorganisms. 
In wild type bioluminescent Gram-negative bacterium Vibrio fischeri, sufficiently high 
bacteria density triggers the expression of a set of genes called the lux operon189. These 
genes induce bioluminescence when active. In wild type, 3-oxohexanoyl-homoserine 
lactone (3OC6-AHL) and C8-AHLs are the primary quorum sensing signals for V. fischeri, 
allowing them to sense cell density and trigger bioluminescence. From an enzymatic point 
of view, bioluminescence is brought on by the enzyme luciferase, which catalyzes the 
oxidation of a luciferin, causing it to produce this visible glow. During this lab, the C8-AHL 
synthesized in the previous week will be used to modulate luminescence in V. fischeri 
DC22, a mutant strain of which lacks the ability to produce its own AHL but responds to 
exogenous C8-AHL. If laboratory synthesis of C8-AHL was successful, addition to the 
DC22 mutant V. fischeri should result in bioluminescence. 
Objectives 
The C8 AHL synthesized during week 1 will be used to modulate the expression of 
bioluminescence in V. fischeri bacterial cultures. Multiple concentrations of AHL will be 
run in order to produce a dose-response curve, and all samples will be run in duplicates. 
Overnight cultures of DC22 will be incubated in wells of a 96-well plate with varying 
concentrations of AHLs, and luminescence will be monitored over time.  
Materials 
• V. fischeri cultures 
• YTSS Media (per liter: 4g tryptone, 2.5g yeast extract, 15g Sea Salts) 
• Octanoy-L-homoserine lactones (C8-AHLs) synthesized by the previous procedure 
• 96 Well Plate with clear bottom 






• Microsoft Excel 
Methods 
1. NOTE: 1:100 V. fischeri cultures diluted into sterile YTSS media will be prepared by 
the stockroom. 
2. Each AHL treatment will be run in duplicate. The treatments are 0 µM, 2.5 µM, 5 µM, 
and 10 µM AHL in V. fischeri culture (final concentrations).  
• 90 μL of a solution containing 1:100 of V. fischeri culture : YTSS media, and  
• 10 μL of AHL solutions 
 
A. Calculations 
The two 0 µM AHL wells will be loaded with 100 µL of 1:100 of V. fischeri culture : YTSS 
media solution. Each of the AHL containing sample wells will be loaded with 90 μL of 
1:100 V. fischeri  : YTSS media solution and 10 μL of AHL solution.  
 
Using the following questions as a guide, make a 10 mM stock solution of C8-AHL, then 
dilute aliquots of the stock solution with DMSO to concentrations of 100 μM, 50 μM, and 
25 μM. Note: The molecular weight of C8-AHL is 227.30 g/mol.  
 





b) Using the synthetic C8-AHL, what total volume is required to yield a 10 mM 








Calculate the dilutions required to give 10 μM, 5 μM, and 2.5 μM solutions of C8-AHL. 
Hint: Use the dilution equation M1V1=M2V2 
c) What volumes of the 10 mM stock solution and of DMSO should be used to 
make 1 mL of 10 µM AHL? 
d) How many µL of the 100 µM solution should be used to make 1mL 50 µM 
solution?  
e) How many µL of the 50 µM solution should be used to make 1mL of 25 µM 
solution?  
f) Calculate the volume of each AHL solution required for achieving the desired 
final concentrations in each well. 
 
B. Assay 
1. Obtain approval from the TA before proceeding with these dilution steps, as 
incorrect calculations will lead to faulty experimental results.  
2. Based on the calculations above, prepare 10 mM a stock solution of C8-AHL. 
Swirl the DMSO around the flask to ensure all AHL has been dissolved.  
3. Based on the above calculations, prepare the three solutions of C8-AHL (100 
µM, 50 µM and 25 µM) using serial dilutions. 
• First prepare the 100 µM solution  
• Dilute and aliquot of the 100 µM dilute solution to prepare the 50 µM 
solution  
• Lastly, using an aliquot of the 50 µM solution, prepare the 25 µM solution  
4. To each control well, add 100 µL of 1:100 of V. fischeri culture : YTSS media 
solution. 
5. To each well containing AHL sample, add 90 µL of prepared 1:100 fischeri : 
YTSS solution. Use the same tip for all wells. 
6. To each well containing AHL sample, add 10 µL of the desired dilute AHL 
sample to its designated well. Change tips between dilution types, and pre-wet 




7. Place plate in Biotech Synergy HTX microplate reader. 
8. Incubate at 24 °C while shaking 200 rpm.  
9. Measure luminescence every 30 min for 5 h  
10.  Record optical density (OD) at 595 nm/600 nm for each time point to provide 
a set of metadata for normalizing the luminescence values.  
 
C. Data Analysis 
1. Once the excel data has been distributed, compare the cells and well 
assignments on the spreadsheet to the layout of the well plate used in lab.  
2. Each group will only analyze the data from their own wells. 
3. Normalize to cell density by dividing peak luminescence by OD600 
4. Create a scatterplot from the normalized luminescence data. Show increase in 
luminescence on the y-axis vs. time (min) on the x-axis. Graph the flourescence 
results from all 4 treatments (0 µM, 10 µM, 5 uM, and 2.5 µM) as well as the 
controls on the same graph.  
5. Make sure to include a legend to identify the data; graph title; axis titles and 
units; and since we are averaging measurements, include standard error bars 
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